syndrome	score	normalized_score
#113100 BRACHYDACTYLY, TYPE C; BDC;;BRACHYDACTYLY, HAWS TYPE	17.563730239999998	100.0
#112500 BRACHYDACTYLY, TYPE A1; BDA1;;FARABEE-TYPE BRACHYDACTYLY	5.35566144	30.492733416065043
MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA	5.1266428500000005	29.188804314043036
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 2	4.1534091	23.647647983917114
SPONDYLOPERIPHERAL DYSPLASIA	3.55091243	20.217302255719456
POSTAXIAL OLIGODACTYLY, TETRAMELIC	3.3569801999999997	19.1131391460041
TRICHORHINOPHALANGEAL SYNDROME, TYPE I	3.2604167	18.56334990032277
606895 SYMPHALANGISM, DISTAL, WITH MICRODONTIA, DENTAL PULP STONES, AND NARROWEDZYGOMATIC ARCH	3.0451374999999996	17.337646720768582
BRACHYDACTYLY, TYPE A2; BDA2	2.76657544	15.751639328297953
#186500 MULTIPLE SYNOSTOSES SYNDROME 1; SYNS1;;SYNOSTOSES, MULTIPLE, WITH BRACHYDACTYLY;;SYMPHALANGISM-BRACHYDACTYLY SYNDROME;;WL SYNDROME;;DEAFNESS-SYMPHALANGISM SYNDROME OF HERRMANN;;FACIOAUDIOSYMPHALANGISM SYNDROME	2.69432254	15.340263732039647
SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS	2.6873634400000004	15.30064173884739
ACROMESOMELIC DYSPLASIA, HUNTER-THOMPSON TYPE	2.6720278	15.213327485038853
259610 OSTEOLYSIS SYNDROME, RECESSIVE;;OSTEOLYSIS, DISTAL, WITH SHORT STATURE, MENTAL RETARDATION, AND CHARACTERISTICFACIAL APPEARANCE	2.5639655999999995	14.598069800461703
ACROCAPITOFEMORAL DYSPLASIA; ACFD	2.52504134	14.376452527433035
SPONDYLOEPIPHYSEAL DYSPLASIA-BRACHYDACTYLY AND DISTINCTIVE SPEECH	2.44746406	13.934762300243575
FRONTOMETAPHYSEAL DYSPLASIA	2.42716457	13.819186111571707
ACHEIROPODY ACHEIROPODIA ACHEIROPODY, BRAZILIAN TYPE	2.4	13.664523237405405
#615072 BRACHYDACTYLY, TYPE A1, C; BDA1C	2.273975	12.9469934286579
LACRIMOAURICULODENTODIGITAL SYNDROME; LADD	2.26080119	12.871987664961997
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	2.194284562	12.493271827887058
#201000 CARPENTER SYNDROME 1; CRPT1;;CARPENTER SYNDROME;;ACROCEPHALOPOLYSYNDACTYLY TYPE II;;ACPS II	2.1761532199999998	12.390040101185248
272150 SUGARMAN BRACHYDACTYLY;;BRACHYDACTYLY WITH MAJOR PROXIMAL PHALANGEAL SHORTENING	2.166667	12.336029820508108
SPONDYLOMEGAEPIPHYSEAL DYSPLASIA WITH UPPER LIMB MESOMELIA, PUNCTATECALCIFICATIONS, AND DEAFNESS	2.10075883	11.96077827029983
PSEUDOACHONDROPLASIA	2.0942612	11.923783680248555
HAIM-MUNK SYNDROME	2.0811595	11.849188478540423
SINGLETON-MERTEN SYNDROME 1; SGMRT1	2.0764706200000003	11.822492099491507
NECROTIZING ENCEPHALOMYELOPATHY, SUBACUTE, OF LEIGH, ADULT	2.0666667	11.76667297755081
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	2.0623194600000003	11.741921743384738
VAN DEN ENDE-GUPTA SYNDROME; VDEGS	2.05167324	11.68130694314285
MARSHALL-SMITH SYNDROME; MRSHSS	2.0481072399999998	11.661003739032603
#101400 SAETHRE-CHOTZEN SYNDROME; SCS;;ACROCEPHALOSYNDACTYLY, TYPE III; ACS3;;ACS III;;CHOTZEN SYNDROME;;ACROCEPHALY, SKULL ASYMMETRY, AND MILD SYNDACTYLYSAETHRE-CHOTZEN SYNDROME WITH EYELID ANOMALIES, INCLUDED;;BLEPHAROPHIMOSIS, EPICANTHUS INVERSUS, AND PTOSIS 3, FORMERLY, INCLUDED;BPES3, FORMERLY, INCLUDED	2.0392067000000003	11.610328057509498
HAND OSTEOARTHRITIS	2.0294118	11.554560291401971
185750 SYMPHALANGISM WITH MULTIPLE ANOMALIES OF HANDS AND FEET	2.0138321	11.46585646945122
%164900 OPHTHALMOMANDIBULOMELIC DYSPLASIA;;OMM SYNDROME	2.0	11.387102697837838
#218600 BALLER-GEROLD SYNDROME; BGS;;CRANIOSYNOSTOSIS WITH RADIAL DEFECTS;;CRANIOSYNOSTOSIS-RADIAL APLASIA SYNDROME	1.97529486	11.246442714665607
#276820 ULNA AND FIBULA, ABSENCE OF, WITH SEVERE LIMB DEFICIENCY;;LIMB/PELVIS-HYPOPLASIA/APLASIA SYNDROME; LPHAS;;AL-AWADI/RAAS-ROTHSCHILD SYNDROME; AARRS;;SCHINZEL PHOCOMELIA SYNDROME	1.93967873	11.043660449660836
FIBULAR APLASIA OR HYPOPLASIA, FEMORAL BOWING AND POLY-, SYN-, AND OLIGODACTYLY	1.8976717	10.804491267340259
#108145 ARTHROGRYPOSIS, DISTAL, TYPE 5; DA5;;ARTHROGRYPOSIS WITH OCULOMOTOR LIMITATION AND ELECTRORETINAL ABNORMALITIES;;OCULOMELIC AMYOPLASIA;;ARTHROGRYPOSIS, DISTAL, TYPE IIB; DAIIB	1.8562377700000001	10.568585059297748
CAMPTODACTYLY-ARTHROPATHY-COXA VARA-PERICARDITIS SYNDROME	1.833333	10.438175575167568
113450 BRACHYDACTYLY-DISTAL SYMPHALANGISM SYNDROME	1.7417425	9.91670036034441
#311300 OTOPALATODIGITAL SYNDROME, TYPE I; OPD1;;OPD I SYNDROME;;OPD SYNDROME 1OTOPALATODIGITAL SPECTRUM DISORDER, INCLUDED;;FRONTOOTOPALATODIGITAL OSTEODYSPLASIA, INCLUDED	1.72639437	9.829314994079526
BASAL CELL NEVUS SYNDROME	1.6704938800000002	9.5110426838348
COFFIN-SIRIS SYNDROME 1; CSS1	1.6643470919999999	9.47604563072588
ARTHROGRYPOSIS, DISTAL, TYPE 1A; DA1A	1.6181239299999999	9.212871684369482
SYNDACTYLY, TYPE V	1.5921189	9.064810710734307
BRACHYDACTYLY, TYPE A1, D	1.5696242199999997	8.936736095076805
SYNPOLYDACTYLY 1	1.5665754399999998	8.91937770959525
ARTHROPATHY, PROGRESSIVE PSEUDORHEUMATOID, OF CHILDHOOD	1.5532213000000001	8.843345227784598
WT LIMB-BLOOD SYNDROME	1.55121207	8.83190557360781
#174500 POLYDACTYLY, PREAXIAL II; PPD2;;POLYDACTYLY OF TRIPHALANGEAL THUMB;;TRIPHALANGEAL THUMB-POLYDACTYLY SYNDROMETRIPHALANGEAL THUMB WITH POLYSYNDACTYLY, INCLUDED;;TRIPHALANGEAL THUMB-POLYSYNDACTYLY SYNDROME, INCLUDED;;TPT-PS SYNDROME, INCLUDED;;TRIPHALANGEAL THUMB, INCLUDED; TPT, INCLUDED	1.5496952	8.823269196373174
EPIPHYSEAL DYSPLASIA, BAUMANN TYPE	1.5462134399999998	8.803445617028562
SYNDACTYLY, TYPE IV; SDTY4	1.537037	8.751199084688288
#150250 LARSEN SYNDROME; LRS	1.52677587	8.692776814135357
#228900 FIBULAR HYPOPLASIA AND COMPLEX BRACHYDACTYLY;;DU PAN SYNDROME	1.5247024	8.680971406219912
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	1.50127551	8.547589205059438
%601356 LETHAL SHORT-LIMB SKELETAL DYSPLASIA, AL GAZALI TYPE	1.5	8.540327023378378
120400 COLOBOMA OF MACULA WITH TYPE B BRACHYDACTYLY;;APICAL DYSTROPHY;;SORSBY SYNDROME	1.4678571	8.357319771725214
METAPHYSEAL ACROSCYPHODYSPLASIA	1.45198534	8.266953091167494
MUCOLIPIDOSIS III ALPHA/BETA	1.4117060000000001	8.037620600576933
#186570 TARSAL-CARPAL COALITION SYNDROME; TCC; SYNOSTOSIS OF TALUS AND CALCANEUS WITH SHORT STATURE, INCLUDED	1.4043149	7.9955389932019365
IVIC SYNDROME	1.3995884	7.968628422751273
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	1.3944740700000002	7.939509722280956
Jawad syndrome	1.393000382	7.93111920398067
%112440 BRACHYDACTYLY, COMBINED B AND E TYPES;;PITT-WILLIAMS BRACHYDACTYLY;;BRACHYDACTYLY, BALLARD TYPE	1.372997	7.817228921411629
#304120 OTOPALATODIGITAL SYNDROME, TYPE II; OPD2;;OPD II SYNDROME;;OPD SYNDROME 2;;CRANIOORODIGITAL SYNDROME;;FACIOPALATOOSSEOUS SYNDROME; FPO	1.37267817	7.8154136464350525
%211960 CAMPTODACTYLY WITH MUSCULAR HYPOPLASIA, SKELETAL DYSPLASIA, AND ABNORMALPALMAR CREASES;;TEL HASHOMER CAMPTODACTYLY SYNDROME	1.36501664	7.77179233196877
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	1.361517422	7.751869354604708
SYNOSTOSIS, CARPAL, WITH DYSPLASTIC ELBOW JOINTS AND BRACHYDACTYLY	1.3283919	7.563267494137965
BRACHYDACTYLY, TYPE A6	1.3257976	7.548496713873466
CRANIOSYNOSTOSIS, ADELAIDE TYPE	1.3214283	7.523619879964634
MESOMELIA-SYNOSTOSES SYNDROME	1.31435874	7.483368977090371
CLEIDOCRANIAL DYSPLASIA; CCD	1.29918984	7.397004066033755
Muenke syndrome	1.2940444720000002	7.367708649116671
#100800 ACHONDROPLASIA; ACH	1.2863727900000002	7.324029533717094
BRACHYDACTYLY, MONONEN TYPE	1.2625	7.1881085780101355
260150 PALANT CLEFT PALATE SYNDROME	1.25662252	7.154644843827891
POLYDACTYLY, PREAXIAL IV; PPD4	1.25	7.116939186148649
#108721 ATELOSTEOGENESIS, TYPE III; AOIII;;AO3	1.25	7.116939186148649
ACROMESOMELIC DYSPLASIA, DEMIRHAN TYPE; AMDD	1.2449896	7.088412216470026
CATEL-MANZKE SYNDROME; CATMANS	1.224739462	6.973117015944331
TOWNES-BROCKS SYNDROME 1; TBS1	1.198345722	6.822842901964315
COFFIN-LOWRY SYNDROME; CLS	1.18864823	6.7676297333065865
ARTHROGRYPOSIS, DISTAL, TYPE 2A	1.18709625	6.758793455484089
SPLIT-HAND/FOOT MALFORMATION WITH LONG BONE DEFICIENCY 1	1.18254	6.732852212150578
#200700 CHONDRODYSPLASIA, GREBE TYPE;;ACHONDROGENESIS, BRAZILIAN;;GREBE CHONDRODYSPLASIA;;GREBE DYSPLASIA;;ACROMESOMELIC DYSPLASIA, GREBE TYPE; AMDG;;ACHONDROGENESIS, TYPE II, FORMERLY	1.1698009	6.660321492161565
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	1.1568223	6.586427166624487
ELLIS-VAN CREVELD SYNDROME	1.1555152	6.578985125656314
ROBERTS SYNDROME; RBS	1.1318608900000002	6.4443080970480695
RADIAL RAY HYPOPLASIA WITH CHOANAL ATRESIA	1.1181818	6.366425495726584
#102500 HAJDU-CHENEY SYNDROME; HJCYS;;ACROOSTEOLYSIS WITH OSTEOPOROSIS AND CHANGES IN SKULL AND MANDIBLE;;CHENEY SYNDROME;;ARTHRODENTOOSTEODYSPLASIA;;SERPENTINE FIBULA-POLYCYSTIC KIDNEY SYNDROME; SFPKS	1.11380143	6.3414856342043215
%252100 MOHR SYNDROME;;OROFACIODIGITAL SYNDROME II; OFD2;;OFDS II;;ORAL-FACIAL-DIGITAL SYNDROME, TYPE II	1.11024632	6.321244432868266
#252500 MUCOLIPIDOSIS II ALPHA/BETA;;MUCOLIPIDOSIS II; ML II;;ML II ALPHA/BETA;;I-CELL DISEASE; ICD	1.099140912	6.25801522216957
#231050 GELEOPHYSIC DYSPLASIA 1; GPHYSD1	1.0941517420000002	6.2296091265860865
263540 POLYDACTYLY, POSTAXIAL, WITH DENTAL AND VERTEBRAL ANOMALIES	1.09357701	6.226336860432218
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	1.092803	6.221929994752641
601957 ODONTOTRICHOUNGUAL-DIGITAL-PALMAR SYNDROME;;OTUDP SYNDROME	1.0886405	6.198230587262766
MARTSOLF SYNDROME	1.0717319900000002	6.101961117344058
RAPADILINO SYNDROME	1.0673095	6.076781443438977
TEMPLE-BARAITSER SYNDROME; TMBTS	1.067035052	6.075218859658369
TALO-PATELLO-SCAPHOID OSTEOLYSIS, SYNOVITIS, AND SHORT FOURTH METACARPALS	1.0666667	6.073121628631893
BRACHYDACTYLY, TYPE A3	1.06657544	6.07260203513579
OTOSCLEROSIS 7	1.06490139	6.063070745500132
CRANIOSYNOSTOSIS WITH ANOMALIES OF THE CRANIAL BASE AND DIGITS	1.0645162	6.060877646456041
KLIPPEL-FEIL SYNDROME 1, AUTOSOMAL DOMINANT; KFS1	1.0629433	6.051922259539326
DEAFNESS, AUTOSOMAL DOMINANT 1	1.05810013	6.0243474224527835
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	1.056613352	6.015882375565341
#218400 CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL RECESSIVE; CMDR	1.05304925	5.9955899778155555
MESOAXIAL HEXADACTYLY AND CARDIAC MALFORMATION	1.05	5.978228916364865
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	1.04602283	5.955584694746486
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	1.04565678	5.953500570275214
CHROMOSOME 9P DELETION SYNDROME	1.0443461520000001	5.946038442457883
MULTIPLE SYNOSTOSES SYNDROME 2	1.04	5.921293402875676
ACROMICRIC DYSPLASIA	1.0398539	5.920461575023599
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	1.039779492	5.920037929254828
#185800 SYMPHALANGISM, PROXIMAL, 1A; SYM1A;;SYM1;;CUSHING SYMPHALANGISM;;HEREDITARY ABSENCE OF THE PROXIMAL INTERPHALANGEAL JOINTS	1.03942479	5.918018415204264
KEUTEL SYNDROME; KTLS	1.0361266	5.8992400010807735
MULTIPLE EPIPHYSEAL DYSPLASIA WITH ROBIN PHENOTYPE	1.0358173	5.8974789856485526
CHAR SYNDROME	1.035732762	5.896997664204618
311895 PIERRE ROBIN SEQUENCE WITH FACIAL AND DIGITAL ANOMALIES	1.0349516399999998	5.892550305987847
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	1.032422392	5.878149902625697
DEAFNESS, AUTOSOMAL DOMINANT 6	1.03125	5.8714748285726355
100050 AARSKOG SYNDROME, AUTOSOMAL DOMINANT	1.03039164	5.866587711836777
BRACHYDACTYLY, LONG-THUMB TYPE	1.030303	5.866083035445209
#265000 MULTIPLE PTERYGIUM SYNDROME, ESCOBAR VARIANT; EVMPS;;ESCOBAR SYNDROME;;MULTIPLE PTERYGIUM SYNDROME, NONLETHAL TYPE;;PTERYGIUM SYNDROME;;MULTIPLE PTERYGIUM SYNDROME;;PTERYGIUM COLLI SYNDROME;;PTERYGIUM UNIVERSALE	1.0289546600000001	5.858406192419408
#260660 COUSIN SYNDROME;;CRANIOFACIAL DYSMORPHISM, HYPOPLASIA OF SCAPULA AND PELVIS, AND SHORTSTATURE;;PELVISCAPULAR DYSPLASIA	1.02611817	5.842256490953712
EPIDERMOLYSIS BULLOSA, JUNCTIONAL, NON-HERLITZ TYPE	1.0238095	5.829111959761004
CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT; CDPX2	1.0214287400000002	5.815556980451553
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	1.020426672	5.809851654838443
MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	1.0163068	5.7863949520554705
#615226 POLYDACTYLY, POSTAXIAL, TYPE A6; PAPA6	1.0126582	5.765621460603804
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	1.010454562	5.753074934496376
EPIPHYSEAL DYSPLASIA, MULTIPLE, 4	1.0104167	5.752859365255202
MYOPATHY, DISTAL, 1; MPD1	1.00990099	5.749923143889052
#602471 SHORT STATURE, AUDITORY CANAL ATRESIA, MANDIBULAR HYPOPLASIA, ANDSKELETAL ABNORMALITIES; SAMS	1.00934579	5.746762084180132
CHROMOSOME 8q22.1 DUPLICATION SYNDROME	1.00653512	5.730759390210265
PEROXISOME BIOGENESIS DISORDER 11B	1.00641649	5.730083964213745
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	1.00406881	5.716717327582913
MENTAL RETARDATION, X-LINKED 9	1.0038926620000002	5.715714419899905
LIMB-GIRDLE MUSCULAR DYSTROPHY, TYPE 1G; LGMD1G	1.00362319	5.7141801672308095
CARDIOAUDITORY SYNDROME OF SANCHEZ CASCOS	1.0027933	5.709455145901854
ENDOSTEAL HYPEROSTOSIS, AUTOSOMAL DOMINANT	1.00254453	5.708038761132784
#222300 WOLFRAM SYNDROME 1; WFS1;;WFS;;DIABETES INSIPIDUS AND MELLITUS WITH OPTIC ATROPHY AND DEAFNESS; DIDMOAD	1.00254453	5.708038761132784
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	1.00254453	5.708038761132784
SPONDYLO-MEGAEPIPHYSEAL-METAPHYSEAL DYSPLASIA; SMMD	1.00185874	5.704134180553209
COLOBOMA OF MACULA AND SKELETAL ANOMALIES	1.0	5.693551348918919
POROKERATOSIS PUNCTATA PALMARIS ET PLANTARIS	1.0	5.693551348918919
#611390 SPASTIC ATAXIA 3, AUTOSOMAL RECESSIVE; SPAX3;;AUTOSOMAL RECESSIVE SPASTIC ATAXIA WITH LEUKOENCEPHALOPATHY; ARSAL	1.0	5.693551348918919
NEUROFIBROMATOSIS, TYPE III, MIXED CENTRAL AND PERIPHERAL	1.0	5.693551348918919
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	1.0	5.693551348918919
%608645 DEAFNESS, AUTOSOMAL DOMINANT 31; DFNA31	1.0	5.693551348918919
DYSTELEPHALANGY	1.0	5.693551348918919
PARANA HARD-SKIN SYNDROME	1.0	5.693551348918919
SKIN FRAGILITY-WOOLLY HAIR SYNDROME; SFWHS	1.0	5.693551348918919
DEAFNESS, AMINOGLYCOSIDE-INDUCED	1.0	5.693551348918919
KERATOSIS, FOCAL PALMOPLANTAR AND GINGIVAL	1.0	5.693551348918919
MAL DE MELEDA	1.0	5.693551348918919
RADIAL HYPOPLASIA, TRIPHALANGEAL THUMBS, HYPOSPADIAS, AND MAXILLARYDIASTEMA	1.0	5.693551348918919
#148500 TYLOSIS WITH ESOPHAGEAL CANCER; TOC;;KERATOSIS PALMARIS ET PLANTARIS WITH ESOPHAGEAL CANCER	1.0	5.693551348918919
SYMPHALANGISM, C. S. LEWIS TYPE	1.0	5.693551348918919
207620 APHALANGY WITH HEMIVERTEBRAE	1.0	5.693551348918919
139750 HAND AND FOOT DEFORMITY WITH FLAT FACIES	1.0	5.693551348918919
FRASER-LIKE SYNDROME	1.0	5.693551348918919
SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE	1.0	5.693551348918919
RADIAL LOOP, PLAIN, ON RIGHT INDEX FINGER	1.0	5.693551348918919
ANKYLOSING VERTEBRAL HYPEROSTOSIS WITH TYLOSISDIFFUSE IDIOPATHIC SKELETAL HYPEROSTOSIS, INCLUDED	1.0	5.693551348918919
%173800 POLAND SYNDROME;;POLAND SYNDACTYLY;;POLAND ANOMALY;;POLAND SEQUENCEPECTORALIS MUSCLE, ABSENCE OF, INCLUDED	1.0	5.693551348918919
Ullrich congenital muscular dystrophy 1	1.0	5.693551348918919
SECOND METATARSAL-METACARPAL SYNDROME	1.0	5.693551348918919
MACROEPIPHYSEAL DYSPLASIA WITH OSTEOPOROSIS, WRINKLED SKIN, AND AGED APPEARANCE	1.0	5.693551348918919
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.9808617099999999	5.584586512073416
MULTICENTRIC CARPOTARSAL OSTEOLYSIS SYNDROME; MCTO	0.9791663	5.574933608180947
SYNDACTYLY, MESOAXIAL SYNOSTOTIC, WITH PHALANGEAL REDUCTION	0.97707394	5.563020649080523
EPIDERMOLYSIS BULLOSA, LETHAL ACANTHOLYTIC; EBLA	0.933333	5.313979361140541
ACROPECTOROVERTEBRAL DYSPLASIA, F-FORM OF	0.9306466	5.298684204796806
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.918337952	5.228604285373038
BRACHYDACTYLY, TYPE B2	0.9103901299999999	5.183352952703969
Orofaciodigital syndrome XVII	0.90954578	5.17854560262251
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.895833	5.100471185556081
300106 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED;;SEMD, X-LINKED; SEMDX	0.8912851999999999	5.074578052731468
NASODIGITOACOUSTIC SYNDROME	0.8824632	5.024349542731306
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.8723442519999999	4.966736792696265
KOOLEN-DE VRIES SYNDROME; KDVS	0.8375611519999998	4.768697426771682
OMODYSPLASIA 1; OMOD1	0.8365903299999999	4.763170001864023
PALLISTER-HALL SYNDROME	0.8353771119999999	4.75626248288359
302900 CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY AND FRIEDREICH ATAXIA,COMBINED	0.833333	4.74462422624865
OROFACIODIGITAL SYNDROME VI	0.8316513419999999	4.735049620074329
%118651 CHONDRODYSPLASIA PUNCTATA, TIBIA-METACARPAL TYPE;;CHONDRODYSPLASIA PUNCTATA, MT TYPE	0.8166667	4.649733791402162
LERI-WEILL DYSCHONDROSTEOSIS	0.7958337	4.531120036150135
#206920 MICROPHTHALMIA WITH LIMB ANOMALIES;;WAARDENBURG ANOPHTHALMIA SYNDROME;;ANOPHTHALMIA-SYNDACTYLY;;OPHTHALMOACROMELIC SYNDROME; OAS	0.78375683	4.462359756670916
#268310 ROBINOW SYNDROME, AUTOSOMAL RECESSIVE; RRS;;COSTOVERTEBRAL SEGMENTATION DEFECT WITH MESOMELIA, FORMERLY;;COVESDEM SYNDROME, FORMERLYROBINOW SYNDROME, AUTOSOMAL RECESSIVE, WITH APLASIA/HYPOPLASIA OFPHALANGES AND METACARPALS/METATARSALS, INCLUDED;;ROBINOW SYNDROME, AUTOSOMAL RECESSIVE, WITH BRACHY-SYN-POLYDACTYLY,INCLUDED	0.7790823619999999	4.435745433084037
MULTIPLE SYNOSTOSES SYNDROME 3; SYNS3	0.7696078	4.381801527828522
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.764157902	4.3507722537191515
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.74964158	4.26812282901471
EARLOBES, THICKENED, WITH CONDUCTIVE DEAFNESS FROM INCUDOSTAPEDIALABNORMALITIES	0.7	3.985485944243243
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.6781067000000001	3.8608353164959572
SKELETAL DYSPLASIA WITH DELAYED EPIPHYSEAL AND CARPAL BONE OSSIFICATION	0.67623024	3.850151595131764
DESBUQUOIS DYSPLASIA 1	0.6625	3.771977768658784
SYNOSTOSES, TARSAL, CARPAL, AND DIGITAL	0.6615276999999999	3.76644192868223
HAND-FOOT-GENITAL SYNDROME; HFG	0.66049864	3.7605829227311114
DUANE-RADIAL RAY SYNDROME; DRRS	0.6539690199999999	3.7234061959721827
171480 PHOCOMELIA-ECTRODACTYLY, EAR MALFORMATION, DEAFNESS, AND SINUS ARRHYTHMIA;;FACIOAURICULORADIAL DYSPLASIA	0.65021879	3.7020540688969277
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.6491631099999999	3.6960435006089005
#180700 ROBINOW SYNDROME, AUTOSOMAL DOMINANT; DRS;;ROBINOW DWARFISM;;FETAL FACE SYNDROME;;ACRAL DYSOSTOSIS WITH FACIAL AND GENITAL ABNORMALITIES	0.6461052119999998	3.6786332013261434
#607641 NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VIIB; HMN7B;;HMN VIIB;;NEUROPATHY, DISTAL HEREDITARY MOTOR, TYPE VIIB;;DHMN7B;;NEUROPATHY, DISTAL HEREDITARY MOTOR, WITH VOCAL CORD PARALYSIS, TYPEVIIB;;LOWER MOTOR NEURON DISEASE, DYNACTIN TYPE	0.642857	3.6601393395119697
#101200 APERT SYNDROME;;ACROCEPHALOSYNDACTYLY, TYPE I; ACS1;;ACS IAPERT-CROUZON DISEASE, INCLUDED;;ACROCEPHALOSYNDACTYLY, TYPE II, INCLUDED;;ACS II, INCLUDED;;VOGT CEPHALODACTYLY, INCLUDED	0.63768024	3.63066519063094
POLYDACTYLY, PREAXIAL I; PPD1	0.6370370000000001	3.627002870661262
LICHTENSTEIN SYNDROME	0.6308952699999999	3.5920346155350646
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.62713717	3.5706376802106936
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2E; CMT2E	0.626984	3.569765598950579
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.625384332	3.5606578070513573
SYMPHALANGISM, DISTAL	0.611111	3.479391858389189
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.6050448099999998	3.44485369413189
FEINGOLD SYNDROME 1; FGLDS1	0.5972816599999999	3.4006538009775307
CRANIOACROFACIAL SYNDROME	0.583333	3.3212363890189196
#615298 SYMPHALANGISM, PROXIMAL, 1B; SYM1B	0.583333	3.3212363890189196
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.5833159499999999	3.32113931396842
TUKEL SYNDROME	0.573333	3.2643008755297305
LETHAL CONGENITAL CONTRACTURE SYNDROME 10; LCCS10	0.5717703000000001	3.2554035628367757
HOLT-ORAM SYNDROME	0.5681437399999999	3.2347555572568387
SPONDYLOMETAPHYSEAL DYSPLASIA, ALGERIAN TYPE	0.5625	3.2026226337668917
ULNAR HYPOPLASIA WITH MENTAL RETARDATION	0.5625	3.2026226337668917
OMODYSPLASIA	0.5625	3.2026226337668917
CRANIOECTODERMAL DYSPLASIA 1	0.56162018	3.1976133334190857
#156500 METAPHYSEAL CHONDRODYSPLASIA, SCHMID TYPE; MCDS;;SPONDYLOMETAPHYSEAL DYSPLASIA, JAPANESE TYPE	0.5586298	3.1805874513363057
WEILL-MARCHESANI SYNDROME 2; WMS2	0.55524343	3.161306979854867
WEILL-MARCHESANI SYNDROME 1; WMS1	0.55524343	3.161306979854867
SYNDACTYLY, TYPE III	0.5526316	3.1464363916352203
%606242 MENTAL RETARDATION, MICROCEPHALY, GROWTH RETARDATION, JOINT CONTRACTURES,AND FACIAL DYSMORPHISM;;KONDOH SYNDROME	0.55182601	3.141849723604045
MIRAGE SYNDROME; MIRAGE	0.546298382	3.110377889748323
TERMINAL OSSEOUS DYSPLASIA; TOD	0.53844938	3.0656891938235553
TRIPHALANGEAL THUMB WITH DOUBLE PHALANGES	0.537037	3.0576477357693697
CHARGE SYNDROME	0.5348580799999999	3.0452419428641826
VACTERL ASSOCIATION WITH HYDROCEPHALUS	0.5322581	3.0304388232280206
#604864 OSTEOARTHRITIS WITH MILD CHONDRODYSPLASIA	0.5294118	3.014233268023593
LARSEN-LIKE SYNDROME	0.526603072	2.9982416309304467
CHROMOSOME 10q22.3-q23.2 DELETION SYNDROME	0.523817942	2.982384350262032
#611936 CHROMOSOME 3q29 DUPLICATION SYNDROME;;MICRODUPLICATION 3q29 SYNDROME	0.523395992	2.979981956270356
HYPOGLOSSIA-HYPODACTYLIA	0.51913033	2.955695190636223
ADACTYLIA, UNILATERAL	0.5181818	2.9502946863752335
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.5178571	2.9484459902522393
#300831 CK SYNDROME;;MENTAL RETARDATION, X-LINKED, WITH THIN BODY HABITUS AND CORTICALMALFORMATION	0.5150480219999999	2.9324523604161206
138790 GOITER, MULTINODULAR, CYSTIC RENAL DISEASE, AND DIGITAL ANOMALIES;;MULTINODULAR GOITER/CYSTIC RENAL DISEASE/DIGITAL ANOMALIES;;MNG/CRD/DA	0.5126582	2.918845786144345
HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	0.5120482	2.9153727198215043
ACROCALLOSAL SYNDROME; ACLS	0.5119288099999999	2.9146929667259567
DEAFNESS AND MYOPIA; DFNMYP	0.50934579	2.8999864097206727
POTOCKI-LUPSKI SYNDROME	0.506771432	2.885329170257172
#614082 FANCONI ANEMIA, COMPLEMENTATION GROUP G; FANCG	0.50648384	2.883691750437634
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.505869012	2.8801911956488806
SCLEROSTEOSIS 1; SOST1	0.50465204	2.873262303076684
CAMPOMELIC DYSPLASIA	0.50465204	2.873262303076684
#226600 EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE; RDEB;;DYSTROPHIC EPIDERMOLYSIS BULLOSA, AUTOSOMAL RECESSIVE;;EPIDERMOLYSIS BULLOSA DYSTROPHICA, HALLOPEAU-SIEMENS TYPE; EBR1EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE, LOCALISATAVARIANT, INCLUDED;;EPIDERMOLYSIS BULLOSA DYSTROPHICA INVERSA, AUTOSOMAL RECESSIVE, INCLUDED	0.50362319	2.867404492771349
OSTEOGENESIS IMPERFECTA, TYPE XVII; OI17	0.50304878	2.8641340599410166
#253010 MUCOPOLYSACCHARIDOSIS TYPE IVB;;MORQUIO SYNDROME B;;MPS IVB; MPS4B	0.5027933	2.862679471442395
MORQUIO SYNDROME A	0.5027933	2.862679471442395
NEPHROSIS WITH DEAFNESS AND URINARY TRACT AND DIGITAL MALFORMATIONS	0.5027933	2.862679471442395
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 6; CMTX6	0.50254453	2.861263086673324
TRICHOHEPATOENTERIC SYNDROME 1	0.50185874	2.8573585060937488
FANCONI ANEMIA, COMPLEMENTATION GROUP U	0.50127551	2.8540378561405193
STORM SYNDROME	0.5	2.8467756744594594
#200610 ACHONDROGENESIS, TYPE II; ACG2;;ACHONDROGENESIS, LANGER-SALDINO TYPE;;CHONDROGENESIS IMPERFECTA;;ACHONDROGENESIS, TYPE IB, FORMERLYHYPOCHONDROGENESIS, INCLUDED	0.5	2.8467756744594594
ROMBO SYNDROME	0.5	2.8467756744594594
EPIDERMOLYSIS BULLOSA WITH DIAPHRAGMATIC HERNIA	0.5	2.8467756744594594
IMMUNODEFICIENCY 36; IMD36	0.5	2.8467756744594594
SPONDYLOMETAPHYSEAL DYSPLASIA, EAST AFRICAN TYPE	0.5	2.8467756744594594
DEAFNESS, UNILATERAL	0.5	2.8467756744594594
ECTODERMAL DYSPLASIA, TRICHOODONTOONYCHIAL TYPE	0.5	2.8467756744594594
SCALP DEFECTS AND POSTAXIAL POLYDACTYLY	0.5	2.8467756744594594
DEAFNESS, AUTOSOMAL RECESSIVE 102; DFNB102	0.5	2.8467756744594594
EPIDERMOLYSIS BULLOSA SIMPLEX, WEBER-COCKAYNE TYPE	0.5	2.8467756744594594
#601152 HEREDITARY MOTOR AND SENSORY NEUROPATHY VI;;HMSN6;;HMSN VI;;PERIPHERAL NEUROPATHY AND OPTIC ATROPHY;;CHARCOT-MARIE-TOOTH DISEASE, TYPE 6; CMT6	0.5	2.8467756744594594
OSTEOARTHRITIS OF DISTAL INTERPHALANGEAL JOINTS	0.5	2.8467756744594594
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, AUTOSOMAL RECESSIVE	0.5	2.8467756744594594
190410 TRIGGER THUMB	0.5	2.8467756744594594
SPINAL DYSPLASIA, ANHALT TYPE	0.5	2.8467756744594594
DEAFNESS, UNILATERAL, WITH DELAYED ENDOLYMPHATIC HYDROPS	0.5	2.8467756744594594
#200600 ACHONDROGENESIS, TYPE IA; ACG1A;;ACHONDROGENESIS, HOUSTON-HARRIS TYPE	0.5	2.8467756744594594
MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE	0.5	2.8467756744594594
TENDONS, EXTENSOR, OF FINGERS, ANOMALOUS INSERTION OF	0.5	2.8467756744594594
SPONDYLOEPIPHYSEAL DYSPLASIA, STANESCU TYPE	0.5	2.8467756744594594
POLYDACTYLY, POSTAXIAL, TYPE A10; PAPA10	0.5	2.8467756744594594
OSSICULAR MALFORMATIONS, FAMILIAL	0.5	2.8467756744594594
118610 CHONDROCALCINOSIS DUE TO APATITE CRYSTAL DEPOSITION;;FAMILIAL APATITE DISEASE	0.5	2.8467756744594594
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.497983652	2.8352954935841694
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IIB; HSAN2B	0.49761940000000005	2.833221606118223
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE II	0.4833337	2.751885239612972
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.472395212	2.6896063965054386
#133540 COCKAYNE SYNDROME, TYPE B; CSB;;CKN2	0.45872966	2.611800874482117
ANGEL-SHAPED PHALANGOEPIPHYSEAL DYSPLASIA	0.458333	2.609542470404055
#194190 WOLF-HIRSCHHORN SYNDROME; WHS;;CHROMOSOME 4p16.3 DELETION SYNDROME;;PITT-ROGERS-DANKS SYNDROME; PRDS;;PITT SYNDROME	0.45581618199999996	2.595212837885171
SPLIT-HAND/FOOT MALFORMATION 4; SHFM4	0.445767	2.53799730415354
PELGER-HUET ANOMALY; PHA	0.44436932200000007	2.530039552691286
134780 FEMORAL-FACIAL SYNDROME; FFS;;FEMORAL HYPOPLASIA-UNUSUAL FACIES SYNDROME; FHUFS	0.43949252	2.502273230085775
COCKAYNE SYNDROME A; CSA	0.43401052	2.4710611815910015
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.43102535000000003	2.454064962910749
#300845 MOYAMOYA DISEASE 4 WITH SHORT STATURE, HYPERGONADOTROPIC HYPOGONADISM,AND FACIAL DYSMORPHISM; MYMY4;;CHROMOSOME XQ28 DELETION SYNDROME, 3.4-KB;;SYNDROMIC MOYAMOYA DISEASE	0.430709912	2.452269000460349
SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE; SMDS	0.42405269999999995	2.414365822097709
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.42148466	2.399744554491632
250230 METAPHYSEAL CHONDRODYSPLASIA, KAITILA TYPE	0.4207767	2.395713747878651
STUVE-WIEDEMANN SYNDROME	0.4204584	2.39390149048429
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.41898527199999996	2.38551416057276
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.417510882	2.3771196453994277
3MC SYNDROME 1	0.4160005	2.368520207925945
#101600 PFEIFFER SYNDROME;;ACROCEPHALOSYNDACTYLY, TYPE V; ACS5;;ACS V;;NOACK SYNDROMECRANIOFACIAL-SKELETAL-DERMATOLOGIC DYSPLASIA, INCLUDED	0.41432354	2.3589723500558617
#222600 DIASTROPHIC DYSPLASIA;;DTD;;DDDIASTROPHIC DYSPLASIA, BROAD BONE-PLATYSPONDYLIC VARIANT, INCLUDED	0.41166769999999997	2.3438511886413487
SECKEL SYNDROME 1; SCKL1	0.40793165	2.3225797961242205
#219000 FRASER SYNDROME;;CRYPTOPHTHALMOS WITH OTHER MALFORMATIONSCRYPTOPHTHALMOS-SYNDACTYLY SYNDROME, INCLUDED	0.40414674	2.3010302166881837
CAMPTOBRACHYDACTYLY	0.3976187	2.263862485740387
#614976 CARPENTER SYNDROME 2; CRPT2	0.396691862	2.258585485995258
601165 CLEFT LIP/PALATE WITH CHARACTERISTIC FACIES, INTESTINAL MALROTATION,AND LETHAL CONGENITAL HEART DISEASE	0.39642204	2.2570492405831897
NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VA; HMN5A	0.392857	2.2367515022822397
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2D; CMT2D	0.392857	2.2367515022822397
#270685 SPASTIC PARAPLEGIA 17; SPG17;;SPASTIC PARAPLEGIA WITH AMYOTROPHY OF HANDS AND FEET;;SILVER SYNDROME;;SILVER SPASTIC PARAPLEGIA SYNDROME	0.392857	2.2367515022822397
SPASTIC PARAPLEGIA 38, AUTOSOMAL DOMINANT; SPG38	0.392857	2.2367515022822397
EPIPHYSEAL DYSPLASIA, MULTIPLE, 1	0.3874472	2.205950528194858
ARTHROGRYPOSIS, DISTAL, TYPE 2B	0.3874458	2.20594255722297
ARTHROGRYPOSIS, DISTAL, TYPE 4; DA4	0.3855986	2.195425429171247
METAPHYSEAL DYSPLASIA WITH MAXILLARY HYPOPLASIA AND BRACHYDACTYLY	0.3838235	2.1853188061717805
CORNELIA DE LANGE SYNDROME 3	0.38167674200000007	2.173096129265079
#602875 ACROMESOMELIC DYSPLASIA, MAROTEAUX TYPE; AMDMST. HELENA DYSPLASIA, INCLUDED	0.3731576999999999	2.1245925261944807
#215140 GREENBERG DYSPLASIA; GRBGD;;HYDROPS-ECTOPIC CALCIFICATION-MOTH-EATEN SKELETAL DYSPLASIA;;HEM SKELETAL DYSPLASIA;;MOTH-EATEN SKELETAL DYSPLASIA;;CHONDRODYSTROPHY, HYDROPIC AND PRENATALLY LETHAL TYPE	0.37071444	2.1106816999257214
THUMB AGENESIS, SHORT STATURE, AND IMMUNODEFICIENCY	0.3655911	2.0815117005577517
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.36494403999999997	2.0778276312219197
Temtamy preaxial brachydactyly syndrome	0.364613622	2.075946379372313
#304700 MOHR-TRANEBJAERG SYNDROME; MTS;;DYSTONIA-DEAFNESS SYNDROME; DDS;;DEAFNESS-DYSTONIA-OPTIC ATROPHY SYNDROME; DDP;;DEAFNESS SYNDROME, PROGRESSIVE, WITH BLINDNESS, DYSTONIA, FRACTURES,AND MENTAL DEFICIENCY	0.364583	2.0757720314429062
SAY SYNDROME	0.36180820999999996	2.0599736220954394
ZUNICH NEUROECTODERMAL SYNDROME	0.36158621999999996	2.0587097106314927
HYDROCEPHALUS DUE TO CONGENITAL STENOSIS OF AQUEDUCT OF SYLVIUS	0.3596488	2.0476789103770705
FONTAINE PROGEROID SYNDROME; FPS	0.35908018999999997	2.0444415001445613
YUNIS-VARON SYNDROME	0.35573956000000007	2.025421451701823
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.354320292	2.0173407764659452
KAPUR-TORIELLO SYNDROME	0.35104661000000004	1.9987018998989141
CHROMOSOME 16p13.2 DELETION SYNDROME	0.350002732	1.992758526903907
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.34780560000000005	1.9802490430415542
DUPUYTREN CONTRACTUREDUPUYTREN CONTRACTURE 1, INCLUDED	0.3464909	1.97276373108313
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.34101467999999996	1.9415845913151535
PSEUDODIASTROPHIC DYSPLASIA	0.34013572	1.9365801874215078
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.33902479999999996	1.9302551073569665
%106995 ANONYCHIA-ONYCHODYSTROPHY WITH HYPOPLASIA OR ABSENCE OF DISTAL PHALANGES;;COOKS SYNDROME	0.33834559999999997	1.9263880472807808
#614653 NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VI; HSAN6;;HSAN VI	0.3378137	1.9233596473182912
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIc; CDG2C	0.335452392	1.9099154189696779
AICARDI-GOUTIERES SYNDROME 5	0.335452392	1.9099154189696779
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.334176882	1.9026532372886187
#225750 AICARDI-GOUTIERES SYNDROME 1; AGS1;;AGS;;ENCEPHALOPATHY, FAMILIAL INFANTILE, WITH INTRACRANIAL CALCIFICATIONAND CHRONIC CEREBROSPINAL FLUID LYMPHOCYTOSIS;;CREE ENCEPHALITIS;;PSEUDOTOXOPLASMOSIS SYNDROMEAICARDI-GOUTIERES SYNDROME 1, AUTOSOMAL DOMINANT, INCLUDED	0.334176882	1.9026532372886187
#215150 OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA; OSMED;;CHONDRODYSTROPHY WITH SENSORINEURAL DEAFNESS;;NANCE-INSLEY SYNDROME;;NANCE-SWEENEY CHONDRODYSPLASIA	0.33406513	1.902016971538274
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.33373812199999997	1.9001551346987666
HYPOHIDROSIS WITH ABNORMAL PALMAR DERMAL RIDGES	0.333333	1.8978485517891899
PALMOPLANTAR KERATODERMA, PUNCTATE TYPE IA; PPKP1A	0.333333	1.8978485517891899
#309630 METACARPAL 4-5 FUSION; MF4	0.333333	1.8978485517891899
#615575 NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IID; HMN2D;;HMN IID;;NEUROPATHY, DISTAL HEREDITARY MOTOR, TYPE IID; DHMN2D;;SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL DOMINANT, CALF-PREDOMINANT	0.333333	1.8978485517891899
POROKERATOSIS PLANTARIS, PALMARIS, ET DISSEMINATA	0.333333	1.8978485517891899
ULNAR/FIBULAR RAY DEFECT AND BRACHYDACTYLY	0.333333	1.8978485517891899
#601369 DEAFNESS, AUTOSOMAL DOMINANT 9; DFNA9	0.333333	1.8978485517891899
%107000 NAIL DISORDER, NONSYNDROMIC CONGENITAL, 6; NDNC6;;ANONYCHIA/HYPONYCHIA AND ONYCHODYSTROPHY;;ANONYCHIA, PARTIAL	0.333333	1.8978485517891899
#610140 HEART-HAND SYNDROME, SLOVENIAN TYPE	0.333333	1.8978485517891899
DERMATOGLYPHICS--ARCH ON ANY DIGIT	0.333333	1.8978485517891899
TOTAL ANOMALOUS PULMONARY VENOUS RETURN 1	0.333333	1.8978485517891899
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA SYNDROME; HLTS	0.333333	1.8978485517891899
DERMAL RIDGES-OFF-THE-END	0.333333	1.8978485517891899
AICARDI-GOUTIERES SYNDROME 3; AGS3	0.333333	1.8978485517891899
#160565 MYOPATHY, TUBULAR AGGREGATE, 1; TAM1;;MYOPATHY, TUBULAR AGGREGATE; TAM;;TUBULAR AGGREGATE MYOPATHY	0.333333	1.8978485517891899
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; MEN2A	0.333333	1.8978485517891899
#131960 EPIDERMOLYSIS BULLOSA SIMPLEX WITH MOTTLED PIGMENTATION; EBS-MP;;SPECKLED HYPERPIGMENTATION WITH PUNCTATE PALMOPLANTAR KERATOSES ANDCHILDHOOD BLISTERING	0.333333	1.8978485517891899
REYNOLDS SYNDROME	0.333333	1.8978485517891899
PALMOPLANTAR CARCINOMA, MULTIPLE SELF-HEALING; MSPC	0.333333	1.8978485517891899
PEYRONIE DISEASE	0.333333	1.8978485517891899
FACIOCARDIOMELIC DYSPLASIA, LETHAL	0.33180240000000005	1.8891340020945349
251190 MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.3310724	1.884977709609824
CURRY-JONES SYNDROME	0.330554112	1.8820268102682953
TURNPENNY-FRY SYNDROME; TPFS	0.329027942	1.873337483006116
CLEFT LIP/PALATE WITH ABNORMAL THUMBS AND MICROCEPHALY	0.32182825000000004	1.8323456669077154
SILVER-RUSSELL SYNDROME; SRS	0.317419322	1.8072432089460286
RHIZOMELIC SYNDROME	0.31079951	1.769552969403839
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.31009901	1.7655646366839215
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.30834035200000004	1.7555516270557343
DIAMOND-BLACKFAN ANEMIA 7; DBA7	0.3080121	1.753682707438349
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.30100304	1.7137762644206953
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.29903771	1.7025865571481245
BOHRING-OPITZ SYNDROME	0.29825105199999996	1.6981076794310865
608028 THAI SYMPHALANGISM SYNDROME	0.2969292	1.6905816471934156
MICROPHTHALMIA, SYNDROMIC 1	0.29513357999999995	1.6803581925202693
#184460 STAPES ANKYLOSIS WITH BROAD THUMB AND TOES;;ANKYLOSIS OF STAPES, HYPEROPIA, BROAD THUMBS, BROAD FIRST TOES, ANDSYNDACTYLY;;TEUNISSEN-CREMERS SYNDROME;;STAPES ANKYLOSIS SYNDROME WITHOUT SYMPHALANGISM	0.29410509	1.6745024318934203
WIEACKER-WOLFF SYNDROME	0.29404879200000006	1.674181896339579
112450 BRACHYDACTYLY, PREAXIAL, WITH HALLUX VARUS AND THUMB ABDUCTION;;CHRISTIAN BRACHYDACTYLY	0.29375	1.6724807087449327
Pierpont syndrome	0.29222857199999996	1.6638183803032491
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.292158232	1.6634178959013666
EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 2; EDSKSCL2	0.2916667	1.6606193332197297
SYNPOLYDACTYLY 2	0.29	1.6511298911864865
SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME; SCT	0.2895105	1.648342897801191
CRI-DU-CHAT SYNDROME	0.28726255	1.6355440790463884
SMITH-KINGSMORE SYNDROME; SKS	0.28260204	1.6090092260492386
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.28066851000000004	1.5980005737095633
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.27751575	1.5800501727587457
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.277343132	1.5790673633119978
MALE PSEUDOHERMAPHRODITISM/MENTAL RETARDATION SYNDROME, VERLOES TYPE	0.27630172999999997	1.5731380875501306
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.27629873	1.5731210068960844
133705 EXTERNAL AUDITORY CANAL, BILATERAL ATRESIA OF, WITH CONGENITAL VERTICALTALUS;;RASMUSSEN SYNDROME	0.27622372	1.572693933609402
MOEBIUS SYNDROME; MBS	0.26938936999999996	1.5337822109479176
FANCONI ANEMIA, COMPLEMENTATION GROUP T; FANCT	0.2681818	1.5269068491455038
FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2	0.26566999999999996	1.512605786867289
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.26475082200000005	1.5073723997254929
613627 BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY,PTOSIS, HEARING LOSS, AND MENTAL RETARDATION;;TSUKAHARA SYNDROME	0.26296736000000004	1.4972181672496472
%263450 POLYDACTYLY, POSTAXIAL, TYPE A5; PAPA5	0.2626582	1.4954579489146154
#236700 MCKUSICK-KAUFMAN SYNDROME; MKKS;;HYDROMETROCOLPOS SYNDROME;;HYDROMETROCOLPOS, POSTAXIAL POLYDACTYLY, AND CONGENITAL HEART MALFORMATION;HMCS;;KAUFMAN-MCKUSICK SYNDROME	0.2626582	1.4954579489146154
OSTEOGENESIS IMPERFECTA, TYPE V	0.2625	1.4945572290912164
268650 RUDIGER SYNDROME	0.260989	1.485954273003
BRACHYDACTYLY, TYPE A4	0.2588235	1.4736248875569158
TALONAVICULAR COALITION	0.25775194	1.4675239056734684
WEAVER SYNDROME	0.254291432	1.4478213256821235
#308940 LEIOMYOMATOSIS, DIFFUSE, WITH ALPORT SYNDROME; DL-ATS;;LEIOMYOMATOSIS, ESOPHAGEAL AND VULVAL, WITH NEPHROPATHY;;ALPORT SYNDROME AND DIFFUSE LEIOMYOMATOSIS; ATS-DL;;CHROMOSOME Xq22.3 CENTROMERIC DELETION SYNDROME	0.25362319	1.4440166555416194
DEAFNESS, CONGENITAL, WITH KERATOPACHYDERMIA AND CONSTRICTIONS OFFINGERS AND TOES	0.2527933	1.439291634212665
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.25253608	1.4378271389346962
LOWE OCULOCEREBRORENAL SYNDROME	0.25197965	1.4346590761576172
223540 DWARFISM, MENTAL RETARDATION, AND EYE ABNORMALITY;;MOLLICA SYNDROME	0.25127551	1.4306500189107891
BRACHYDACTYLY, TYPE D	0.25	1.4233878372297297
YEMENITE DEAF-BLIND HYPOPIGMENTATION SYNDROME	0.25	1.4233878372297297
#615726 PACHYONYCHIA CONGENITA 3; PC3	0.25	1.4233878372297297
#613908 SPINOCEREBELLAR ATAXIA 35; SCA35	0.25	1.4233878372297297
#604213 CHUDLEY-MCCULLOUGH SYNDROME; CMCS;;DEAFNESS, SENSORINEURAL, WITH PARTIAL AGENESIS OF THE CORPUS CALLOSUMAND ARACHNOID CYSTS;;DEAFNESS, AUTOSOMAL RECESSIVE 82; DFNB82	0.25	1.4233878372297297
%603964 DEAFNESS, AUTOSOMAL DOMINANT 16; DFNA16	0.25	1.4233878372297297
DEAFNESS, AUTOSOMAL RECESSIVE 28	0.25	1.4233878372297297
#612643 DEAFNESS, AUTOSOMAL DOMINANT 3B; DFNA3B	0.25	1.4233878372297297
SONODA SYNDROME	0.25	1.4233878372297297
CATARACT-ATAXIA-DEAFNESS-RETARDATION SYNDROME	0.25	1.4233878372297297
BASALOID FOLLICULAR HAMARTOMA SYNDROME, GENERALIZED, AUTOSOMAL DOMINANT; GBFHS	0.25	1.4233878372297297
DYSTONIA 6, TORSION	0.25	1.4233878372297297
EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 3; EV3	0.25	1.4233878372297297
DARIER-WHITE DISEASE; DAR	0.25	1.4233878372297297
DERMATOGLYPHICS--HYPOTHENAR RADIAL ARCH	0.25	1.4233878372297297
ALBINISM, OCULAR, WITH LATE-ONSET SENSORINEURAL DEAFNESS	0.25	1.4233878372297297
FECHTNER SYNDROME	0.25	1.4233878372297297
KLEEBLATTSCHAEDEL SYNDROME	0.25	1.4233878372297297
ECTODERMAL DYSPLASIA-SYNDACTYLY SYNDROME 1	0.25	1.4233878372297297
#215400 CHORDOMA, SUSCEPTIBILITY TO; CHDM	0.25	1.4233878372297297
HYPERPARATHYROIDISM 2	0.25	1.4233878372297297
FINGERPRINTS, ABSENCE OF	0.25	1.4233878372297297
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.25	1.4233878372297297
RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA 2	0.24799903	1.4119952117870835
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.24764831199999998	1.4099983808450933
140450 HEART-HAND SYNDROME, SPANISH TYPE	0.2434783	1.3862562033974852
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES; SEMDJL1	0.24132580000000003	1.3740008341189376
GONADAL DYSGENESIS, DYSMORPHIC FACIES, RETINAL DYSTROPHY, AND MYOPATHY; GDRM	0.24080183	1.3710175840186443
FLOATING-HARBOR SYNDROME	0.24075563000000003	1.3707545419463243
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.24043979999999998	1.368956347623795
%607004 BRACHYDACTYLY, TYPE A1, B; BDA1B	0.23688800000000002	1.348733991942705
#610168 LOEYS-DIETZ SYNDROME 2; LDS2;;AORTIC ANEURYSM, FAMILIAL THORACIC 3; AAT3;;MARFAN SYNDROME, TYPE II, FORMERLY	0.235507962	1.3408766747262455
OCULODENTODIGITAL DYSPLASIA; ODDD	0.23419457	1.333398809932986
DYSSEGMENTAL DYSPLASIA, ROLLAND-DESBUQUOIS TYPE	0.23261092000000003	1.324382217339271
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.23040355	1.3118144428982077
271960 SUBAORTIC STENOSIS--SHORT STATURE SYNDROME;;ONAT SYNDROME	0.22962652	1.3073903826935571
NESTOR-GUILLERMO PROGERIA SYNDROME; NGPS	0.2294118	1.3061678633479172
MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY; MADA	0.2294118	1.3061678633479172
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, IRAPA TYPE	0.22486399999999995	1.2802747305233035
NAIL-PATELLA SYNDROME	0.22257222	1.2672263634128784
PROGEROID FACIAL APPEARANCE WITH HAND ANOMALIES	0.22080706	1.2571763343138207
TRIPHALANGEAL THUMBS WITH BRACHYECTRODACTYLY	0.21957700000000002	1.2501729245415696
BRACHYDACTYLY, TYPE B1	0.219101	1.247462794099484
Contractural arachnodactyly, congenital	0.21886012	1.2460913314505564
#117550 SOTOS SYNDROME 1; SOTOS1;;SOTOS SYNDROME;;CEREBRAL GIGANTISM;;CHROMOSOME 5q35 DELETION SYNDROME	0.218715412	1.2452674290219572
HYPERTELORISM AND OTHER FACIAL DYSMORPHISM, BRACHYDACTYLY, GENITAL ABNORMALITIES, MENTAL RETARDATION, AND RECURRENT INFLAMMATORY EPISODES	0.21820019999999998	1.2423340430443777
BRANCHIOOCULOFACIAL SYNDROME	0.21758945999999998	1.238856763493539
PETERS-PLUS SYNDROME; PTRPLS	0.21712144199999997	1.2361920789783205
#166250 OSTEOGLOPHONIC DYSPLASIA; OGD;;OSTEOGLOPHONIC DWARFISM	0.21703022	1.2356727018371698
SPONDYLOCHEIRODYSPLASIA, EHLERS-DANLOS SYNDROME-LIKE	0.216575	1.2330808833921147
HAMAMY SYNDROME; HMMS	0.21635243	1.2318136696683861
ANONYCHIA-ECTRODACTYLY	0.215873	1.229084010345174
MANDIBULOACRAL DYSPLASIA WITH TYPE B LIPODYSTROPHY; MADB	0.21428570000000002	1.220046636289035
CORNELIA DE LANGE SYNDROME 1	0.21150567	1.2042183927324999
RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA	0.21029647	1.197333750441387
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.20341792199999997	1.1581703841973834
#227645 FANCONI ANEMIA, COMPLEMENTATION GROUP C; FANCC;;FACC; FAC;;FANCONI PANCYTOPENIA, TYPE 3; FA3	0.20257403999999998	1.153365698697955
#227646 FANCONI ANEMIA, COMPLEMENTATION GROUP D2; FANCD2;;FAD2;;FANCONI ANEMIA, COMPLEMENTATION GROUP D; FANCD; FACD;;FANCONI PANCYTOPENIA, TYPE 4; FA4	0.20257403999999998	1.153365698697955
FANCONI ANEMIA	0.20257403999999998	1.153365698697955
FOCAL DERMAL HYPOPLASIA; FDH	0.20227534000000003	1.1516650349100332
TYSHCHENKO SYNDROME	0.20111362199999994	1.1450507338240692
#615706 AURICULOCONDYLAR SYNDROME 3; ARCND3	0.2	1.1387102697837839
MUCOPOLYSACCHARIDOSES, UNCLASSIFIED TYPES	0.2	1.1387102697837839
PAGET DISEASE OF BONE 2, EARLY-ONSET; PDB2	0.2	1.1387102697837839
PYCNODYSOSTOSIS	0.2	1.1387102697837839
Leri-Weill dyschondrostosis (LWD) - SHOX deletion	0.2	1.1387102697837839
CLEFT PALATE, DEAFNESS, AND OLIGODONTIA	0.2	1.1387102697837839
DEAFNESS, PROGRESSIVE, WITH STAPES FIXATION	0.2	1.1387102697837839
176800 PRONATION-SUPINATION OF THE FOREARM, IMPAIRMENT OF	0.2	1.1387102697837839
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 3; PRAAS3	0.2	1.1387102697837839
COSTELLO SYNDROME; CSTLO	0.19762665199999999	1.1251974910769296
Aarskog-Scott syndrome	0.196085062	1.1164203692529497
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.19546447199999997	1.1128870082213242
#605355 NEMALINE MYOPATHY 5; NEM5;;NEMALINE MYOPATHY, AMISH TYPE; ANM;;AMISH NEMALINE MYOPATHY	0.1952384	1.1115998556807716
Diamond-Blackfan anemia 1	0.19386847999999998	1.1038001458168605
#278250 WRINKLY SKIN SYNDROME; WSS	0.19237269999999998	1.0952838455801746
HEMIFACIAL MICROSOMIA WITH RADIAL DEFECTS	0.18923979	1.0774464616236328
Myhre syndrome	0.18886457	1.0753101272864918
FRYNS SYNDROME; FRNS	0.18771447	1.0687619738801
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.18761298999999998	1.0681841922892117
RENPENNING SYNDROME 1; RENS1	0.18624958	1.0604215474445822
183800 SPLIT-HAND WITH CONGENITAL NYSTAGMUS, FUNDAL CHANGES, AND CATARACTS;;NYSTAGMUS-SPLIT HAND SYNDROME;;KARSCH-NEUGEBAUER SYNDROME; KNS	0.18616319	1.059929681543549
PRADER-WILLI SYNDROME; PWS	0.18545198200000002	1.0558803822757872
HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 1; PHOAR1	0.18456644	1.0508385034271628
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.18453253	1.050645435100921
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.18311707000000002	1.04258644090858
FEMUR, UNILATERAL BIFID, WITH MONODACTYLOUS ECTRODACTYLY	0.18254	1.0393008632316596
TETRAMELIC MONODACTYLY	0.18254	1.0393008632316596
DESBUQUOIS DYSPLASIA 2; DBQD2	0.18037364200000003	1.0269665927185183
COFFIN-SIRIS SYNDROME 2; CSS2	0.18026316199999998	1.0263375691654895
258840 ORAL AND DIGITAL ANOMALIES WITH ICHTHYOSIS	0.17871520000000002	1.0175241680323144
#274000 THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME; TAR;;TAR SYNDROME;;CHROMOSOME 1q21.1 DELETION SYNDROME, 200-KB	0.17810784200000002	1.014066144072138
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.177720222	1.01185920969827
191482 UNCOMBABLE HAIR, RETINAL PIGMENTARY DYSTROPHY, DENTAL ANOMALIES, ANDBRACHYDACTYLY;;BORK SYNDROME	0.1770837	1.0082351390065531
#305450 OPITZ-KAVEGGIA SYNDROME; OKS;;FG SYNDROME 1; FGS1;;FG SYNDROME; FGS;;MENTAL RETARDATION, LARGE HEAD, IMPERFORATE ANUS, CONGENITAL HYPOTONIA,AND PARTIAL AGENESIS OF CORPUS CALLOSUM;;KELLER SYNDROME	0.176585182	1.005396801175193
#304150 OCCIPITAL HORN SYNDROME; OHS;;CUTIS LAXA, X-LINKED, FORMERLY;;EHLERS-DANLOS SYNDROME, OCCIPITAL HORN TYPE, FORMERLY;;EDS IX, FORMERLY;;EDS9, FORMERLY	0.17503863999999997	0.9965914848849329
DEAFNESS, AUTOSOMAL DOMINANT 39, WITH DENTINOGENESIS IMPERFECTA 1	0.175	0.9963714860608107
LETHAL CONGENITAL CONTRACTURE SYNDROME 9; LCCS9	0.17400784000000002	0.9907225721544675
SCHAAF-YANG SYNDROME; SHFYNG	0.173672112	0.9888110875471975
COHEN SYNDROME	0.17324291	0.9863674039211389
NANCE-HORAN SYNDROME	0.17215495	0.980173047795569
113480 BRACHYTELEPHALANGY WITH CHARACTERISTIC FACIES AND KALLMANN SYNDROME	0.17198861	0.9792259824641898
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.17022054999999997	0.9691594420662201
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.169879422	0.9672172122816662
SECKEL SYNDROME 7; SCKL7	0.16794251000000002	0.9561893043513292
MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD	0.16768227	0.9547076145482863
NAVAJO NEUROHEPATOPATHY	0.167510882	0.9537318081696978
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE V	0.166667	0.9489271226702696
SPECIFIC LANGUAGE IMPAIRMENT 2; SLI2	0.166667	0.9489271226702696
DEAFNESS, AUTOSOMAL RECESSIVE 48	0.166667	0.9489271226702696
#610706 DEAFNESS, CONGENITAL, WITH INNER EAR AGENESIS, MICROTIA, AND MICRODONTIA;;DEAFNESS, CONGENITAL, WITH LABYRINTHINE APLASIA, MICROTIA, AND MICRODONTIA;;DEAFNESS WITH LAMM	0.166667	0.9489271226702696
DYSPHASIA, FAMILIAL DEVELOPMENTAL	0.166667	0.9489271226702696
FINGERS, RELATIVE LENGTH OF	0.166667	0.9489271226702696
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH HYPOTRICHOSIS	0.166667	0.9489271226702696
NEUROPATHY, HEREDITARY SENSORY, WITH SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE	0.166667	0.9489271226702696
DEAFNESS, AUTOSOMAL RECESSIVE, 24	0.166667	0.9489271226702696
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 46	0.166667	0.9489271226702696
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, AUTOSOMAL RECESSIVE, LEROY-SPRANGERTYPE	0.166667	0.9489271226702696
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 3	0.166667	0.9489271226702696
AL KAISSI SYNDROME; ALKAS	0.166035972	0.9453343323496639
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.16592941199999994	0.9447276275179227
CHOPS SYNDROME; CHOPS	0.16548961199999998	0.9422236036346685
201020 ACROCEPHALOPOLYSYNDACTYLY TYPE IV;;ACPS IV;;GOODMAN SYNDROME	0.16403510000000002	0.9339422648750499
#300867 KABUKI SYNDROME 2; KABUK2	0.163475422	0.9307557094431895
604381 PATENT DUCTUS ARTERIOSUS AND BICUSPID AORTIC VALVE WITH HAND ANOMALIES	0.16305494	0.9283616735848935
ENDOCRINE-CEREBROOSTEODYSPLASIA; ECO	0.16250000000000003	0.9252020941993245
MELNICK-NEEDLES SYNDROME	0.16147387	0.9193597703536581
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.161405382	0.9189698304088733
COFFIN-SIRIS SYNDROME 3; CSS3	0.16128319199999996	0.9182741353695487
COFFIN-SIRIS SYNDROME 4; CSS4	0.16128319199999996	0.9182741353695487
HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC; HMSN2C	0.15968722999999999	0.9091874437716255
600736 VELOFACIOSKELETAL SYNDROME	0.15877027	0.9039666849267208
SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	0.15874667	0.9038323171148865
106990 ANONYCHIA-ONYCHODYSTROPHY WITH BRACHYDACTYLY TYPE B AND ECTRODACTYLY	0.15872999999999998	0.9037374056138999
#300799 MENTAL RETARDATION, X-LINKED, SYNDROMIC, RAYMOND TYPE; MRXSR	0.15734979999999998	0.895879166042122
#604360 SPASTIC PARAPLEGIA 11, AUTOSOMAL RECESSIVE; SPG11;;SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, WITH MENTAL IMPAIRMENT ANDTHIN CORPUS CALLOSUM;;SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, COMPLICATED, WITH THIN CORPUSCALLOSUM;;HSP-TCC	0.1571427	0.8947000315577609
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.154495962	0.879630692847626
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.15385371999999997	0.8759740550421936
WAHAB SYNDROME	0.1533991	0.8733856527279482
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.15274942200000002	0.8696866776746853
C SYNDROME	0.152618042	0.8689386588984642
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.151111	0.8603582378864867
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.15063540199999997	0.8576503962520434
CRANIOFACIAL-DEAFNESS-HAND SYNDROME; CDHS	0.15023657	0.8553796257804516
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIj; CDG2J	0.14915763999999998	0.8492366824235623
KABUKI SYNDROME 1	0.14845339200000002	0.8452270102731892
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.147630922	0.8405442350952437
ALOPECIA, NEUROLOGIC DEFECTS, AND ENDOCRINOPATHY SYNDROME; ANES	0.14710881	0.837571563613357
MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN	0.14649546	0.8340794238934974
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.14599852200000002	0.8312500818732687
PSEUDOARTHROGRYPOSIS	0.1458333	0.8303093819322973
BROWN-VIALETTO-VAN LAERE SYNDROME 1; BVVLS1	0.14540152999999997	0.8278510772663745
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.14529936200000002	0.8272693785121583
TEEBI-SHALTOUT SYNDROME; TBSH	0.14494142999999998	0.825231474290737
RETINOPATHY, PIGMENTARY, AND MENTAL RETARDATION	0.1443915	0.8221004195974262
MYOPATHY, SCAPULOHUMEROPERONEAL	0.14285699999999998	0.8133636650525099
SPONDYLOEPIPHYSEAL DYSPLASIA WITH ATLANTOAXIAL INSTABILITY	0.14285699999999998	0.8133636650525099
DANDY-WALKER MALFORMATION WITH MENTAL RETARDATION, MACROCEPHALY, MYOPIA, AND BRACHYTELEPHALANGY	0.14285699999999998	0.8133636650525099
AMYOTROPHIC LATERAL SCLEROSIS 2, JUVENILE; ALS2	0.14285699999999998	0.8133636650525099
ICHTHYOSIS, LEUKOCYTE VACUOLES, ALOPECIA, AND SCLEROSING CHOLANGITIS; ILVASC	0.14285699999999998	0.8133636650525099
SPINAL MUSCULAR ATROPHY, SEGMENTAL	0.14285699999999998	0.8133636650525099
%605967 ACROPECTORAL SYNDROME; ACRPS;;ACRP SYNDROME;;SYNDACTYLY, PREAXIAL POLYDACTYLY, AND STERNAL DEFORMITY	0.14219164	0.8095754037269933
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.14084062199999997	0.8018833133706793
PACHYONYCHIA CONGENITA 2	0.14052279999999998	0.8000737774938633
#190685 DOWN SYNDROMETRISOMY 21, INCLUDED;;DOWN SYNDROME CHROMOSOME REGION, INCLUDED; DCR, INCLUDED;;DOWN SYNDROME CRITICAL REGION, INCLUDED; DSCR, INCLUDED;;TRANSIENT MYELOPROLIFERATIVE DISORDER OF DOWN SYNDROME, INCLUDED;;LEUKEMIA, MEGAKARYOBLASTIC, OF DOWN SYNDROME, INCLUDED	0.14040416	0.7993982945618276
CHROMOSOME 17P13.1 DELETION SYNDROME	0.139673812	0.7952400207212474
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B2; CMT4B2	0.13933245	0.7932964586456778
EHLERS-DANLOS SYNDROME, TYPE VI	0.13866504999999998	0.7894965824754093
PTERYGIUM COLLI AND MENTAL RETARDATION WITH FACIAL AND DIGITAL ANOMALIES	0.13845118000000003	0.7882789026484163
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIe; CDG2E	0.13822311999999998	0.7869804313277815
FOUNTAIN SYNDROME	0.13801693	0.785806477975148
CODAS SYNDROME	0.135817892	0.773286142203924
SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	0.13528134	0.770231255840559
CHROMOSOME 1P36 DELETION SYNDROME	0.134910332	0.7681189027416992
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.13430162	0.7646531697129961
WITTEVEEN-KOLK SYNDROME	0.133525492	0.7602342450916624
WHISTLING FACE SYNDROME, RECESSIVE FORM	0.13350778000000002	0.7601334009101705
184705 STEINFELD SYNDROME	0.13300163	0.757251609894915
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.13220858200000002	0.7527363503847576
#101800 ACRODYSOSTOSIS 1, WITH OR WITHOUT HORMONE RESISTANCE; ACRDYS1;;ADOHR	0.13145679	0.748455984029051
PROGEROID SHORT STATURE WITH PIGMENTED NEVI	0.13116772	0.746810149140619
258650 OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMALRECESSIVE	0.13024434000000001	0.7415528376960544
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1A	0.12977729999999998	0.7388937214740552
PETTIGREW SYNDROME	0.12838841199999998	0.7309860163281579
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.127970032	0.7286039483147974
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.127926222	0.7283545138302011
DEAFNESS, X-LINKED 4	0.12754453	0.7261813308287295
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4A; CMT4A	0.12698399999999999	0.72298992449112
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1B; CMT1B	0.12698399999999999	0.72298992449112
HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS	0.12698399999999999	0.72298992449112
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2F; CMT2F	0.12698399999999999	0.72298992449112
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.12660646	0.7208403811148492
AU-KLINE SYNDROME; AUKS	0.126368922	0.7194879463145297
EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 1; EDSPD1	0.1256038	0.7151316849193421
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 7	0.125	0.7116939186148649
#612644 DEAFNESS, AUTOSOMAL DOMINANT 2B; DFNA2B	0.125	0.7116939186148649
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 17	0.125	0.7116939186148649
THUMB DEFORMITY	0.125	0.7116939186148649
#300455 RETINITIS PIGMENTOSA, X-LINKED, AND SINORESPIRATORY INFECTIONS, WITHOR WITHOUT DEAFNESS	0.125	0.7116939186148649
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.124815612	0.7106440960687405
DIGITOTALAR DYSMORPHISM	0.1238095	0.704915745733977
WEYERS ULNAR RAY/OLIGODACTYLY SYNDROME	0.1233397	0.7022409153102548
ODONTOCHONDRODYSPLASIA; ODCD	0.1229167	0.6998325430896621
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.12207867000000001	0.6950611762527277
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2EE; CMT2EE	0.12101198999999999	0.6889879788998626
COHEN-GIBSON SYNDROME; COGIS	0.120602212	0.6866548868152055
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.12045125000000001	0.68579537691647
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.12030862	0.6849833056875736
127200 DWARFISM WITH STIFF JOINTS AND OCULAR ABNORMALITIES;;MOORE-FEDERMAN SYNDROME	0.11962460999999999	0.6810888596293996
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.11912329200000002	0.6782345798542624
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.11862742000000001	0.6754113071597712
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.11838546200000001	0.6740337068624894
CRANIOFACIOFRONTODIGITAL SYNDROME	0.11812437999999999	0.6725472230892109
FIBULAR APLASIA, TIBIAL CAMPOMELIA, AND OLIGOSYNDACTYLY SYNDROME	0.117647	0.6698292355462641
%135750 LAURIN-SANDROW SYNDROME;;LSS;;SANDROW SYNDROME;;MIRROR HANDS AND FEET WITH NASAL DEFECTS;;TETRAMELIC MIRROR-IMAGE POLYDACTYLY; TMIP;;MIRROR-IMAGE POLYDACTYLY; MIP;;FIBULA AND ULNA, DUPLICATION OF, WITH ABSENCE OF TIBIA AND RADIUSLAURIN-SANDROW SYNDROME, SEGMENTAL, INCLUDED	0.11734	0.668081315282146
BRITTLE CORNEA SYNDROME	0.11716162999999999	0.6670657565280392
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.1169543	0.6658853125268679
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.116660502	0.6642125585276583
URUGUAY FACIOCARDIOMUSCULOSKELETAL SYNDROME; FCMSU	0.116564	0.6636631194353848
METAPHYSEAL DYSOSTOSIS, MENTAL RETARDATION, AND CONDUCTIVE DEAFNESS	0.11640908999999999	0.6627811313959238
NOONAN SYNDROME 8; NS8	0.11622706999999999	0.6617447911793936
ALSTROM SYNDROME; ALMS	0.115917382	0.6599815666492496
KEIPERT SYNDROME; KPTS	0.11492017	0.6543038889214915
SPLIT-HAND/FOOT MALFORMATION 1; SHFM1	0.1145268	0.6520642166273672
EPIPHYSEAL CHONDRODYSPLASIA, MIURA TYPE; ECDM	0.1144928	0.6518706358815041
METAPHYSEAL CHONDRODYSPLASIA, JANSEN TYPE	0.11444479999999999	0.6515973454167558
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.11362854200000001	0.6469499385797901
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.11334409	0.6453303965114873
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.11280536	0.6422631095932843
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.112579562	0.6409775170858011
FILIPPI SYNDROME; FLPIS	0.11226451	0.6391837523462215
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.11181743	0.6366382794091469
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.11143161199999999	0.6344416048148095
CRANIOECTODERMAL DYSPLASIA 4	0.11121524	0.6332096797223413
PALMOPLANTAR HYPERKERATOSIS WITH SQUAMOUS CELL CARCINOMA OF SKIN AND 46,XX SEX REVERSAL	0.11111099999999999	0.63261618392973
%164800 NAIL DISORDER, NONSYNDROMIC CONGENITAL, 5; NDNC5;;ONYCHOLYSIS, PARTIAL, WITH SCLERONYCHIA;;ONYCHOLYSIS, HEREDITARY DISTAL	0.11111099999999999	0.63261618392973
HYPERHIDROSIS PALMARIS ET PLANTARIS	0.11111099999999999	0.63261618392973
ODONTOONYCHODERMAL DYSPLASIA; OODD	0.11111099999999999	0.63261618392973
BOOK SYNDROME	0.11111099999999999	0.63261618392973
#608340 CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE A; CMTRIA;;CHARCOT-MARIE-TOOTH NEUROPATHY, RECESSIVE INTERMEDIATE A;;RI-CMTA	0.11111099999999999	0.63261618392973
PALMOPLANTAR KERATODERMA, NAGASHIMA TYPE; PPKN	0.11111099999999999	0.63261618392973
CHROMOSOME 2q35 DUPLICATION SYNDROME	0.11111099999999999	0.63261618392973
KERATOLYTIC WINTER ERYTHEMA; KWE	0.11111099999999999	0.63261618392973
Congenital disorder of glycosylation, type IIh	0.11040185200000001	0.6285786133777469
OSTEOCHONDRODYSPLASIA, BRACHYDACTYLY, AND OVERLAPPING MALFORMED DIGITS; OCBMD	0.11025824	0.6277609510814259
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.11012050999999999	0.6269767782541392
CHROMOSOME 17q23.1-q23.2 DELETION SYNDROME	0.110040892	0.6265234690828411
CHROMOSOME 17q12 DELETION SYNDROME	0.10991911	0.6258300970124671
ZIMMERMANN-LABAND SYNDROME 1	0.10907578999999999	0.6210286112888967
Glycosylphosphatidylinositol biosynthesis defect 18	0.10879613199999999	0.6194363641057606
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.10839991	0.6171804538031894
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.10817698	0.615911190400975
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.10685174	0.6083658684113336
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.10586712999999999	0.6027599408176745
DEAFNESS, SENSORINEURAL, WITH PERIPHERAL NEUROPATHY AND ARTERIAL DISEASE	0.1055556	0.6009862287659459
OROFACIODIGITAL SYNDROME X	0.10538431	0.6000109803553896
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.105114292	0.5984736190072572
PHELAN-MCDERMID SYNDROME; PHMDS	0.104742342	0.5963559025830267
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.104398512	0.5943982888227279
FACIAL CLEFTING, OBLIQUE, 1; OBLFC1	0.10413159999999999	0.5928786116450853
LUSCAN-LUMISH SYNDROME; LLS	0.10389266200000001	0.5915182058728774
OTODENTAL DYSPLASIA	0.10373493000000002	0.5906201506315097
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.10315743999999999	0.5873321816630225
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.102838342	0.5855153808146851
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.102260692	0.5822265008779821
CHROMOSOME 10Q26 DELETION SYNDROME	0.10196549200000002	0.5805457645197813
#148820 WAARDENBURG SYNDROME, TYPE 3; WS3;;WAARDENBURG SYNDROME WITH UPPER LIMB ANOMALIES;;WAARDENBURG SYNDROME, TYPE III;;KLEIN-WAARDENBURG SYNDROME	0.10180555000000001	0.5796351265299325
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE II	0.10137365000000001	0.5771760817023345
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.101161702	0.5759693448810338
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2B, PRENATAL ONSET, AUTOSOMAL DOMINANT; SMALED2B	0.1010101	0.575106191109435
MENTAL RETARDATION, X-LINKED 91; MRX91	0.100275942	0.5709262248382153
#215045 CHONDRODYSPLASIA, BLOMSTRAND TYPE; BOCD	0.1	0.5693551348918919
SHORT-RIB THORACIC DYSPLASIA 1 WITH OR WITHOUT POLYDACTYLY; SRTD1	0.1	0.5693551348918919
GRANGE SYNDROME; GRNG	0.1	0.5693551348918919
SCHNECKENBECKEN DYSPLASIA	0.1	0.5693551348918919
EPIPHYSEAL DYSPLASIA, MULTIPLE, 7; EDM7	0.1	0.5693551348918919
GROWTH RESTRICTION, SEVERE, WITH DISTINCTIVE FACIES; GRDF	0.1	0.5693551348918919
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.09966609000000001	0.5674540011609744
%129900 ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME1; EEC1;;EEC;;EEC SYNDROME 1	0.09964155	0.5673142814108719
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.09893753200000001	0.5633059187773088
WIEDEMANN-STEINER SYNDROME; WDSTS	0.09729497200000001	0.5539539190736285
KBG SYNDROME	0.09682494200000001	0.5512777791330962
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.09664906999999999	0.550276442870259
FRONTONASAL DYSPLASIA 1; FND1	0.09627518000000002	0.5481476809564118
VAN BOGAERT-HOZAY SYNDROME	0.0960785	0.5470278732771063
#264470 PEROXISOMAL ACYL-CoA OXIDASE DEFICIENCY;;STRAIGHT-CHAIN ACYL-CoA OXIDASE DEFICIENCY;;PSEUDONEONATAL ADRENOLEUKODYSTROPHY	0.09569846	0.5448640960224632
CHROMOSOME 18Q DELETION SYNDROME	0.09554000000000001	0.5439618958757136
TIETZ SYNDROME	0.0954545	0.543475097235381
NOONAN SYNDROME 7; NS7	0.09495667999999999	0.540640733502862
#607095 ANAUXETIC DYSPLASIA;;SPONDYLOMETAEPIPHYSEAL DYSPLASIA, ANAUXETIC TYPE;;SPONDYLOMETAEPIPHYSEAL DYSPLASIA, MENGER TYPE	0.09466174	0.5389614774680119
SIDERIUS X-LINKED MENTAL RETARDATION SYNDROME; MRXSSD	0.09420690000000001	0.5363718225724697
KYPHOMELIC DYSPLASIA	0.09375000000000001	0.5337704389611487
SCARF SYNDROME	0.09345873	0.532112078259749
PALLISTER-KILLIAN SYNDROME	0.09325172000000001	0.5309334561950094
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.09226708	0.5253273577948099
#614700 IMMUNODEFICIENCY, COMMON VARIABLE, 8, WITH AUTOIMMUNITY; CVID8	0.09166669999999999	0.5219090634359458
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.09164705999999999	0.521797242087453
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1A; CPSKF1A	0.09150810999999999	0.5210061231275207
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SPONASTRIME TYPE; SEMDSP	0.09138574	0.5203094032489536
MICROGASTRIA-LIMB REDUCTION DEFECTS ASSOCIATION; MLRD	0.0910816	0.5185777665416934
BROAD TERMINAL PHALANGES, FAMILIAL	0.0909091	0.5175956289340049
610680 HOLOPROSENCEPHALY, RECURRENT INFECTIONS, AND MONOCYTOSIS	0.09072375999999999	0.5165403861269963
JABERI-ELAHI SYNDROME; JABELS	0.090709982	0.5164619403765108
OROFACIODIGITAL SYNDROME IV; OFD4	0.09057371	0.515686068747091
OROFACIODIGITAL SYNDROME XVIII; OFD18	0.09052701999999999	0.5154202368346098
VELOCARDIOFACIAL SYNDROME	0.09040201	0.5147084859804817
SPASTIC PARAPLEGIA 9A, AUTOSOMAL DOMINANT; SPG9A	0.09030988	0.5141839390947056
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.08995582000000002	0.5121680803041077
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.089386012	0.5089238491970827
DEAFNESS, AUTOSOMAL DOMINANT 50	0.08935013	0.5087195531875808
HEART AND BRAIN MALFORMATION SYNDROME	0.088551562	0.5041728652739773
MEND SYNDROME; MEND	0.08838307200000001	0.503213558807198
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.08835677	0.5030638070196187
MUCOLIPIDOSIS III GAMMA	0.0882353	0.5023722113372655
ACRORENAL-MANDIBULAR SYNDROME	0.08799823000000001	0.5010224411189774
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.087786642	0.4998177539761622
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.08693345999999999	0.49496011844918886
DEAFNESS, AUTOSOMAL RECESSIVE 30; DFNB30	0.08680560000000001	0.4942321409737162
PAGET DISEASE OF BONE 5, JUVENILE-ONSET	0.08587783000000002	0.4889498348387297
TARP SYNDROME; TARPS	0.085512962	0.4868724401451523
RUVALCABA SYNDROME	0.08539781	0.48621681632022157
%263210 POLYCYSTIC KIDNEY DISEASE, POTTER TYPE I, WITH MICROBRACHYCEPHALY,HYPERTELORISM, AND BRACHYMELIA	0.08521811000000001	0.48519368514282096
RESTRICTIVE DERMOPATHY, LETHAL	0.08519204000000001	0.4850452542591545
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.08431964	0.4800782000623577
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.084256882	0.47972088416680225
SHASHI-PENA SYNDROME; SHAPNS	0.084182802	0.4792991058828743
ARTHROGRYPOSIS, DISTAL, TYPE 2B2; DA2B2	0.08381850000000002	0.47722493373936054
VAN MALDERGEM SYNDROME 1; VMLDS1	0.08367309	0.47639703443771414
VAN MALDERGEM SYNDROME 2; VMLDS2	0.08367309	0.47639703443771414
#313400 SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, X-LINKED; SEDT;;SED TARDA, X-LINKED;;SPONDYLOEPIPHYSEAL DYSPLASIA, LATE	0.08333330000000001	0.47446242262486504
STIFF SKIN SYNDROME	0.08333330000000001	0.47446242262486504
OSSEOUS HETEROPLASIA, PROGRESSIVE; POH	0.08333330000000001	0.47446242262486504
AURICULOCONDYLAR SYNDROME 1; ARCND1	0.08333330000000001	0.47446242262486504
AURICULOCONDYLAR SYNDROME 2; ARCND2	0.08333330000000001	0.47446242262486504
FASCIAL DYSTROPHY, CONGENITAL	0.08333330000000001	0.47446242262486504
ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 1; GACI1	0.08333330000000001	0.47446242262486504
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Id; CDG1D	0.08331192200000001	0.4743407058841278
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.08301019	0.47262277924851576
GOLDBERG-SHPRINTZEN SYNDROME	0.082607302	0.47032891573265245
HYPERTRYPTOPHANEMIA; HYPTRP	0.082399452	0.4691455110847797
VACTERL ASSOCIATION, X-LINKED, WITH OR WITHOUT HYDROCEPHALUS; VACTERLX	0.0822581	0.4683407162145073
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.08214744	0.46771066782223597
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA; FOP	0.08214226	0.4676811752262485
WAARDENBURG SYNDROME, TYPE 1; WS1	0.08184485	0.46598785611956656
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.08153264	0.4642102724529206
DEAFNESS, AUTOSOMAL DOMINANT 20	0.08125	0.46260104709966215
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.08125	0.46260104709966215
HALLERMANN-STREIFF SYNDROME; HSS	0.08088788999999999	0.4605393552207051
DESANTO-SHINAWI SYNDROME	0.079936752	0.4551240021777971
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.07989163200000002	0.454867109140934
ACROCRANIOFACIAL DYSOSTOSIS	0.07954496	0.4528933143077014
239710 ACROFRONTOFACIONASAL DYSOSTOSIS 2;;AFFN DYSOSTOSIS 2; AFFND2;;ACROFRONTOFACIONASAL DYSOSTOSIS WITH GENITOURINARY ANOMALIES;;NAGUIB-RICHIERI-COSTA SYNDROME;;HYPERTELORISM, HYPOSPADIAS, AND POLYSYNDACTYLY SYNDROME	0.07954477	0.4528922325329452
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.07908390200000001	0.4502682569098717
#273750 THREE M SYNDROME 1; 3M1;;3@M SYNDROME;;LE MERRER SYNDROME;;DOLICHOSPONDYLIC DYSPLASIA;;GLOOMY FACE SYNDROMEYAKUT SHORT STATURE SYNDROME, INCLUDED	0.07905168	0.4500847992983067
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.07764776200000001	0.44209152007563524
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.07758961199999999	0.4417604400646955
#300337 HYPOMELANOSIS OF ITO; HMI;;INCONTINENTIA PIGMENTI ACHROMIANS; IPA;;ITO HYPOMELANOSIS; ITO;;INCONTINENTIA PIGMENTI, TYPE I, FORMERLY; IP1, FORMERLY	0.07755867000000001	0.4415842701988574
SATOYOSHI SYNDROME	0.0770834	0.43887829604925654
MARFANOID HABITUS WITH SITUS INVERSUS	0.0769928	0.4383624602970445
DEAFNESS, CONGENITAL NEUROSENSORY, AUTOSOMAL RECESSIVE 39	0.07692310000000001	0.43796561976802495
DEAFNESS, CONGENITAL NEUROSENSORY, AUTOSOMAL RECESSIVE 40	0.07692310000000001	0.43796561976802495
DEAFNESS, AUTOSOMAL RECESSIVE 83	0.07692310000000001	0.43796561976802495
DEAFNESS, AUTOSOMAL RECESSIVE 44	0.07692310000000001	0.43796561976802495
DEAFNESS, AUTOSOMAL RECESSIVE 71	0.07692310000000001	0.43796561976802495
DEAFNESS, AUTOSOMAL RECESSIVE 104; DFNB104	0.07692310000000001	0.43796561976802495
DEAFNESS, AUTOSOMAL RECESSIVE 45	0.07692310000000001	0.43796561976802495
DEAFNESS, AUTOSOMAL RECESSIVE 62	0.07692310000000001	0.43796561976802495
DEAFNESS, CONGENITAL NEUROSENSORY, AUTOSOMAL RECESSIVE 38	0.07692310000000001	0.43796561976802495
#601869 DEAFNESS, AUTOSOMAL RECESSIVE 15; DFNB15;;DEAFNESS, AUTOSOMAL RECESSIVE 72; DFNB72;;DEAFNESS, AUTOSOMAL RECESSIVE 95; DFNB95	0.07692310000000001	0.43796561976802495
DEAFNESS, AUTOSOMAL RECESSIVE 49	0.07692310000000001	0.43796561976802495
DEAFNESS, AUTOSOMAL RECESSIVE 12; DFNB12	0.07692310000000001	0.43796561976802495
DEAFNESS, AUTOSOMAL RECESSIVE 85	0.07692310000000001	0.43796561976802495
OCULOSKELETODENTAL SYNDROME; OCSKD	0.076842932	0.43750917914348475
VATER-LIKE DEFECTS WITH PULMONARY HYPERTENSION, LARYNGEAL WEBS, AND GROWTH DEFICIENCY	0.07671951	0.4368064696488985
#606835 DIGITAL ARTHROPATHY-BRACHYDACTYLY, FAMILIAL; FDAB	0.07617370000000001	0.43369887238714516
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.07590617	0.43217567659476874
#250460 METAPHYSEAL DYSPLASIA WITHOUT HYPOTRICHOSIS;;CARTILAGE-HAIR HYPOPLASIA-LIKE SKELETAL DYSPLASIA WITHOUT HYPOTRICHOSISOR IMMUNODEFICIENCY;;CARTILAGE-HAIR HYPOPLASIA VARIANT, SKELETAL MANIFESTATIONS ONLY; CHHV	0.07554280000000001	0.4301068108411122
#151100 LEOPARD SYNDROME 1;;LENTIGINOSIS, CARDIOMYOPATHIC;;MULTIPLE LENTIGINES SYNDROME	0.07531524	0.42881118629615217
BARDET-BIEDL SYNDROME 1; BBS1	0.07531517200000001	0.42881079913466047
OROFACIODIGITAL SYNDROME IX; OFD9	0.07526664200000001	0.4285344910876975
MYOPATHY, CONGENITAL, COMPTON-NORTH	0.07496394	0.42681104170727696
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.07473462	0.42550539651194286
SPLIT-HAND/FOOT MALFORMATION 6	0.0746965	0.425288358334522
CHROMOSOME 5Q12 DELETION SYNDROME	0.074612262	0.4248087449559918
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 3; SEMDJL3	0.07454820000000001	0.4244440046694774
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0744235	0.4237340188162672
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.074373192	0.42344758763500584
SAUL-WILSON SYNDROME; SWILS	0.073952992	0.42105515735819
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.073816622	0.42027872776073794
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.073719822	0.41972759199016263
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.07269540199999999	0.41389500411730307
#615583 VERHEIJ SYNDROME; VRJS;;CHROMOSOME 8q24.3 DELETION SYNDROME	0.072608092	0.413397900149029
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.072418102	0.4123161823282479
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.071834872	0.40899553237501785
#601455 CHARCOT-MARIE-TOOTH DISEASE, TYPE 4D; CMT4D;;NEUROPATHY, HEREDITARY MOTOR AND SENSORY, LOM TYPE; HMSNL;;CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, AUTOSOMAL RECESSIVE, TYPE4D;;CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 4D;;HMSN4D	0.07151779	0.4071902097261999
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.071307992	0.4059957140402995
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.071213042	0.4054551113397197
SHORT-RIB THORACIC DYSPLASIA 16 WITH OR WITHOUT POLYDACTYLY; SRTD16	0.07080631000000001	0.40313936181247123
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.070789852	0.40304565734437064
WHITE-SUTTON SYNDROME; WHSUS	0.070686812	0.402458993813378
COFFIN-SIRIS SYNDROME 5	0.070302322	0.40026988025523225
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.07029225	0.40021253480604585
175500 POLYPOSIS, SKIN PIGMENTATION, ALOPECIA, AND FINGERNAIL CHANGES;;CRONKHITE-CANADA SYNDROME	0.07028989	0.4001990980248624
BARTSOCAS-PAPAS SYNDROME; BPS	0.07027757	0.4001289534722437
ATKIN-FLAITZ SYNDROME	0.07023494	0.39988623737823936
#608940 SPONDYLOMETAPHYSEAL DYSPLASIA WITH CONE-ROD DYSTROPHY; SMDCRD	0.0701315	0.39929729642670714
PRIMROSE SYNDROME; PRIMS	0.06996785999999999	0.39836560368397
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.069923662	0.39811396010145056
PEROXISOME BIOGENESIS DISORDER 14B	0.06984130000000001	0.39764502782525096
ELSAHY-WATERS SYNDROME; ESWS	0.069761592	0.3971912062343313
SMITH-MAGENIS SYNDROME; SMS	0.06954628199999999	0.39596532769339543
POLYDACTYLY, POSTAXIAL, TYPE A1; PAPA1	0.069303	0.3945801891341279
PREMATURE AGING SYNDROME, PENTTINEN TYPE	0.06921123	0.39405769192683754
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC; ARCL2C	0.06917904	0.39387441650891586
STICKLER SYNDROME, TYPE II	0.06892594	0.3924333786625045
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.068843072	0.3919615654493223
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.06852543999999999	0.39015311134726244
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.068515042	0.3900939098003364
CLARK-BARAITSER SYNDROME	0.0683762	0.3893034057439498
ALOPECIA-CONTRACTURES-DWARFISM MENTAL RETARDATION SYNDROME	0.06834731	0.3891389190454795
#300534 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CLAES-JENSEN TYPE; MRXSCJ;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, JARID1C-RELATED; MRXSJ	0.06820417000000001	0.3883239441053953
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.06801672200000002	0.38725669929214324
3MC SYNDROME 2	0.067995922	0.38713827342408563
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.06798149	0.38705610409101804
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.06782011	0.38613727877432946
BLAU SYNDROME	0.06753961	0.38454023762095774
KETOADIPICACIDURIA	0.067510582	0.3843749652124013
GERODERMA OSTEODYSPLASTICUM; GO	0.06682429	0.380467526470049
ACROOSTEOLYSIS	0.0666667	0.37957027971297286
SPONDYLOCOSTAL DYSOSTOSIS 3, AUTOSOMAL RECESSIVE; SCDO3	0.0666667	0.37957027971297286
%253240 MUCUS INSPISSATION OF RESPIRATORY TRACT	0.0666667	0.37957027971297286
COMPLEMENT HYPERACTIVATION, ANGIOPATHIC THROMBOSIS, AND PROTEIN-LOSING ENTEROPATHY; CHAPLE	0.0666667	0.37957027971297286
IMMUNODEFICIENCY 59 AND HYPOGLYCEMIA; IMD59	0.0666667	0.37957027971297286
173700 POIKILODERMA, HEREDITARY SCLEROSING	0.0666667	0.37957027971297286
PULMONARY FIBROSIS, IDIOPATHIC; IPF	0.0666667	0.37957027971297286
AASE-SMITH SYNDROME I	0.0666667	0.37957027971297286
PULMONARY ARTERIOVENOUS FISTULAS	0.0666667	0.37957027971297286
ACROFACIAL DYSOSTOSIS, PALAGONIA TYPE	0.0666667	0.37957027971297286
PEUTZ-JEGHERS SYNDROME	0.0666667	0.37957027971297286
NEUROPATHY, HEREDITARY SENSORY, TYPE IF; HSN1F	0.0666667	0.37957027971297286
HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL DOMINANT	0.0666667	0.37957027971297286
BRACHYDACTYLY, TYPE E, WITH ATRIAL SEPTAL DEFECT, TYPE II	0.0666667	0.37957027971297286
%162700 NEUTROPENIA, CHRONIC FAMILIAL;;LEUKOPENIA, BENIGN FAMILIAL	0.0666667	0.37957027971297286
178610 PULMONARY NODULAR LYMPHOID HYPERPLASIA, FAMILIAL	0.0666667	0.37957027971297286
EHLERS-DANLOS SYNDROME, VASCULAR TYPE; EDSVASC	0.0666667	0.37957027971297286
CLEIDORHIZOMELIC SYNDROME	0.06657544	0.37905068621687055
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.066478132	0.37849665812220995
#269000 SC PHOCOMELIA SYNDROME;;SC PSEUDOTHALIDOMIDE SYNDROME	0.066416492	0.37814570761706257
THAUVIN-ROBINET-FAIVRE SYNDROME	0.06636158200000002	0.37783307471249356
SPONDYLOOCULAR SYNDROME; SOS	0.06590582	0.3752381703626075
EHLERS-DANLOS SYNDROME, TYPE I	0.06575733	0.3743927349228065
Rothmund-Thomson syndrome	0.06558695	0.37342266764397775
MICROCEPHALY-MICROMELIA SYNDROME; MIMIS	0.06530734	0.3718306937513065
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Il; CDG1L	0.064484552	0.3671461080240322
#156200 MENTAL RETARDATION, AUTOSOMAL DOMINANT 1; MRD1CHROMOSOME 2q23.1 DELETION SYNDROME, INCLUDED	0.06428851	0.3660299328304874
FLYNN-AIRD SYNDROME	0.06428499	0.36600989152973923
CHROMOSOME 3pter-p25 DELETION SYNDROME	0.063786332	0.36317075660119
FEINGOLD SYNDROME 2; FGLDS2	0.06293561	0.358327127210535
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.06288174	0.35802041559936876
MECKEL SYNDROME, TYPE 6; MKS6	0.0626582	0.3567476791308314
MACDERMOT-WINTER SYNDROME	0.062595592	0.35639121726797834
EPIPHYSEAL DYSPLASIA, MULTIPLE, 5; EDM5	0.0625	0.35584695930743243
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, DI ROCCO TYPE; SEMDDR	0.0625	0.35584695930743243
ULNAR HYPOPLASIA	0.0625	0.35584695930743243
SPONDYLOEPIPHYSEAL DYSPLASIA, KONDO-FU TYPE; SEDKF	0.0625	0.35584695930743243
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 2; EDSARTH2	0.0625	0.35584695930743243
#252940 MUCOPOLYSACCHARIDOSIS, TYPE IIID; MPS3D;;MPS IIID;;SANFILIPPO SYNDROME D;;N-ACETYLGLUCOSAMINE-6-SULFATASE DEFICIENCY	0.06223803	0.35435541966055617
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.06201399	0.3530798364163444
157980 MOMO SYNDROME;;MACROSOMIA, OBESITY, MACROCEPHALY, AND OCULAR ABNORMALITIES	0.06172271	0.3514214187794312
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIa; CDG2A	0.061549	0.3504323919746105
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ij; CDG1J	0.061520521999999994	0.35027025101929604
BARATELA-SCOTT SYNDROME	0.060958892	0.3470725817752027
ROSSELLI-GULIENETTI SYNDROME	0.060558681999999996	0.3447939655898518
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.060171621999999994	0.3425902196047393
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.060067659999999995	0.34199830661940295
ROIFMAN SYNDROME; RFMN	0.059848432	0.3407501207442822
CLEFT LIP/PALATE-ECTODERMAL DYSPLASIA SYNDROME; CLPED1	0.0597148	0.33998928009042345
ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 2	0.0597148	0.33998928009042345
RETINITIS PIGMENTOSA, DEAFNESS, MENTAL RETARDATION, AND HYPOGONADISM	0.0597148	0.33998928009042345
RECOMBINANT CHROMOSOME 8 SYNDROME	0.05963972199999999	0.3395618196422493
SHORT-RIB THORACIC DYSPLASIA 6 WITH OR WITHOUT POLYDACTYLY; SRTD6	0.0595467	0.3390321941086702
%609166 BRANCHIOGENIC-DEAFNESS SYNDROME	0.059362729999999996	0.33798475146700957
BLOOM SYNDROME	0.05902745	0.33607581757074406
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 2; EDSMC2	0.058993870000000004	0.33588462811644737
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.05898460199999999	0.3358318602825455
%300712 CRANIOFACIOSKELETAL SYNDROME	0.058930932	0.3355262873816491
OTOONYCHOPERONEAL SYNDROME	0.05887439999999999	0.335204419536792
ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA 5; EKVP5	0.0588236	0.3349151871282669
ULNAR AGENESIS AND ENDOCARDIAL FIBROELASTOSIS	0.0588235	0.33491461777313203
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH SEVERE PROXIMAL FEMORAL DYSPLASIA	0.0588235	0.33491461777313203
Fabry disease	0.0588235	0.33491461777313203
WIDOW&#39;S PEAK SYNDROME	0.0588235	0.33491461777313203
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, RUSSE TYPE; HMSNR	0.0588235	0.33491461777313203
DERMOCHONDROCORNEAL DYSTROPHY	0.0588235	0.33491461777313203
PIERRE ROBIN SYNDROME AND OLIGODACTYLY	0.0588235	0.33491461777313203
#256850 GIANT AXONAL NEUROPATHY 1, AUTOSOMAL RECESSIVE; GAN1;;GAN	0.0588235	0.33491461777313203
APROSENCEPHALY SYNDROME	0.0588235	0.33491461777313203
245800 LAURENCE-MOON SYNDROME	0.0588235	0.33491461777313203
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2X; CMT2X	0.0588235	0.33491461777313203
ACRORENAL SYNDROME	0.0588235	0.33491461777313203
EPISODIC ATAXIA, TYPE 1; EA1	0.0588235	0.33491461777313203
601016 MIDLINE MALFORMATIONS, MULTIPLE, WITH LIMB ABNORMALITIES AND HYPOPITUITARISM;;DINCSOY SYNDROME	0.0586124	0.33371270908337525
ACROCEPHALOPOLYSYNDACTYLY TYPE III	0.05850354000000001	0.33309290908353195
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.05820892	0.3314154749851134
DEAFNESS, MID-TONE NEURAL	0.05810013000000001	0.3307960735338646
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 49	0.05810013000000001	0.3307960735338646
211930 CAMPTODACTYLY WITH FIBROUS TISSUE HYPERPLASIA AND SKELETAL DYSPLASIA	0.0579537	0.32996236680984237
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3	0.057949200000000006	0.32993674582877225
MUCOPOLYSACCHARIDOSIS, TYPE VI; MPS6	0.05788201999999999	0.3295542530491518
601976 OTOFACIOOSSEOUS-GONADAL SYNDROME	0.05775922000000001	0.3288550849435046
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.057674992	0.3283755285004879
NEMALINE MYOPATHY 2; NEM2	0.05741434	0.32689149295428943
MEIER-GORLIN SYNDROME 1; MGORS1	0.05737154999999999	0.3266478658920692
DYSSEGMENTAL DYSPLASIA WITH GLAUCOMA	0.057243220000000004	0.32591721244746247
MEIER-GORLIN SYNDROME 6; MGORS6	0.057148380000000006	0.325377236037531
DIAMOND-BLACKFAN ANEMIA 6; DBA6	0.057077539999999996	0.3249739048599736
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.05698029000000001	0.32442020699129126
#193510 WAARDENBURG SYNDROME, TYPE 2A; WS2A;;WAARDENBURG SYNDROME, TYPE IIA;;WAARDENBURG SYNDROME WITHOUT DYSTOPIA CANTHORUM;;WS2	0.0569488	0.32424091705931374
WARBURG MICRO SYNDROME 3; WARBM3	0.056429690000000005	0.32128533761857647
#300860 MENTAL RETARDATION, X-LINKED, SYNDROMIC, NASCIMENTO TYPE; MRXSN;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 30; MRXS30	0.05606012	0.3191811718465565
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.055653072	0.3168636231570817
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.055645892	0.3168227434583965
DEAFNESS, AUTOSOMAL DOMINANT 65; DFNA65	0.055555600000000004	0.3163086613199999
POLYENDOCRINE-POLYNEUROPATHY SYNDROME; PEPNS	0.055555600000000004	0.3163086613199999
PERRAULT SYNDROME 4	0.055555600000000004	0.3163086613199999
#613453 DEAFNESS, AUTOSOMAL RECESSIVE 91; DFNB91	0.055555600000000004	0.3163086613199999
%606012 DEAFNESS, AUTOSOMAL DOMINANT 18; DFNA18	0.055555600000000004	0.3163086613199999
OSTEOGENESIS IMPERFECTA, TYPE XII; OI12	0.055555600000000004	0.3163086613199999
DEAFNESS WITH ANHIDROTIC ECTODERMAL DYSPLASIA	0.055555600000000004	0.3163086613199999
DEAFNESS, AUTOSOMAL RECESSIVE 112; DFNB112	0.055555600000000004	0.3163086613199999
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.055358692	0.315187555510987
#192350 VATER ASSOCIATIONVACTERL ASSOCIATION, INCLUDED	0.0552188	0.314391073225684
HYPERTELORISM, TEEBI TYPE; TBHS	0.05513446	0.3139108791049162
WAARDENBURG SYNDROME, TYPE 2D; WS2D	0.05497831	0.3130218310617825
HYDROLETHALUS SYNDROME 1	0.05490353	0.31259606729191036
HIRSCHSPRUNG DISEASE WITH POLYDACTYLY, RENAL AGENESIS, AND DEAFNESS	0.05465204	0.3111641960631707
HURLER SYNDROME	0.054617602	0.3109681215418167
FANCONI ANEMIA, COMPLEMENTATION GROUP P; FANCP	0.054508709999999995	0.31034813934833017
311450 PALLISTER W SYNDROME;;W SYNDROME	0.05384905	0.30659233126550234
FACIODIGITOGENITAL SYNDROME, AUTOSOMAL RECESSIVE	0.05377314	0.30616013378260587
OTOFACIOCERVICAL SYNDROME 2	0.053714899999999996	0.30582854135204485
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.053699342	0.30573996108015833
MCDONOUGH SYNDROME	0.0536631	0.30553361539217083
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.05339225	0.30399151700931615
FIBROCHONDROGENESIS 1; FBCG1	0.05330274	0.30348188722807445
PALMOPLANTAR KERATODERMA AND CONGENITAL ALOPECIA 2; PPKCA2	0.0532213	0.30301820440621846
CRANIOFRONTONASAL SYNDROME; CFNS	0.053212331999999994	0.30296714463772134
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.052928822	0.3013529658947894
FRONTOOCULAR SYNDROME	0.052915372	0.30127638762914644
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.052902932	0.30120555985036584
15q26 overgrowth syndrome	0.05289503	0.3011605694076067
THREE M SYNDROME 2; 3M2	0.0526316	0.299660717175761
%223200 DISORGANIZATION, MOUSE, HOMOLOG OF;;DS	0.052544530000000006	0.29916497965981065
ASPHYXIATING THORACIC DYSTROPHY 2; ATD2	0.0524867	0.2988357215853026
#608836 CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LETHAL NEONATAL;;CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, NEONATAL;;CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, ANTENATAL;;CPT II DEFICIENCY, LETHAL NEONATAL;;CPT2 DEFICIENCY, LETHAL NEONATAL	0.0524815	0.29880611511828825
#610758 CEREBROOCULOFACIOSKELETAL SYNDROME 4; COFS4	0.052244692	0.29745783661045344
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.0520482	0.2963390993188017
SHORT-RIB THORACIC DYSPLASIA 20 WITH POLYDACTYLY; SRTD20	0.05181308999999999	0.29500048846115734
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.051725162000000005	0.29449986587814964
#156550 KNIEST DYSPLASIA	0.05144137	0.29288408155373724
TRICHOTHIODYSTROPHY 6, NONPHOTOSENSITIVE; TTD6	0.05127551	0.29193974912700554
#219100 CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IA; ARCL1A;;ARCL1;;CUTIS LAXA, AUTOSOMAL RECESSIVE	0.05122595	0.2916575767221531
RAINE SYNDROME	0.05079947199999999	0.2892294023299688
SWEENEY-COX SYNDROME; SWCOS	0.050760142	0.2890054749554159
FANCONI ANEMIA, COMPLEMENTATION GROUP O	0.050439899999999996	0.28718216068433533
DEAFNESS, SENSORINEURAL, AND MALE INFERTILITY	0.05	0.28467756744594597
DEAFNESS, AUTOSOMAL RECESSIVE 77; DFNB77	0.05	0.28467756744594597
#610265 DEAFNESS, AUTOSOMAL RECESSIVE 67; DFNB67	0.05	0.28467756744594597
#602722 RENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL RECESSIVE; RTADR;;RTA, DISTAL, AUTOSOMAL RECESSIVE;;RENAL TUBULAR ACIDOSIS, AUTOSOMAL RECESSIVE, WITH PRESERVED HEARINGRENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL RECESSIVE, WITH LATE-ONSETSENSORINEURAL HEARING LOSS, INCLUDED	0.05	0.28467756744594597
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 11	0.05	0.28467756744594597
HOLZGREVE SYNDROME	0.05	0.28467756744594597
DEAFNESS, AUTOSOMAL RECESSIVE 94; DFNB94	0.05	0.28467756744594597
%217100 CONSTRICTING BANDS, CONGENITAL;;AMNIOTIC BAND SEQUENCE; ABS;;STREETER ANOMALYADAM COMPLEX, INCLUDED;;TERMINAL TRANSVERSE DEFECTS OF ARM, INCLUDED;;AMPUTATION, CONGENITAL, INCLUDED	0.05	0.28467756744594597
DEAFNESS, AUTOSOMAL RECESSIVE 101; DFNB101	0.05	0.28467756744594597
PERIPHERAL DYSOSTOSIS	0.05	0.28467756744594597
SPASTIC PARAPLEGIA, SENSORINEURAL DEAFNESS, MENTAL RETARDATION, AND	0.05	0.28467756744594597
DEAFNESS, AUTOSOMAL RECESSIVE 37; DFNB37	0.05	0.28467756744594597
DISPROPORTIONATE SHORT STATURE WITH PTOSIS AND VALVULAR HEART LESIONS	0.0499368	0.2843177350006943
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.049929082	0.2842737921713833
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, AGGRECAN TYPE; SEMDAG	0.0499108	0.2841697026656224
ACROFACIAL DYSOSTOSIS SYNDROME OF RODRIGUEZ	0.04988474	0.28402132871746955
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.049838242	0.28375658996684755
ULNAR-MAMMARY SYNDROME; UMS	0.0496952	0.2829421729947955
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.049638472	0.282619189213874
CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG	0.04943651	0.28146930819634364
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIg; CDG2G	0.04907532199999999	0.27941286577173025
CARTILAGE-HAIR HYPOPLASIA; CHH	0.04898122	0.2788770912026943
#170100 PROLIDASE DEFICIENCY	0.048979222	0.2788657154870992
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.048690781999999995	0.277223467536017
MENTAL RETARDATION, AUTOSOMAL DOMINANT 27	0.04868511	0.2771911737127659
RITSCHER-SCHINZEL SYNDROME 1	0.048639042	0.27692888318922393
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 2; DRS2	0.04850836	0.27618483851184455
SHORT-RIB THORACIC DYSPLASIA 10 WITH OR WITHOUT POLYDACTYLY; SRTD10	0.048372500000000006	0.27541131262558044
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.048279699999999995	0.27488295106040067
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.04800281	0.2733064636273986
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.047908722	0.2727707687680815
GENITOPATELLAR SYNDROME; GTPTS	0.047769792	0.27197976367917615
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.047762922	0.27194064898140907
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.047651382000000006	0.27130559026395074
#600175 SPINAL MUSCULAR ATROPHY, DISTAL, CONGENITAL NONPROGRESSIVE;;SPINAL MUSCULAR ATROPHY, CONGENITAL BENIGN, WITH CONTRACTURES	0.047439300000000004	0.2700980905067693
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.047439300000000004	0.2700980905067693
#259450 BRUCK SYNDROME 1; BRKS1	0.047439300000000004	0.2700980905067693
ALAZAMI-YUAN SYNDROME	0.047127192	0.26832108758236084
236410 HUMERORADIAL SYNOSTOSIS WITH CRANIOFACIAL ANOMALIES	0.04680272	0.26647368958907447
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.046787732	0.2663883546414569
PERRAULT SYNDROME 3	0.04673001	0.26605971147049456
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ip; CDG1P	0.046726052000000004	0.26603717639425556
SOTOS SYNDROME 2	0.04666492	0.2656891182131934
CHROMOSOME 2q37 DELETION SYNDROME	0.046658232	0.2656510397417719
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.046608371999999995	0.2653671592715148
#163950 NOONAN SYNDROME 1; NS1;;NOONAN SYNDROME;;MALE TURNER SYNDROME;;FEMALE PSEUDO-TURNER SYNDROME;;TURNER PHENOTYPE WITH NORMAL KARYOTYPEPTERYGIUM COLLI SYNDROME, INCLUDED	0.04648110000000001	0.26464252960423523
#614185 GELEOPHYSIC DYSPLASIA 2; GPHYSD2	0.04642204	0.264306268461568
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.046420192	0.26429574677867523
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.046401472	0.26418916349742344
CHROMOSOME 15q25 DELETION SYNDROME	0.046318762	0.2637182498653544
HUNTER-MACDONALD SYNDROME	0.0462254	0.2631866885243166
SPLIT-FOOT DEFORMITY WITH MANDIBULOFACIAL DYSOSTOSIS	0.046175999999999995	0.26290542708768
SHORT SYNDROME	0.04608813	0.26240513473065047
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.046045831999999995	0.26216430889569386
OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	0.045776580000000004	0.26063130880789487
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.045767911999999994	0.26058195710480236
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.045767911999999994	0.26058195710480236
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.04575324199999999	0.2604984327065137
#300004 CORPUS CALLOSUM, AGENESIS OF, WITH ABNORMAL GENITALIA;;ACC WITH ABNORMAL GENITALIA;;PROUD SYNDROME	0.045661892	0.25997832679079
LAMB-SHAFFER SYNDROME	0.045611492000000003	0.2596913718028045
#612626 CHROMOSOME 15q26-qter DELETION SYNDROME;;DRAYER SYNDROME	0.045597692	0.2596128007941894
USHER SYNDROME, TYPE IIA	0.0454545	0.258797529789435
DEAFNESS, AUTOSOMAL RECESSIVE 109; DFNB109	0.0454545	0.258797529789435
DEAFNESS, X-LINKED 3	0.0454545	0.258797529789435
%300700 ALBINISM-DEAFNESS SYNDROME; ADFN;;ALDS	0.0454545	0.258797529789435
USHER SYNDROME, TYPE IF	0.0454545	0.258797529789435
DEAFNESS, AUTOSOMAL RECESSIVE 108; DFNB108	0.0454545	0.258797529789435
JERVELL AND LANGE-NIELSEN SYNDROME 2	0.0454545	0.258797529789435
USHER SYNDROME, TYPE IE; USH1E	0.0454545	0.258797529789435
POLYMICROGYRIA, PERISYLVIAN, WITH CEREBELLAR HYPOPLASIA AND ARTHROGRYPOSIS; PMGYCHA	0.0454545	0.258797529789435
PENDRED SYNDROME	0.0454545	0.258797529789435
DEAFNESS-OLIGODONTIA SYNDROME	0.0454545	0.258797529789435
%226500 EPIDERMOLYSIS BULLOSA DYSTROPHICA NEUROTROPHICA;;EPIDERMOLYSIS BULLOSA WITH CONGENITAL DEAFNESS;;EPIDERMOLYSIS BULLOSA PROGRESSIVA, RECESSIVE; EBR3	0.0454545	0.258797529789435
USHER SYNDROME, TYPE IC	0.0454545	0.258797529789435
DEAFNESS, AUTOSOMAL RECESSIVE 63	0.0454545	0.258797529789435
JERVELL AND LANGE-NIELSEN SYNDROME 1	0.0454545	0.258797529789435
ARTHROGRYPOSIS, DISTAL, TYPE 2B3; DA2B3	0.0454545	0.258797529789435
USHER SYNDROME, TYPE IIC	0.0454545	0.258797529789435
HOMOZYGOUS 11P15-P14 DELETION SYNDROME	0.0454545	0.258797529789435
SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1	0.045352489999999995	0.25821673061633177
#300672 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 2; EIEE2;;INFANTILE SPASM SYNDROME, X-LINKED 2; ISSX2	0.045284982	0.257832370351869
ARTHROGRYPOSIS, DISTAL, TYPE 5D; DA5D	0.0451837	0.25725571608414777
STICKLER SYNDROME, TYPE I	0.04496487	0.25600979624246384
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 7; MDDGA7	0.04495124	0.2559321931375781
KLEEFSTRA SYNDROME	0.04488487	0.2555543121345503
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.044598971999999994	0.25392653719099706
#610313 COLD-INDUCED SWEATING SYNDROME 2; CISS2	0.0445709	0.2537667078175302
CORNEODERMATOOSSEOUS SYNDROME	0.0445633	0.2537234368272785
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.044527372	0.25351887891441455
#103580 PSEUDOHYPOPARATHYROIDISM, TYPE IA; PHP1A;;PHP IA;;ALBRIGHT HEREDITARY OSTEODYSTROPHY WITH MULTIPLE HORMONE RESISTANCE	0.044342889999999996	0.2524685211744632
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.044307971999999994	0.25226971374846163
#303110 CHOROIDEREMIA, DEAFNESS, AND MENTAL RETARDATION;;CHROMOSOME Xq21 DELETION SYNDROME	0.044232971999999995	0.2518426973972927
#602588 BRANCHIOOTIC SYNDROME 1; BOS1;;BO SYNDROME 1;;BRANCHIOOTIC DYSPLASIAANTERIOR SEGMENT ANOMALIES WITH OR WITHOUT CATARACT, INCLUDED	0.04421123	0.25171890820386456
BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS	0.04414393999999999	0.25133578913359583
611961 STEVENSON-CAREY SYNDROME	0.043869932	0.24977571051558126
CHONDRODYSPLASIA-PSEUDOHERMAPHRODITISM SYNDROME	0.04383501	0.24957688031537428
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.0436994	0.2488047778169474
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.0436994	0.2488047778169474
#252930 MUCOPOLYSACCHARIDOSIS TYPE IIIC;;MPS IIIC; MPS3C;;SANFILIPPO SYNDROME C;;ACETYL-CoA:ALPHA-GLUCOSAMINIDE N-ACETYLTRANSFERASE DEFICIENCY	0.0436994	0.2488047778169474
MUCOPOLYSACCHARIDOSIS, TYPE II	0.0436663	0.24861632126729816
BULLOUS DYSTROPHY, HEREDITARY MACULAR TYPE	0.04362671	0.24839091356939452
603463 HYPOSPADIAS, HYPERTELORISM, UPPER LID COLOBOMA, AND MIXED-TYPE HEARINGLOSS	0.04352543999999999	0.24781432762428943
CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT	0.04352543999999999	0.24781432762428943
#256050 ATELOSTEOGENESIS, TYPE II; AOII;;AO2;;NEONATAL OSSEOUS DYSPLASIA IDE LA CHAPELLE DYSPLASIA, INCLUDED; DLCD, INCLUDED	0.043478300000000004	0.24754593361370147
%309620 MENTAL RETARDATION, SKELETAL DYSPLASIA, AND ABDUCENS PALSY; MRSD;;CHRISTIAN SYNDROME; CHRS	0.043478300000000004	0.24754593361370147
INFANTILE LIVER FAILURE SYNDROME 1	0.043125422000000004	0.24553680460079763
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.043011522	0.24488830910215578
FRANK-TER HAAR SYNDROME; FTHS	0.0428677	0.24406945116005158
BOSMA ARHINIA MICROPHTHALMIA SYNDROME	0.04283496	0.2438830442888879
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.042831890000000004	0.24386556508624677
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.042807402	0.24372614140081447
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.042803730000000005	0.24370523468026126
BETHLEM MYOPATHY 1	0.042677400000000004	0.2429859683383523
%187370 ARTHROGRYPOSIS, DISTAL, TYPE 10; DA10;;CONGENITAL PLANTAR CONTRACTURES;;TENDO CALCANEUS, SHORT	0.042677400000000004	0.2429859683383523
#256520 NEU-LAXOVA SYNDROME; NLS	0.04266757	0.24293000072859242
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.042616732000000004	0.2426405519651161
AICARDI SYNDROME; AIC	0.042365129999999994	0.24120804305862534
GABRIELE-DE VRIES SYNDROME; GADEVS	0.042354162	0.24114559618743045
CHROMOSOME 19p13.13 DELETION SYNDROME	0.042205172	0.24029731397195497
DUBOWITZ SYNDROME	0.041830400000000004	0.23816353034581797
#158350 COWDEN SYNDROME 1; CWS1;;CS; CD;;MULTIPLE HAMARTOMA SYNDROME; MHAMDYSPLASTIC GANGLIOCYTOMA OF THE CEREBELLUM, INCLUDED;;CEREBELLOPARENCHYMAL DISORDER VI, INCLUDED; CPD6, INCLUDED;;CEREBELLAR GRANULE CELL HYPERTROPHY AND MEGALENCEPHALY, INCLUDED;;LHERMITTE-DUCLOS DISEASE, INCLUDED; LDD, INCLUDED;;PROTEUS-LIKE SYNDROME, INCLUDED	0.041826812	0.23814310188357804
#615663 WARBURG MICRO SYNDROME 4; WARBM4	0.04181497000000001	0.2380756788485042
#616395 TRICHOTHIODYSTROPHY 3, PHOTOSENSITIVE; TTD3 ;;TRICHOTHIODYSTROPHY, COMPLEMENTATION GROUP A; TTDA	0.04178109	0.23788278132880278
#616351 MENTAL RETARDATION, AUTOSOMAL DOMINANT 34; MRD34	0.041678032000000004	0.23729601531388592
BRANCHIOOTORENAL SYNDROME 1	0.041666699999999994	0.23723149598999987
#612290 MICROTIA, HEARING IMPAIRMENT, AND CLEFT PALATEMICROTIA WITH OR WITHOUT HEARING IMPAIRMENT, INCLUDED	0.041666699999999994	0.23723149598999987
CALVARIAL DOUGHNUT LESIONS WITH BONE FRAGILITY; CDL	0.041666699999999994	0.23723149598999987
OTOSCLEROSIS 4	0.041666699999999994	0.23723149598999987
#218000 AGENESIS OF THE CORPUS CALLOSUM WITH PERIPHERAL NEUROPATHY; ACCPN;;CHARLEVOIX DISEASE;;ANDERMANN SYNDROME;;POLYNEUROPATHY, SENSORIMOTOR, WITH OR WITHOUT AGENESIS OF THE CORPUSCALLOSUM;;CORPUS CALLOSUM, AGENESIS OF, WITH NEURONOPATHY	0.041553542	0.23658722510645894
PEROXISOME BIOGENESIS DISORDER 10B	0.041504071999999996	0.2363055651212279
OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY	0.04115099	0.23429527462384894
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.041039400000000004	0.23365993122882311
COWDEN SYNDROME 6; CWS6	0.04098293	0.23333841638414962
COWDEN SYNDROME 5; CWS5	0.04098293	0.23333841638414962
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.040884380000000005	0.23277731689871373
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.040739359999999995	0.23195163808209346
DEAFNESS, X-LINKED 2	0.04059579	0.23113421491492916
SPLIT-HAND/FOOT MALFORMATION 2	0.0405754	0.2310181234029247
CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	0.04049847	0.2305801184976524
122430 CORNEAL HYPESTHESIA WITH RETINAL ABNORMALITIES, SENSORINEURAL DEAFNESS,UNUSUAL FACIES, PERSISTENT DUCTUS ARTERIOSUS, AND MENTAL RETARDATION;;RAMOS-ARROYO SYNDROME	0.040437589999999995	0.23023349509153018
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ig; CDG1G	0.040425412	0.23016415902320306
#230600 GM1-GANGLIOSIDOSIS, TYPE II;;GANGLIOSIDOSIS, GENERALIZED GM1, JUVENILE TYPE;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE II;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE 2GANGLIOSIDOSIS, GENERALIZED GM1, LATE-INFANTILE TYPE, INCLUDED	0.040203989999999995	0.2289034814964227
ADAMS-OLIVER SYNDROME 2; AOS2	0.040175462	0.2287410558635408
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.040169052	0.22870456019939417
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.040159242000000005	0.22864870646066132
ACROMEGALOID CHANGES, CUTIS VERTICIS GYRATA, AND CORNEAL LEUKOMA	0.04	0.22774205395675678
DERMATOLEUKODYSTROPHY	0.04	0.22774205395675678
Lipodystrophy, congenital generalized, type 2	0.04	0.22774205395675678
CHROMOSOME Xq26.3 DUPLICATION SYNDROME	0.04	0.22774205395675678
#246200 DONOHUE SYNDROME;;LEPRECHAUNISMINSULIN RECEPTOR, DEFECT IN, INCLUDED	0.04	0.22774205395675678
Lipodystrophy, congenital generalized, type 1	0.04	0.22774205395675678
#606764 GASTROINTESTINAL STROMAL TUMOR; GIST	0.04	0.22774205395675678
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.04	0.22774205395675678
MESOMELIC DYSPLASIA, KANTAPUTRA TYPE	0.04	0.22774205395675678
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.039919122	0.2272815709107589
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.03975389	0.22634081403427433
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.03970132999999999	0.2260415609753751
DEAFNESS, CONGENITAL, AND ONYCHODYSTROPHY, AUTOSOMAL DOMINANT	0.039581530000000004	0.22535947352377467
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.03950868	0.22494469830800592
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.039382512	0.2242263543214155
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.03937209200000001	0.22416702751635983
KAGAMI-OGATA SYNDROME	0.039305382	0.2237872107058734
#309520 LUJAN-FRYNS SYNDROME;;MENTAL RETARDATION, X-LINKED, WITH MARFANOID HABITUS	0.039255240000000004	0.22350172465413592
MARDEN-WALKER SYNDROME	0.039250610000000005	0.22347536351139044
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.039156392	0.22293892849039798
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia; CDG1A	0.039156392	0.22293892849039798
#300706 MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST;;MENTAL RETARDATION AND MACROCEPHALY SYNDROME	0.039075200000000004	0.22247665766927655
%263630 POLYSYNDACTYLY WITH CARDIAC MALFORMATION;;BONNEAU SYNDROME	0.03889574	0.22145489294419954
SCHOLTE SYNDROME; SHLTS	0.03888595	0.22139915307649366
#269921 SIALURIA;;SIALURIA, FRENCH TYPE	0.038730852	0.22051609464937902
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.038709412000000006	0.22039402490845822
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.038611931999999995	0.21983901752296556
MECKEL SYNDROME, TYPE 1; MKS1	0.038544680000000005	0.2194561148076481
THUMBS, CONGENITAL CLASPED	0.0384757	0.21906337363559966
%300158 ARTHROGRYPOSIS, CONGENITAL, LOWER LIMB, X-LINKED; ACLLX;;ARTHROGRYPOSIS, X-LINKED, TYPE V, FORMERLY; AMCX5, FORMERLY	0.03847239	0.21904452798063473
MENKES DISEASE	0.038381229999999995	0.21852550383966726
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.03838113	0.2185249344845324
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.038233852	0.2176863996289663
TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1	0.03815581	0.21724206349459396
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.0380952	0.216896977347336
AYME-GRIPP SYNDROME; AYGRP	0.03782465	0.215356587029886
#600638 FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3A, WITH OR WITHOUT EXTRAOCULARINVOLVEMENT; CFEOM3A;;FEOM3 LOCUS	0.037811282	0.21528047563545366
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.03776805	0.21503433202353714
IMMUNODEFICIENCY 23; IMD23	0.037734202	0.21484161669747898
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.037553712	0.21381398761451265
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.037469262	0.21333316720309642
#614069 IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME2; ICF2	0.03737417	0.212791756018225
BARAITSER-WINTER SYNDROME 2; BRWS2	0.03724128	0.21203513997946716
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.037123902	0.21136684230923375
#615550 DIAMOND-BLACKFAN ANEMIA 12; DBA12	0.037037	0.21087206130991
KENNERKNECHT SYNDROME	0.037037	0.21087206130991
%190600 TRIPHALANGEAL THUMB, NONOPPOSABLE	0.037037	0.21087206130991
TRIPHALANGEAL THUMBS AND DISLOCATION OF PATELLA	0.037037	0.21087206130991
%174600 POLYDACTYLY, PREAXIAL III;;INDEX FINGER POLYDACTYLY	0.037037	0.21087206130991
PREAXIAL HALLUCAL POLYDACTYLY	0.037037	0.21087206130991
HALLUX VARUS AND PREAXIAL POLYSYNDACTYLY	0.037037	0.21087206130991
BIEMOND SYNDROME II	0.037037	0.21087206130991
CRANIOSYNOSTOSIS 2	0.037037	0.21087206130991
256690 NEUROFACIODIGITORENAL SYNDROME;;NFDR SYNDROME	0.037037	0.21087206130991
SYNDACTYLY-POLYDACTYLY-EARLOBE SYNDROME	0.037037	0.21087206130991
CERVICAL RIBS, SPRENGEL ANOMALY, ANAL ATRESIA, AND URETHRAL OBSTRUCTION	0.037037	0.21087206130991
NIPPLES INVERTED	0.037037	0.21087206130991
WARBURG MICRO SYNDROME 2; WARBM2	0.03703618	0.2108673925978039
FIBROSCLEROSIS, MULTIFOCAL	0.0369674	0.21047579013602524
138770 GMS SYNDROME;;GONIODYSGENESIS--MENTAL RETARDATION--SHORT STATURE SYNDROME	0.03692574	0.2102385967868293
DEAFNESS, AUTOSOMAL RECESSIVE 79; DFNB79	0.036843310000000004	0.20976927734913794
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.036804242	0.20954684168503832
#615665 JOUBERT SYNDROME 22; JBTS22	0.036567511999999996	0.20819900727420873
RETINITIS PIGMENTOSA 80; RP80	0.036558182	0.20814588644012338
TRANSALDOLASE DEFICIENCY	0.0364943	0.2077821709928517
MANITOBA OCULOTRICHOANAL SYNDROME	0.03647887	0.20769431949553785
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	0.03642129	0.20736648480886716
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.036336532000000005	0.20688391078363552
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.03631651200000001	0.20676992588563015
#610185 CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME2; CAMRQ2;;CEREBELLAR ATAXIA AND MENTAL RETARDATION WITH OR WITHOUT QUADRUPEDALLOCOMOTION 2	0.036285562	0.2065937104713811
BARAITSER-WINTER SYNDROME 1; BRWS1	0.036264922	0.20647619557153934
OROFACIODIGITAL SYNDROME I; OFD1	0.03625259000000001	0.20640598269630459
TENORIO SYNDROME; TNORS	0.03598708	0.20489428787765304
PITT-HOPKINS SYNDROME	0.035960360000000004	0.20474215618560995
264475 PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HANDANOMALIES;;ACROOTOOCULAR SYNDROME;;AOO SYNDROME	0.03590767	0.20444216296503542
WEYERS ACROFACIAL DYSOSTOSIS	0.03556164	0.20247202339176898
FRYNS MICROPHTHALMIA SYNDROME	0.035511329999999994	0.20218558082340488
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.035509492000000004	0.2021751160760256
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.035464642000000005	0.20191976029802658
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.035439972	0.2017793003862487
%312150 MULTIPLE PTERYGIUM SYNDROME, X-LINKED;;PTERYGIUM SYNDROME, MULTIPLE, X-LINKED	0.03541907	0.2016602937759536
#253290 MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE; LMPS;;PTERYGIUM SYNDROME, MULTIPLE, LETHAL TYPE	0.03541907	0.2016602937759536
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.035336172000000006	0.20118830975623098
212540 CATARACT, MICROCEPHALY, FAILURE TO THRIVE, KYPHOSCOLIOSIS SYNDROME;;CAMFAK SYNDROMECATARACT, MICROCEPHALY, ARTHROGRYPOSIS, KYPHOSIS SYNDROME, INCLUDED;;CAMAK SYNDROME, INCLUDED	0.035201699999999995	0.20042268651923908
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.035126620000000004	0.1999952146839623
SCLEROSTEOSIS 2; SOST2	0.03495503999999999	0.19901831514351473
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.03462005	0.19711103237714042
2p15-16.1 microdeletion syndrome	0.03460882	0.19704709379549207
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.0343105	0.19534859355708256
#244460 KENNY-CAFFEY SYNDROME, TYPE 1; KCS1;;KCS;;KENNY-CAFFEY SYNDROME, AUTOSOMAL RECESSIVE	0.03425164	0.1950134711246852
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.03425164	0.1950134711246852
%601927 LYMPHEDEMA, CARDIAC SEPTAL DEFECTS, AND CHARACTERISTIC FACIES;;IRONS-BIANCHI SYNDROME;;LYMPHEDEMA, ATRIAL SEPTAL DEFECT, AND CHARACTERISTIC FACIES	0.03421714	0.1948170436031475
DEAFNESS, AUTOSOMAL DOMINANT 41; DFNA41	0.0340433	0.19382727663665142
#191900 MUCKLE-WELLS SYNDROME; MWS;;URTICARIA-DEAFNESS-AMYLOIDOSIS SYNDROME;;UDA SYNDROME;;CRYOPYRIN-ASSOCIATED PERIODIC SYNDROME 2; CAPS2	0.0340433	0.19382727663665142
JACOBSEN SYNDROME	0.034030300000000006	0.19375326046911553
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.034008732	0.19363046195362202
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.03398496200000001	0.19349512623805823
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.033795882	0.19241858954900462
CEREBELLAR ATAXIA, AREFLEXIA, PES CAVUS, OPTIC ATROPHY, AND SENSORINEURAL HEARING LOSS; CAPOS	0.03379453	0.1924108918675809
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2J	0.03379453	0.1924108918675809
221745 DEAFNESS, SENSORINEURAL, AUTOSOMAL-MITOCHONDRIAL TYPE	0.03379453	0.1924108918675809
#615328 SHAHEEN SYNDROME; SHNS	0.033736089999999996	0.19207816072675002
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.033668409999999996	0.1916928211714552
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.033610112	0.19136089851491594
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.033551262	0.19102583301803205
FANCONI ANEMIA, COMPLEMENTATION GROUP Q; FANCQ	0.03353361	0.19092533044962093
FANCONI ANEMIA, COMPLEMENTATION GROUP W; FANCW	0.03353361	0.19092533044962093
SKELETAL DEFECTS, GENITAL HYPOPLASIA, AND MENTAL RETARDATION	0.03353361	0.19092533044962093
201310 ACRORENAL SYNDROME, AUTOSOMAL RECESSIVE	0.0334169	0.19026083607168864
COFFIN-SIRIS SYNDROME 6; CSS6	0.033415122	0.19025071293739024
SPEECH-LANGUAGE DISORDER 1	0.03335178	0.18989007200784702
CRANIOSYNOSTOSIS 6; CRS6	0.033325382	0.18973977363933828
COACH SYNDROME	0.033217922000000004	0.18912794461138346
KLIPPEL-FEIL SYNDROME, AUTOSOMAL RECESSIVE	0.03316692	0.18883756210548588
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.033101981999999995	0.18846783426798977
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.033101981999999995	0.18846783426798977
MARFAN SYNDROME; MFS	0.03307455	0.18831164876738624
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.03303794200000001	0.18810321923960507
WERNER SYNDROME; WRN	0.03303499	0.188086411876023
#129500 CLOUSTON SYNDROME;;ECTODERMAL DYSPLASIA 2, CLOUSTON TYPE; ECTD2;;ECTODERMAL DYSPLASIA, HIDROTIC, AUTOSOMAL DOMINANT;;CLOUSTON HIDROTIC ECTODERMAL DYSPLASIA;;ECTODERMAL DYSPLASIA, HIDROTIC, 2, FORMERLY; HED2, FORMERLY	0.03303499	0.188086411876023
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.032980492	0.18777612471460964
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.032869682	0.1871452222896359
WAARDENBURG SYNDROME, TYPE IIB	0.03284753	0.18701909874015465
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.032759739999999996	0.18651926186723305
#263750 POSTAXIAL ACROFACIAL DYSOSTOSIS; POADS;;MILLER SYNDROME;;GENEE-WIEDEMANN SYNDROME	0.03268223	0.18607795470217836
SCALP-EAR-NIPPLE SYNDROME; SENS	0.03266913	0.18600336917950752
PFEIFFER-PALM-TELLER SYNDROME	0.03266913	0.18600336917950752
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.032573302000000005	0.18545776754084337
#103285 ADULT SYNDROME;;ACRO-DERMATO-UNGUAL-LACRIMAL-TOOTH SYNDROME	0.0325397	0.18526645282841694
CREE MENTAL RETARDATION SYNDROME	0.032517081999999996	0.18513767608400708
SPINOCEREBELLAR ATAXIA 47; SCA47	0.03233838	0.1841202270708526
VENTRICULOMEGALY WITH DEFECTS OF THE RADIUS AND KIDNEY	0.0322581	0.18366314876856138
ECTODERMAL DYSPLASIA 1, HYPOHIDROTIC, X-LINKED; XHED	0.0322581	0.18366314876856138
HUMEROFEMORAL HYPOPLASIA WITH RADIOTIBIAL RAY DEFICIENCY; HHRRD	0.0322581	0.18366314876856138
MENTAL RETARDATION, AUTOSOMAL DOMINANT 4; MRD4	0.0322581	0.18366314876856138
FANCONI ANEMIA, COMPLEMENTATION GROUP B; FANCB	0.0322581	0.18366314876856138
RADIAL-RENAL SYNDROME	0.0322581	0.18366314876856138
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 4; CEMCOX4	0.0322581	0.18366314876856138
DIAMOND-BLACKFAN ANEMIA 11; DBA11	0.0322581	0.18366314876856138
KERATODERMA, PALMOPLANTAR, WITH DEAFNESS	0.0322051	0.18336139054706868
CHONDRODYSPLASIA PUNCTATA, AUTOSOMAL DOMINANTCHONDRODYSPLASIA PUNCTATA DUE TO VITAMIN K DEFICIENCY, INCLUDED	0.03219459	0.18330155132239156
#615314 CRANIOSYNOSTOSIS 3; CRS3	0.031832882	0.18124214825107676
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.03175158	0.18077925113930698
15q24 recurrent microdeletion syndrome	0.03157851	0.17979386820734955
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.031531192	0.17952446074462142
#231550 ACHALASIA-ADDISONIANISM-ALACRIMA SYNDROME; AAAS;;TRIPLE-A SYNDROME;;ALACRIMA-ACHALASIA-ADRENAL INSUFFICIENCY NEUROLOGIC DISORDER;;GLUCOCORTICOID DEFICIENCY AND ACHALASIA;;ALLGROVE SYNDROME;;ADDISONIAN-ACHALASIA SYNDROME;;HYPOADRENALISM WITH ACHALASIA;;ALACRIMA-ACHALASIA-ADDISONIANISM;;ACTH-RESISTANT ADRENAL INSUFFICIENCY, ACHALASIA AND ALACRIMAACHALASIA-ALACRIMA SYNDROME, INCLUDED	0.031531192	0.17952446074462142
CARDIAC VALVULAR DYSPLASIA, X-LINKED; CVD1	0.03127054	0.178040425198423
#230500 GM1-GANGLIOSIDOSIS, TYPE I;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE I;;GANGLIOSIDOSIS, GENERALIZED GM1, INFANTILE FORM;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE 1;;BETA-GALACTOSIDASE-1 DEFICIENCY;;GLB1 DEFICIENCYGM1-GANGLIOSIDOSIS, TYPE I, WITH CARDIAC INVOLVEMENT, INCLUDED;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE I, WITH CARDIAC INVOLVEMENT,INCLUDED	0.03127054	0.178040425198423
FIBROMATOSIS, GINGIVAL, WITH PROGRESSIVE DEAFNESS	0.03125	0.17792347965371622
OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMALDOMINANT	0.03125	0.17792347965371622
#600208 MACROTHROMBOCYTOPENIA AND PROGRESSIVE SENSORINEURAL DEAFNESS	0.03125	0.17792347965371622
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 4	0.03125	0.17792347965371622
USHER SYNDROME, TYPE IV; USH4	0.03125	0.17792347965371622
DEAFNESS, AUTOSOMAL RECESSIVE 111; DFNB111	0.03125	0.17792347965371622
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 5	0.03125	0.17792347965371622
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME	0.03125	0.17792347965371622
#613285 DEAFNESS, AUTOSOMAL RECESSIVE 25; DFNB25	0.03125	0.17792347965371622
DEAFNESS, AUTOSOMAL DOMINANT 70	0.03125	0.17792347965371622
#615540 DEAFNESS, AUTOSOMAL RECESSIVE 76; DFNB76	0.03125	0.17792347965371622
DEAFNESS, AUTOSOMAL DOMINANT 22; DFNA22	0.03125	0.17792347965371622
CINCA SYNDROME; CINCA	0.03125	0.17792347965371622
ATAXIA-DEAFNESS-RETARDATION SYNDROME	0.03125	0.17792347965371622
MICROCEPHALY 4, PRIMARY, AUTOSOMAL RECESSIVE; MCPH4	0.03119083	0.17758659222040069
SEPTOOPTIC DYSPLASIA	0.031146881999999997	0.1773363720257184
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.031146881999999997	0.1773363720257184
PREAXIAL DEFICIENCY, POSTAXIAL POLYDACTYLY, AND HYPOSPADIAS	0.03084	0.17558912360065945
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.030830072	0.1755325980228674
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.030606902000000002	0.17426196816832917
POTOCKI-SHAFFER SYNDROME	0.030572859999999997	0.17406814829330924
WILLIAMS-BEUREN SYNDROME; WBS	0.03047314	0.17350038735279508
#220600 SPLIT-HAND/FOOT MALFORMATION 1 WITH SENSORINEURAL HEARING LOSS; SHFM1D;;DEAFNESS, CONGENITAL, AND SPLIT HANDS AND FEET	0.03046573	0.1734581981372996
HADZISELIMOVIC SYNDROME	0.030401852	0.17309450546423333
EXCHONDROSIS OF PINNA, POSTERIOR	0.030302999999999997	0.17253168652629
DARWINIAN TUBERCLE OF PINNA	0.030302999999999997	0.17253168652629
15q13.3 microdeletion syndrome	0.030302999999999997	0.17253168652629
ULNAR HYPOPLASIA WITH LOBSTER-CLAW DEFORMITY OF FEET	0.030302999999999997	0.17253168652629
NASAL BONES, ABSENCE OF	0.030302999999999997	0.17253168652629
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.030302999999999997	0.17253168652629
CYANIDE, INABILITY TO SMELL	0.030302999999999997	0.17253168652629
NASAL ALAR COLLAPSE, BILATERAL	0.030302999999999997	0.17253168652629
#604367 LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 3; FPLD3;;LIPODYSTROPHY, FAMILIAL PARTIAL, ASSOCIATED WITH PPARG MUTATIONS	0.030302999999999997	0.17253168652629
MUSICAL PERFECT PITCH	0.030302999999999997	0.17253168652629
OSTEOMA OF MIDDLE EAR	0.030302999999999997	0.17253168652629
#242500 ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4B; ARCI4B;;ICHTHYOSIS CONGENITA, HARLEQUIN FETUS TYPE;;HARLEQUIN ICHTHYOSIS; HI;;'HARLEQUIN FETUS'	0.030302999999999997	0.17253168652629
CLEFT CHIN	0.030302999999999997	0.17253168652629
ECTODERMAL DYSPLASIA WITH MENTAL RETARDATION AND SYNDACTYLY	0.030302999999999997	0.17253168652629
EAR MALFORMATION	0.030302999999999997	0.17253168652629
OROFACIAL CLEFT 3	0.030302999999999997	0.17253168652629
HAIRY EARS, Y-LINKED	0.030302999999999997	0.17253168652629
208081 ARTHROGRYPOSIS, DISTAL, WITH MENTAL RETARDATION AND CHARACTERISTICFACIES	0.030302999999999997	0.17253168652629
NASAL GROOVE, FAMILIAL TRANSVERSE	0.030302999999999997	0.17253168652629
METATROPIC DYSPLASIA	0.030302999999999997	0.17253168652629
OSSIFIED EAR CARTILAGES	0.030302999999999997	0.17253168652629
DARWINIAN POINT OF PINNA	0.030302999999999997	0.17253168652629
#128200 EPISODIC KINESIGENIC DYSKINESIA 1; EKD1;;PAROXYSMAL KINESIGENIC CHOREOATHETOSIS; PKC;;PAROXYSMAL KINESIGENIC DYSKINESIA; PKD;;DYSTONIA, FAMILIAL PAROXYSMAL;;DYSTONIA 10; DYT10	0.030302999999999997	0.17253168652629
#172800 PIEBALD TRAIT; PBT;;PIEBALDISM	0.030302999999999997	0.17253168652629
FALLOT COMPLEX WITH SEVERE MENTAL AND GROWTH RETARDATION	0.030302999999999997	0.17253168652629
CUTIS LAXA, AUTOSOMAL DOMINANT 1; ADCL1	0.030302999999999997	0.17253168652629
EAR ANTITRAGUS, TAG AT BASE OF	0.030302999999999997	0.17253168652629
#192500 LONG QT SYNDROME 1; LQT1;;WARD-ROMANO SYNDROME; WRS;;ROMANO-WARD SYNDROME; RWS;;VENTRICULAR FIBRILLATION WITH PROLONGED QT INTERVALLONG QT SYNDROME 1/2, DIGENIC, INCLUDED; LQT1/2, DIGENIC, INCLUDED;;LONG QT SYNDROME 1, ACQUIRED, SUSCEPTIBILITY TO, INCLUDED	0.030302999999999997	0.17253168652629
EAR WITHOUT HELIX	0.030302999999999997	0.17253168652629
#230650 GM1-GANGLIOSIDOSIS, TYPE III;;GANGLIOSIDOSIS, GENERALIZED GM1, ADULT TYPE;;GANGLIOSIDOSIS, GENERALIZED GM1, CHRONIC TYPE;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE III;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE 3	0.030302999999999997	0.17253168652629
EAR FOLDING	0.030302999999999997	0.17253168652629
EDINBURGH MALFORMATION SYNDROME	0.030302999999999997	0.17253168652629
ALKAPTONURIA	0.030302999999999997	0.17253168652629
OSTEODYSPLASTY, PRECOCIOUS, OF DANKS, MAYNE, AND KOZLOWSKI	0.030302999999999997	0.17253168652629
AREDYLD	0.030302999999999997	0.17253168652629
22q11.2 distal deletion syndrome	0.030302999999999997	0.17253168652629
211200 BOWEN SYNDROME OF MULTIPLE MALFORMATIONS	0.030302999999999997	0.17253168652629
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 7; FPLD7	0.030302999999999997	0.17253168652629
OPHTHALMOPLEGIA, FAMILIAL TOTAL, WITH IRIS TRANSILLUMINATION	0.030302999999999997	0.17253168652629
DWARFISM, LEVI TYPE	0.030302999999999997	0.17253168652629
Growth hormone deficiency, isolated, type IA	0.030302999999999997	0.17253168652629
DIMPLES, FACIAL	0.030302999999999997	0.17253168652629
OSTEOPENIA AND SPARSE HAIR	0.030302999999999997	0.17253168652629
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.030302999999999997	0.17253168652629
EAR WAX, WET/DRY	0.030302999999999997	0.17253168652629
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.030273962	0.1723663571822201
LATHOSTEROLOSIS	0.030160020000000003	0.17171762255442158
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.030077032000000004	0.1712451261150775
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.029985372	0.1707232551984356
MICROPHTHALMIA/COLOBOMA AND SKELETAL DYSPLASIA SYNDROME; MCSKS	0.02994595	0.1704988040171585
Helsmoortel-van der Aa syndrome	0.029849982	0.16995240528130545
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.029826402	0.16981815134049794
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.029777632	0.16954047684121118
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.029527572000000002	0.16811674739090052
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.02950879	0.1680098111094651
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.029501992	0.16797110634739518
CHROMOSOME 16p13.3 DELETION SYNDROME	0.029479132	0.16784095176355887
Retinitis pigmentosa with or without skeletal anomalies	0.029460862	0.16773693058041414
SPASTIC PARAPLEGIA 16, X-LINKED	0.029437199999999997	0.167602209768396
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.029428352	0.1675518332260608
TRICHODENTOOSSEOUS SYNDROME	0.0294118	0.16745759356413345
HURLER-SCHEIE SYNDROME	0.0294118	0.16745759356413345
245160 KNIEST-LIKE DYSPLASIA WITH PURSED LIPS AND ECTOPIA LENTIS;;BURTON SYNDROME	0.0294118	0.16745759356413345
611426 TENTED EYEBROWS	0.0294118	0.16745759356413345
#609165 ERYTHRODERMA, ICHTHYOSIFORM, CONGENITAL RETICULAR; CRIE;;ICHTHYOSIS WITH CONFETTI; IWC;;ICHTHYOSIS VARIEGATAERYTHROKERATODERMA, RETICULAR, INCLUDED;;AARAU DISEASE, INCLUDED	0.0294118	0.16745759356413345
MIDPHALANGEAL HAIR	0.0294118	0.16745759356413345
138920 GRANDDAD SYNDROME;;GROWTH RETARDATION, AGED FACIES, NORMAL DEVELOPMENT, DECREASED SUBCUTANEOUSFAT, AUTOSOMAL DOMINANT INHERITANCE	0.0294118	0.16745759356413345
AMELOONYCHOHYPOHIDROTIC SYNDROME	0.0294118	0.16745759356413345
#208900 ATAXIA-TELANGIECTASIA; AT;;AT1;;LOUIS-BAR SYNDROMEAT, COMPLEMENTATION GROUP A, INCLUDED; ATA, INCLUDED;;AT, COMPLEMENTATION GROUP C, INCLUDED; ATC, INCLUDED;;AT, COMPLEMENTATION GROUP D, INCLUDED; ATD, INCLUDED;;AT, COMPLEMENTATION GROUP E, INCLUDED; ATE, INCLUDED;;ATAXIA-TELANGIECTASIA VARIANT, INCLUDED	0.0294118	0.16745759356413345
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 6	0.0294118	0.16745759356413345
PACHYONYCHIA CONGENITA, TYPE 1	0.0294118	0.16745759356413345
WEILL-MARCHESANI SYNDROME 3	0.0294118	0.16745759356413345
PALMOPLANTAR KERATODERMA AND CONGENITAL ALOPECIA 1; PPKCA1	0.0294118	0.16745759356413345
EPIDERMOLYSIS BULLOSA SIMPLEX, DOWLING-MEARA TYPE; EBSDM	0.0294118	0.16745759356413345
MENTAL RETARDATION WITH SPASTIC PARAPLEGIA AND PALMOPLANTAR HYPERKERATOSIS	0.0294118	0.16745759356413345
ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 1; ARCI1	0.0294118	0.16745759356413345
#226670 EPIDERMOLYSIS BULLOSA SIMPLEX WITH MUSCULAR DYSTROPHY;;EBS-MD;;EPIDERMOLYSIS BULLOSA SIMPLEX AND LIMB-GIRDLE MUSCULAR DYSTROPHY;;MD-EBS; MDEBS	0.0294118	0.16745759356413345
PALMOPLANTAR KERATODERMA, EPIDERMOLYTIC	0.0294118	0.16745759356413345
ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 13; ARCI13	0.0294118	0.16745759356413345
HAIRY NOSE TIP	0.0294118	0.16745759356413345
TRICHODISCOMAS, FAMILIAL MULTIPLE	0.0294118	0.16745759356413345
CATATRICHY	0.0294118	0.16745759356413345
ALBINISM, OCULOCUTANEOUS, TYPE VI; OCA6	0.0294118	0.16745759356413345
SYNDESMODYSPLASIC DWARFISM	0.0294118	0.16745759356413345
RINGED HAIR	0.0294118	0.16745759356413345
BUSCHKE-OLLENDORFF SYNDROME; BOS	0.0294118	0.16745759356413345
EPIDERMOLYSIS BULLOSA SIMPLEX, KOEBNER TYPE	0.0294118	0.16745759356413345
PALMOPLANTAR KERATODERMA, MUTILATING, WITH PERIORIFICIAL KERATOTIC PLAQUES, X-LINKED	0.0294118	0.16745759356413345
%152800 LYMPHANGIECTASIA, INTESTINAL	0.0294118	0.16745759356413345
ICHTHYOSIS, SPLIT HAIRS, AND AMINO ACIDURIA	0.0294118	0.16745759356413345
HERMANSKY-PUDLAK SYNDROME 1; HPS1	0.0294118	0.16745759356413345
HAIR WHORL	0.0294118	0.16745759356413345
PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS; PPSH	0.0294118	0.16745759356413345
ICHTHYOSIS, CYCLIC, WITH EPIDERMOLYTIC HYPERKERATOSIS	0.0294118	0.16745759356413345
ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA 4; EKVP4	0.0294118	0.16745759356413345
RED SKIN PIGMENT ANOMALY OF NEW GUINEA	0.0294118	0.16745759356413345
EPIDERMOLYTIC HYPERKERATOSIS	0.0294118	0.16745759356413345
ANTERIOR CHAMBER CLEAVAGE DISORDER, CEREBELLAR HYPOPLASIA, HYPOTHYROIDISM, AND TRACHEAL STENOSIS	0.0294118	0.16745759356413345
STING-ASSOCIATED VASCULOPATHY, INFANTILE-ONSET; SAVI	0.0294118	0.16745759356413345
PAPILLON-LEFEVRE SYNDROME	0.0294118	0.16745759356413345
KINDLER SYNDROME; KNDLRS	0.0294118	0.16745759356413345
233430 GONADAL DYSGENESIS, XY TYPE, WITH ASSOCIATED ANOMALIES	0.0294118	0.16745759356413345
DERMATOPATHIA PIGMENTOSA RETICULARIS; DPR	0.0294118	0.16745759356413345
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.029312292000000004	0.16689103965650526
CHROMOSOME 16Q22 DELETION SYNDROME	0.029249172	0.1665316626953615
TOE SYNDACTYLY, TELECANTHUS, AND ANOGENITAL AND RENAL MALFORMATIONS; STAR	0.029040450000000002	0.16534329327071245
#603543 LIMB-MAMMARY SYNDROME; LMS	0.0290309	0.16528891985533023
221810 DERMATOOSTEOLYSIS, KIRGHIZIAN TYPE;;KIRGHIZIAN DERMATOOSTEOLYSIS	0.0290309	0.16528891985533023
ECTODERMAL DYSPLASIA, ECTRODACTYLY, AND MACULAR DYSTROPHY SYNDROME	0.0290309	0.16528891985533023
MYOPATHY, DISTAL 3	0.0290309	0.16528891985533023
JOUBERT SYNDROME 14	0.029025382000000002	0.16525750283898694
#614399 MYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET;EMARDDMYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET,MILD VARIANT, INCLUDED	0.02896414	0.16490881836727642
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.028922112	0.16466952979118404
CORTICAL DEFECTS, WORMIAN BONES, AND DENTINOGENESIS IMPERFECTA	0.02888574	0.16446244394152118
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.028812202	0.16404375156242437
EMERY-DREIFUSS MUSCULAR DYSTROPHY 3, AUTOSOMAL RECESSIVE; EDMD3	0.02876889	0.1637971524664
DERMATITIS, ATOPIC	0.02862319	0.16296760203486252
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.028595062	0.16280745382252013
#615290 SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2, AUTOSOMALDOMINANT; SMALED2	0.0285714	0.162672733010502
PROTRUSIO ACETABULI	0.0285714	0.162672733010502
CAMURATI-ENGELMANN DISEASE, TYPE 2	0.0285714	0.162672733010502
MYOPATHY, CENTRONUCLEAR, 5	0.0285714	0.162672733010502
HYPOMELIA WITH MULLERIAN DUCT ANOMALIES	0.0285312	0.16244385224627547
ECTRODACTYLY-POLYDACTYLY	0.0285312	0.16244385224627547
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.028435192	0.16189722576836846
#612936 SPASTIC PARAPLEGIA 50, AUTOSOMAL RECESSIVE; SPG50;;CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3, FORMERLY; CPSQ3, FORMERLY	0.028435192	0.16189722576836846
JOUBERT SYNDROME 24	0.028428202	0.16185742784443952
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.028417900000000003	0.16179877287844296
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.028417900000000003	0.16179877287844296
BRACHYMETAPODY-ANODONTIA-HYPOTRICHOSIS-ALBINOIDISM	0.028325589999999998	0.16127320115342422
LOEYS-DIETZ SYNDROME 5	0.028308899999999998	0.16117817578141078
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.02821369	0.16063609275748023
MICROPHTHALMIA, SYNDROMIC 3	0.027729352000000002	0.15787848948424754
MASA SYNDROME	0.02759131	0.15709254026894007
ZIMMERMANN-LABAND SYNDROME 2; ZLS2	0.027552329999999996	0.1568706056373592
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.027532502	0.15675771390121282
MICROCEPHALY, AUTOSOMAL DOMINANT	0.027505830000000002	0.1566058554996345
POSTERIOR COLUMN ATAXIA WITH RETINITIS PIGMENTOSA; AXPC1	0.0274436	0.15625154579919123
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.027416009999999998	0.15609446071747457
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.027389720000000003	0.15594477725251152
ALAGILLE SYNDROME 1; ALGS1	0.02725595	0.15518315088856663
#132450 EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH MYOPIA AND CONDUCTIVE DEAFNESS;EDMMD	0.027254679999999996	0.15517592007835349
TREACHER COLLINS SYNDROME 2; TCS2	0.02720289	0.154881051053993
TREACHER COLLINS SYNDROME 3; TCS3	0.02720289	0.154881051053993
HYPEREKPLEXIA 4; HKPX4	0.027159682	0.15463504408730888
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.027138521999999998	0.15451456854076576
#614701 CORNELIA DE LANGE SYNDROME 4; CDLS4	0.027127191999999998	0.1544500606039825
HOLOPROSENCEPHALY 11	0.027127191999999998	0.1544500606039825
SECKEL SYNDROME 9; SCKL9	0.027119392000000003	0.15440565090346095
#614457 ICHTHYOSIS, SPASTIC QUADRIPLEGIA, AND MENTAL RETARDATION; ISQMR	0.027119392000000003	0.15440565090346095
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.027119392000000003	0.15440565090346095
#609425 CHROMOSOME 3q29 DELETION SYNDROME;;MICRODELETION 3q29 SYNDROME	0.027074172	0.15414818851146284
227320 FACIOTHORACOGENITAL SYNDROME	0.02702967	0.15389481408933325
RADIOULNAR SYNOSTOSIS	0.027027	0.15387961230723163
#608728 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MATRILIN-3 RELATED;;SEMD, MATN3-RELATED	0.027027	0.15387961230723163
RADIAL HEADS, POSTERIOR DISLOCATION OF	0.027027	0.15387961230723163
PYLE DISEASE; PYL	0.027027	0.15387961230723163
#602111 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MISSOURI TYPE;;SEMD, MISSOURI TYPEMETAPHYSEAL ANADYSPLASIA 1, INCLUDED; MANDP1, INCLUDED	0.027027	0.15387961230723163
PTERYGIUM, ANTECUBITAL	0.027027	0.15387961230723163
HYPOCHONDROPLASIA	0.027027	0.15387961230723163
%229400 FRONTOFACIONASAL DYSPLASIA;;FFND;;FRONTOFACIONASAL DYSOSTOSIS	0.02701679	0.15382148114795915
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.02694783	0.15342885384693772
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.026910552	0.15321660963975273
MANDIBULOFACIAL DYSOSTOSIS WITH MACROBLEPHARON AND MACROSTOMIA	0.026866539999999998	0.1529660250577841
228560 FIBROMATOSIS, GINGIVAL, WITH DISTINCTIVE FACIES	0.026866539999999998	0.1529660250577841
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.026803671999999997	0.15260808287158026
ANTERIOR SEGMENT DYSGENESIS 2; ASGD2	0.026688620000000003	0.15195302840178446
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 5; MDDGA5	0.026688620000000003	0.15195302840178446
#610092 MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 3; MCOPCB3;;MICROPHTHALMIA, COLOBOMATOUS, ISOLATED 3MICROPHTHALMIA, CATARACTS, AND IRIS ABNORMALITIES, INCLUDED	0.026688620000000003	0.15195302840178446
#612109 OCULOAURICULAR SYNDROME; OCACS;;MICROPHTHALMIA, MICROCORNEA, ANTERIOR SEGMENT DYSGENESIS, CATARACT,OCULAR COLOBOMA, RETINAL PIGMENT EPITHELIUM ABNORMALITIES, ROD-CONEDYSTROPHY, AND ANOMALIES OF THE EXTERNAL EAR;;SCHORDERET-MUNIER-FRANCESCHETTI SYNDROME	0.026688620000000003	0.15195302840178446
COLOBOMA, OCULAR, WITH OR WITHOUT HEARING IMPAIRMENT, CLEFT LIP/PALATE, AND/OR MENTAL RETARDATION; COB1	0.026688620000000003	0.15195302840178446
TONNE-KALSCHEUER SYNDROME; TOKAS	0.026634712	0.15164610043566693
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.026609992000000002	0.15150535584632166
SIFRIM-HITZ-WEISS SYNDROME	0.02658009	0.15133510727388627
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.026538032	0.15109564789125343
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.026531602	0.1510590383560799
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IQ	0.026518560000000004	0.1509847830593873
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.026515522000000003	0.1509674860503893
LEGIUS SYNDROME	0.02639267	0.15026802188007188
ARTHROGRYPOSIS MULTIPLEX CONGENITA, MYOGENIC TYPE; AMCM	0.0263158	0.1498303585878805
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.0263158	0.1498303585878805
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.026137142000000002	0.14881316009098536
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.026136582	0.14880997170222993
#607326 SMITH-MCCORT DYSPLASIA 1; SMC1;;SMC	0.02597791	0.14790656452259426
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.025928892000000002	0.14762747802257298
NETHERTON SYNDROME; NETH	0.025843882000000002	0.14714346922240137
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.025843882000000002	0.14714346922240137
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.025843882000000002	0.14714346922240137
#612714 EXOCRINE PANCREATIC INSUFFICIENCY, DYSERYTHROPOIETIC ANEMIA, AND CALVARIALHYPEROSTOSIS	0.025843882000000002	0.14714346922240137
POPOV-CHANG SYNDROME; POPCHAS	0.025837222	0.14710555017041757
DEAFNESS, X-LINKED 7; DFNX7	0.025830609999999997	0.1470679044088985
PSEUDOTRISOMY 13 SYNDROME	0.02576456	0.14669184534230242
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.025751402	0.14661692959365336
CHROMOSOME 19q13.11 DELETION SYNDROME, PROXIMAL	0.025669152	0.14614863499520478
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B3; CMT4B3	0.0254622	0.1449703431564433
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.025442172	0.14485631271002714
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.02531531	0.1441340173988006
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.025294312	0.144014464207576
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.02524307	0.1437227152493547
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.025185922	0.14339734017686667
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.025184822000000003	0.1433910772703829
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.025180889999999997	0.1433686902264789
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.025030572	0.14251284697481215
HYDROCEPHALUS, NORMAL-PRESSURE	0.025030572	0.14251284697481215
AMAUROSIS CONGENITA, CONE-ROD TYPE, WITH CONGENITAL HYPERTRICHOSIS	0.025007799999999997	0.14238319342349454
BLEPHAROPHIMOSIS WITH PTOSIS, SYNDACTYLY, AND SHORT STATURE	0.025007799999999997	0.14238319342349454
ASTHMA, NASAL POLYPS, AND ASPIRIN INTOLERANCE	0.025	0.14233878372297298
CYSTIC FIBROSIS	0.025	0.14233878372297298
#270300 PEELING SKIN SYNDROME 1; PSS1;;PSS;;SKIN PEELING, FAMILIAL CONTINUOUS GENERALIZED;;KERATOLYSIS EXFOLIATIVA CONGENITA;;DECIDUOUS SKIN	0.025	0.14233878372297298
614262 ARTHROGRYPOSIS, PERTHES DISEASE, AND UPWARD GAZE PALSY; APUG	0.025	0.14233878372297298
ASTHMA, SHORT STATURE, AND ELEVATED IGA	0.025	0.14233878372297298
MYELOPROLIFERATIVE/LYMPHOPROLIFERATIVE NEOPLASMS, FAMILIAL (MULTIPLE TYPES), SUSCEPTIBILITY TO; MPLPF	0.025	0.14233878372297298
Yao syndrome	0.025	0.14233878372297298
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 3; FCAS3	0.025	0.14233878372297298
IMMUNODEFICIENCY 58; IMD58	0.025	0.14233878372297298
CASPASE 8 DEFICIENCY	0.025	0.14233878372297298
IMMUNODEFICIENCY 11B WITH ATOPIC DERMATITIS; IMD11B	0.025	0.14233878372297298
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY	0.025	0.14233878372297298
NEUTROPHIL CHEMOTACTIC RESPONSE	0.025	0.14233878372297298
IGE RESPONSIVENESS, ATOPIC	0.025	0.14233878372297298
ECTODERMAL DYSPLASIA/SHORT STATURE SYNDROME	0.025	0.14233878372297298
ASTHMA, SUSCEPTIBILITY TO	0.025	0.14233878372297298
EHLERS-DANLOS SYNDROME, AUTOSOMAL DOMINANT, TYPE UNSPECIFIED	0.025	0.14233878372297298
#243700 HYPER-IgE RECURRENT INFECTION SYNDROME, AUTOSOMAL RECESSIVE;;HYPER-IgE SYNDROME, AUTOSOMAL RECESSIVE;;HIES, AUTOSOMAL RECESSIVE	0.025	0.14233878372297298
ICHTHYOSIS VULGARIS	0.025	0.14233878372297298
CILIARY DYSKINESIA, PRIMARY, 30; CILD30	0.025	0.14233878372297298
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.024997642	0.14232535832889223
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.024829551999999998	0.14136832928265244
MICROPHTHALMIA, SYNDROMIC 4	0.024816130000000002	0.14129191043644726
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.024775972000000004	0.1410632688013774
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.024775972000000004	0.1410632688013774
#112410 HYPERTENSION AND BRACHYDACTYLY SYNDROME; HTNB;;BRACHYDACTYLY WITH HYPERTENSION;;BRACHYDACTYLY, TYPE E, WITH SHORT STATURE AND HYPERTENSION;;BILGINTURAN SYNDROME	0.0247024	0.1406443828415347
SMITH-MCCORT DYSPLASIA 2; SMC2	0.0247024	0.1406443828415347
#615033 SPASTIC PARAPLEGIA 54, AUTOSOMAL RECESSIVE; SPG54	0.024653392	0.14036535327702687
CEREBROOCULONASAL SYNDROME	0.02457699	0.13993035456686678
#610832 FANCONI ANEMIA, COMPLEMENTATION GROUP N; FANCN	0.02457338	0.13990980084649718
VERVERI-BRADY SYNDROME; VERBRAS	0.024570250000000002	0.13989198003077508
#611881 GLYCOGEN STORAGE DISEASE XII; GSD12;;GSD XII;;ALDOLASE A DEFICIENCY;;ALDOA DEFICIENCY;;ALDOLASE DEFICIENCY, RED CELL;;RED CELL ALDOLASE DEFICIENCY	0.02453393	0.13968519024578233
PTERYGIUM COLLI, ISOLATED	0.02453393	0.13968519024578233
ACROCEPHALOPOLYDACTYLOUS DYSPLASIA	0.024396789999999998	0.1389043766137916
NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME; NPLCS	0.024342819999999998	0.13859709564749043
SOLITARY MEDIAN MAXILLARY CENTRAL INCISOR; SMMCI	0.024340940000000002	0.1385863917709545
#609054 FANCONI ANEMIA, COMPLEMENTATION GROUP J; FANCJ	0.024234012	0.13797759171231727
METACHROMATIC LEUKODYSTROPHY	0.02418669	0.13770816147538373
FRONTOTEMPORAL DEMENTIA, CHROMOSOME 3-LINKED; FTD3	0.02418669	0.13770816147538373
#125310 CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTSAND LEUKOENCEPHALOPATHY; CADASIL;;DEMENTIA, HEREDITARY MULTI-INFARCT TYPE;;CASIL	0.02418669	0.13770816147538373
CEREBRAL ARTERIOPATHY, AUTOSOMAL RECESSIVE, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY; CARASIL	0.02418669	0.13770816147538373
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 1; IBGC1	0.02418669	0.13770816147538373
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.024154762	0.13752637776791543
233270 GOMBO SYNDROME;;GROWTH RETARDATION, OCULAR ABNORMALITIES, MICROCEPHALY, BRACHYDACTYLY,AND OLIGOPHRENIA	0.024027740000000002	0.1368031714884731
RUIJS-AALFS SYNDROME; RJALS	0.024022540000000002	0.13677356502145868
EMERY-DREIFUSS MUSCULAR DYSTROPHY 1, X-LINKED; EDMD1	0.024022540000000002	0.13677356502145868
OROFACIODIGITAL SYNDROME VIII; OFD8	0.023991132000000002	0.13659474196069185
%601499 AXENFELD-RIEGER SYNDROME, TYPE 2; RIEG2;;RIEGER SYNDROME, TYPE 2	0.023979769999999997	0.1365300518302654
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.023935480000000002	0.13627788444102182
MESOMELIC LIMB SHORTENING AND BOWING	0.0238095	0.135560610842085
SPONDYLOCAMPTODACTYLY	0.0238095	0.135560610842085
208080 ARTHROGRYPOSIS, DISTAL, WITH HYPOPITUITARISM, MENTAL RETARDATION,AND FACIAL ANOMALIES	0.0238095	0.135560610842085
CHOLESTASIS WITH GALLSTONE, ATAXIA, AND VISUAL DISTURBANCE	0.0238095	0.135560610842085
CAMPTODACTYLY 1; CAMPD1	0.0238095	0.135560610842085
#614438 CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIB; ARCL3B;;DE BARSY SYNDROME B	0.023775420000000002	0.13536657461211385
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.023687382	0.13486532573845772
#257300 MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 1; MVA1;;MVA SYNDROME	0.023440009999999997	0.13345690055417292
OROFACIODIGITAL SYNDROME XIV; OFD14	0.023290852	0.1326076618220709
#272200 MULTIPLE SULFATASE DEFICIENCY; MSD;;MUCOSULFATIDOSIS;;SULFATIDOSIS, JUVENILE, AUSTIN TYPE	0.023244982000000004	0.132346498621696
FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS	0.02313534	0.13172224626469783
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.023110412	0.13158031741667198
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.023110412	0.13158031741667198
MICROPHTHALMIA, ISOLATED 4	0.02306543	0.13132421008989492
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 4	0.02306543	0.13132421008989492
COLOBOMA, OSTEOPETROSIS, MICROPHTHALMIA, MACROCEPHALY, ALBINISM, AND DEAFNESS; COMMAD	0.02306543	0.13132421008989492
#614497 MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 7; MCOPCB7	0.02306543	0.13132421008989492
MICROPHTHALMIA, ISOLATED 8	0.02306543	0.13132421008989492
BASAN SYNDROME	0.0230372	0.13116348113531492
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.023025272000000003	0.13109556845482503
CRANIOSYNOSTOSIS AND DENTAL ANOMALIES; CRSDA	0.02294716	0.13065083377185827
MEGAEPIPHYSEAL DWARFISM	0.02286513	0.13018379175470646
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.02278169	0.12970872183015264
OROFACIAL CLEFT 15	0.02272759	0.12940070070217613
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.02265997	0.12901570275996227
JOHANSON-BLIZZARD SYNDROME; JBS	0.02256098	0.12845209811193276
KLIPPEL-FEIL SYNDROME 4, AUTOSOMAL RECESSIVE, WITH NEMALINE MYOPATHY AND FACIAL DYSMORPHISM; KFS4	0.02255211	0.12840159631146783
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.022532412	0.12828944473699685
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.022513411999999997	0.12818126726136736
MANDIBULOFACIAL DYSOSTOSIS WITH PTOSIS, AUTOSOMAL DOMINANT	0.02250369	0.12812591455515318
#612713 KAHRIZI SYNDROME; KHRZ;;MENTAL RETARDATION, CATARACT, COLOBOMA, AND KYPHOSIS, AUTOSOMAL RECESSIVE	0.02249109	0.1280541758081568
275230 TIBIA, ABSENCE OF, WITH CONGENITAL DEAFNESS	0.0224011	0.1275418131222676
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.022365352000000005	0.12733828004864647
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ii; CDG1I	0.022324172000000003	0.12710381960409797
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.022218032	0.1264995060639237
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.022166552000000003	0.12620640204048136
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.02215233	0.12612542835319707
MOWAT-WILSON SYNDROME; MOWS	0.02214554	0.12608676913953787
HOLOPROSENCEPHALY 5; HPE5	0.022094951999999998	0.12579874376389874
COFFIN-SIRIS SYNDROME 7; CSS7	0.022058202	0.12558950575182598
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.021896152	0.12466686575573367
ECTODERMAL DYSPLASIA 13, HAIR/TOOTH TYPE; ECTD13	0.02185874	0.12445385861266794
NOONAN SYNDROME 4; NS4	0.02178277	0.12402131951669057
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.021727192000000003	0.12370488331982037
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.021702522000000002	0.12356442340804254
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0216612	0.12332915447920247
#259420 OSTEOGENESIS IMPERFECTA, TYPE III;;OI, TYPE III;;OI3;;OSTEOGENESIS IMPERFECTA, PROGRESSIVELY DEFORMING, WITH NORMAL SCLERAE	0.0216612	0.12332915447920247
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.021523052	0.12254260174745205
ARTERIAL TORTUOSITY SYNDROME	0.02150618	0.12244654014909309
COLOBOMA, OCULAR, AUTOSOMAL RECESSIVE	0.02148029	0.12229913410466955
HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME	0.02141243	0.12191276971013193
#148210 KERATITIS-ICHTHYOSIS-DEAFNESS SYNDROME, AUTOSOMAL DOMINANT;;KID SYNDROME, AUTOSOMAL DOMINANT	0.02141243	0.12191276971013193
#608747 INSULIN-LIKE GROWTH FACTOR I DEFICIENCY;;IGF1 DEFICIENCY;;GROWTH RETARDATION WITH SENSORINEURAL DEAFNESS AND MENTAL RETARDATION	0.02136394	0.12163668940522288
ANTLEY-BIXLER SYNDROME WITHOUT GENITAL ANOMALIES OR DISORDERED STEROIDOGENESIS; ABS2	0.02129552	0.1212471366219298
ACHARD SYNDROME	0.02129552	0.1212471366219298
#614416 RADIOHUMERAL FUSIONS WITH OTHER SKELETAL AND CRANIOFACIAL ANOMALIES;RHFCA	0.02129552	0.1212471366219298
MICROCORNEA, MYOPIC CHORIORETINAL ATROPHY, AND TELECANTHUS; MMCAT	0.021288510000000004	0.12120722482697392
EHLERS-DANLOS SYNDROME, CLASSIC-LIKE, 2; EDSCLL2	0.0212766	0.12113941463040828
ARTHROGRYPOSIS AND ECTODERMAL DYSPLASIA	0.02123613	0.12090899660731752
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.021134062000000002	0.12032786720823609
CHROMOSOME 15q13.3 MICRODELETION SYNDROME	0.02110498	0.1201622873479068
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.020886072	0.11891592340921767
CHROMOSOME 1q21.1 DELETION SYNDROME, 1.35-MB	0.020883310000000002	0.11890019782039196
AXENFELD-RIEGER ANOMALY WITH PARTIALLY ABSENT EYE MUSCLES, DISTINCTIVE FACE, HYDROCEPHALY, AND SKELETAL ABNORMALITIES	0.0207298	0.1180261807528194
SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE; SPG46	0.020702190000000002	0.11786898180007578
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.02067917	0.11773791624802364
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.020668702000000004	0.11767831615250318
XQ25 DUPLICATION SYNDROME	0.020663492	0.11764865274997528
CHARGE-LIKE SYNDROME, X-LINKED	0.0206504	0.11757411277571524
#222448 DONNAI-BARROW SYNDROME;;FACIOOCULOACOUSTICORENAL SYNDROME;;DBS/FOAR SYNDROME;;DIAPHRAGMATIC HERNIA, EXOMPHALOS, ABSENT CORPUS CALLOSUM, HYPERTELORISM,MYOPIA, SENSORINEURAL DEAFNESS, AND PROTEINURIA	0.020635042	0.11748667121409855
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.020572142	0.11712854683425156
JOUBERT SYNDROME 2	0.020569152	0.11711152311571829
SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE; SPG5A	0.02045342	0.11645259703100519
MENTAL RETARDATION, X-LINKED 99	0.020451682000000002	0.11644270163876079
BAND HETEROTOPIA; BH	0.020451682000000002	0.11644270163876079
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.020451682000000002	0.11644270163876079
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.020360522000000002	0.11592367749779335
129540 ECTODERMAL DYSPLASIA SYNDROME WITH DISTINCTIVE FACIAL APPEARANCE ANDPREAXIAL POLYDACTYLY OF FEET	0.02032453	0.11571875519764303
TEMPLE SYNDROME	0.02029018	0.11552318170880767
CHROMOSOME 18P DELETION SYNDROME	0.020246522000000003	0.11527461264401659
MENTAL RETARDATION, X-LINKED 98; MRX98	0.020154712	0.11475188769467233
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.020154712	0.11475188769467233
#610829 HOLOPROSENCEPHALY 9; HPE9;;PITUITARY ANOMALIES WITH HOLOPROSENCEPHALY-LIKE FEATURES;;HOLOPROSENCEPHALY WITH MICROPHTHALMIA AND FIRST BRANCHIAL ARCH ANOMALIES	0.019985922	0.1137908731624883
#300143 MENTAL RETARDATION, X-LINKED 21; MRX21;;MENTAL RETARDATION, X-LINKED 34; MRX34	0.019975559999999996	0.11373187658341077
LOEYS-DIETZ SYNDROME 3; LDS3	0.019974730000000003	0.11372715093579122
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.01980354	0.11275247188036977
OROFACIODIGITAL SYNDROME III	0.01967158	0.11200115084436643
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.019660972000000002	0.11194075365165712
GLASS SYNDROME	0.019660972000000002	0.11194075365165712
AORTIC ANEURYSM, FAMILIAL THORACIC 9; AAT9	0.019647440000000002	0.11186370851480354
SPINAL MUSCULAR ATROPHY, TYPE I, WITH CONGENITAL BONE FRACTURES	0.019647440000000002	0.11186370851480354
MARFANOID HYPERMOBILITY SYNDROME	0.019647440000000002	0.11186370851480354
#300676 MENTAL RETARDATION, X-LINKED, SYNDROMIC 14; MRXS14	0.019647440000000002	0.11186370851480354
DYSPLASIA EPIPHYSEALIS HEMIMELICA	0.0196078	0.1116380161393324
BEEMER LETHAL MALFORMATION SYNDROME	0.0196078	0.1116380161393324
248100 MACROSOMIA ADIPOSA CONGENITA	0.0196078	0.1116380161393324
VAN DEN BOSCH SYNDROME	0.0196078	0.1116380161393324
TRACHEOPATHIA OSTEOPLASTICA	0.0196078	0.1116380161393324
OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY	0.0196078	0.1116380161393324
CIRCUMVALLATE PLACENTA SYNDROME	0.0196078	0.1116380161393324
COPPER DEFICIENCY, FAMILIAL BENIGN	0.0196078	0.1116380161393324
#212840 CEREBELLAR ATAXIA AND HYPOGONADOTROPIC HYPOGONADISM; CAHH;;GORDON HOLMES SYNDROME;;LUTEINIZING HORMONE-RELEASING HORMONE, DEFICIENCY OF, WITH ATAXIA;;LHRH DEFICIENCY AND ATAXIA	0.0196078	0.1116380161393324
%600343 PAROTID SALIVARY GLANDS, POLYCYSTIC DYSGENETIC DISEASE OF; PDDP	0.0196078	0.1116380161393324
109740 BIFID NOSE, AUTOSOMAL DOMINANT	0.0196078	0.1116380161393324
TRACHEOBRONCHOMEGALY	0.0196078	0.1116380161393324
HYPERBILIRUBINEMIA, ROTOR TYPE	0.0196078	0.1116380161393324
THROMBOCYTHEMIA, ESSENTIAL	0.0196078	0.1116380161393324
HHHH SYNDROME	0.0196078	0.1116380161393324
%122450 CORNEAL HYPESTHESIA, FAMILIAL;;TRIGEMINAL ANESTHESIA, FAMILIAL	0.0196078	0.1116380161393324
PUBIC BONE DYSPLASIA	0.0196078	0.1116380161393324
RAYNAUD DISEASE	0.0196078	0.1116380161393324
SCAPULA, CONTOUR OF VERTEBRAL BORDER OF	0.0196078	0.1116380161393324
#615422 INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 2; IBMPFD2 ;;MULTISYSTEM PROTEINOPATHY 2; MSP2	0.0196078	0.1116380161393324
TOE, FIFTH, NUMBER OF PHALANGES IN	0.0196078	0.1116380161393324
HYPOURICEMIA, HYPERCALCINURIA, AND DECREASED BONE DENSITY	0.0196078	0.1116380161393324
NEPHROSIALIDOSIS	0.0196078	0.1116380161393324
CARPAL DISPLACEMENT	0.0196078	0.1116380161393324
TOES, RELATIVE LENGTH OF FIRST AND SECOND	0.0196078	0.1116380161393324
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.0196078	0.1116380161393324
LETTERER-SIWE DISEASE	0.0196078	0.1116380161393324
MONOPHALANGY OF GREAT TOE	0.0196078	0.1116380161393324
TOE, MISSHAPEN	0.0196078	0.1116380161393324
DOUBLE NAIL FOR FIFTH TOE	0.0196078	0.1116380161393324
SPINAL ARACHNOIDITIS	0.0196078	0.1116380161393324
256020 NAIL-PATELLA-LIKE RENAL DISEASE;;GLOMERULAR BASEMENT MEMBRANE DISEASE, NAIL-PATELLA SYNDROME TYPE	0.0196078	0.1116380161393324
275220 TIBIAL HEMIMELIA;;THM;;TIBIA, ABSENCE OF	0.0196078	0.1116380161393324
VESICOURETERAL REFLUX 1	0.0196078	0.1116380161393324
KNUCKLE PADS	0.0196078	0.1116380161393324
PACHYDERMODACTYLY, FAMILIAL	0.0196078	0.1116380161393324
THROMBOCYTOPENIA 3	0.0196078	0.1116380161393324
THALIDOMIDE SUSCEPTIBILITY	0.0196078	0.1116380161393324
PALMARIS LONGUS MUSCLE, ABSENCE OF	0.0196078	0.1116380161393324
#215300 CHONDROSARCOMA	0.0196078	0.1116380161393324
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.019590042000000002	0.1115369100544783
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.019512022	0.11109269917823562
FANCONI ANEMIA, COMPLEMENTATION GROUP D1	0.01945731	0.11078119359683355
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.019382512	0.11035532734303714
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.019379920000000002	0.11034056965794074
NOONAN SYNDROME 2; NS2	0.019369322	0.1102802294007449
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.019369322	0.1102802294007449
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.019369322	0.1102802294007449
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.019192722000000002	0.10927474823252584
WARSAW BREAKAGE SYNDROME; WABS	0.019159022	0.10908287555206726
MECKEL SYNDROME, TYPE 4; MKS4	0.019142040000000003	0.10898618766305992
#613885 MECKEL SYNDROME, TYPE 8; MKS8	0.019142040000000003	0.10898618766305992
EVEN-PLUS SYNDROME	0.019140901999999998	0.10897970840162481
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.019075112	0.10860512965837946
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.019025682	0.10832369741520238
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.0188679	0.10742535749626728
RHEUMATOID ARTHRITIS	0.0188679	0.10742535749626728
#615325 MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2R; LGMD2R	0.0188679	0.10742535749626728
JUMPING FRENCHMAN OF MAINE	0.0188679	0.10742535749626728
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0188679	0.10742535749626728
CARDIAC ARRHYTHMIA	0.0188679	0.10742535749626728
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0188679	0.10742535749626728
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0188679	0.10742535749626728
ANDROSTENONE, ABILITY TO SMELL	0.0188679	0.10742535749626728
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0188679	0.10742535749626728
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0188679	0.10742535749626728
MERALGIA PARAESTHETICA, FAMILIAL	0.0188679	0.10742535749626728
PALMOMENTAL REFLEX	0.0188679	0.10742535749626728
PERONEAL NERVE, ACCESSORY DEEP	0.0188679	0.10742535749626728
DIASTEMATOMYELIA	0.0188679	0.10742535749626728
TRANSSEXUALITY	0.0188679	0.10742535749626728
MYOPATHY, MYOFIBRILLAR, 7; MFM7	0.0188679	0.10742535749626728
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0188679	0.10742535749626728
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0188679	0.10742535749626728
MYOPATHY, CONGENITAL	0.0188679	0.10742535749626728
#181350 EMERY-DREIFUSS MUSCULAR DYSTROPHY 2, AUTOSOMAL DOMINANT; EDMD2;;EMD2;;EMERY-DREIFUSS MUSCULAR DYSTROPHY, AUTOSOMAL DOMINANT;;SCAPULOILIOPERONEAL ATROPHY WITH CARDIOPATHY;;MUSCULAR DYSTROPHY WITH EARLY CONTRACTURES AND CARDIOMYOPATHY, AUTOSOMALDOMINANT;;HAUPTMANN-THANNHAUSER MUSCULAR DYSTROPHYEMERY-DREIFUSS MUSCULAR DYSTROPHY, ATYPICAL, AUTOSOMAL RECESSIVE,INCLUDED;;EMERY-DREIFUSS MUSCULAR DYSTROPHY 3, AUTOSOMAL RECESSIVE, INCLUDED;EDMD3, INCLUDED	0.0188679	0.10742535749626728
#610189 SENIOR-LOKEN SYNDROME 6; SLSN6	0.0188679	0.10742535749626728
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0188679	0.10742535749626728
ENDOCARDIAL FIBROELASTOSIS	0.0188679	0.10742535749626728
ALCOHOL DEPENDENCE	0.0188679	0.10742535749626728
SPATIAL VISUALIZATION, APTITUDE FOR	0.0188679	0.10742535749626728
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.0188679	0.10742535749626728
MOTION SICKNESS	0.0188679	0.10742535749626728
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0188679	0.10742535749626728
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.0188679	0.10742535749626728
GRANULOMAS, CONGENITAL CEREBRAL	0.0188679	0.10742535749626728
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0188679	0.10742535749626728
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0188679	0.10742535749626728
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.0188679	0.10742535749626728
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0188679	0.10742535749626728
CERVICAL RIB	0.0188679	0.10742535749626728
#601277 ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4A; ARCI4A;;ICHTHYOSIS CONGENITA IIB; ICR2B;;ICHTHYOSIS, LAMELLAR, 2, FORMERLY; LI2, FORMERLY	0.0188679	0.10742535749626728
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0188679	0.10742535749626728
COGNITIVE FUNCTION 1, SOCIAL	0.0188679	0.10742535749626728
#220100 CYSTINURIA;;CSNU;;CYSTINURIA, TYPE I, FORMERLY; CSNU1, FORMERLY;;CYSTINURIA, TYPE II, FORMERLY;;CYSTINURIA, TYPE III, FORMERLY; CSNU3, FORMERLY;;CYSTINURIA, TYPE NON-I, FORMERLYCYSTINURIA, TYPE A, INCLUDED;;CYSTINURIA, TYPE B, INCLUDED;;CYSTINURIA, TYPE A/B, INCLUDED	0.0188679	0.10742535749626728
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0188679	0.10742535749626728
SPASTIC PSEUDOSCLEROSIS	0.0188679	0.10742535749626728
BRUCK SYNDROME 2	0.0188679	0.10742535749626728
ERYTHERMALGIA, PRIMARY	0.0188679	0.10742535749626728
141405 HEMIFACIAL SPASM, FAMILIAL	0.0188679	0.10742535749626728
NOVELTY SEEKING PERSONALITY TRAIT	0.0188679	0.10742535749626728
269800 SENILE PLAQUE FORMATION	0.0188679	0.10742535749626728
MENTAL RETARDATION SYNDROME, MIETENS-WEBER TYPE	0.0188679	0.10742535749626728
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0188679	0.10742535749626728
MULTINUCLEATED NEURONS, ANHYDRAMNIOS, RENAL DYSPLASIA, CEREBELLAR HYPOPLASIA, AND HYDRANENCEPHALY; MARCH	0.01874094	0.10670250421700854
JOUBERT SYNDROME 23; JBTS23	0.018700982	0.10647500129220844
KLEEFSTRA SYNDROME 2; KLEFS2	0.018681672	0.1063650588156608
ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 3; EEC3	0.018666299999999997	0.1062775375443252
OPTIC DISC ANOMALIES WITH RETINAL AND/OR MACULAR DYSTROPHY; ODRMD	0.018635440000000003	0.1061018345496976
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.018575622	0.10576125769510794
#602398 DESMOSTEROLOSIS	0.018534622	0.10552782208980227
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.018527212	0.1054856328743068
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.01851691	0.10542697790831024
Split hand/foot malformation 1 (SHFM1)	0.018417529999999998	0.10486115277525464
#118300 CHARCOT-MARIE-TOOTH DISEASE AND DEAFNESS;;CHARCOT-MARIE-TOOTH NEUROPATHY AND DEAFNESS, AUTOSOMAL DOMINANT;;CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1E; CMT1E	0.018417529999999998	0.10486115277525464
BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2	0.018417529999999998	0.10486115277525464
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE G; CMTDIG	0.018417529999999998	0.10486115277525464
SHORT-RIB THORACIC DYSPLASIA 7 WITH OR WITHOUT POLYDACTYLY; SRTD7	0.018408829999999998	0.10481161887851906
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.018355982	0.1045107260768314
Mental retardation, autosomal dominant 21	0.018224462	0.10376191020342157
SHORT STATURE AND ADVANCED BONE AGE, WITH OR WITHOUT EARLY-ONSET OSTEOARTHRITIS AND/OR OSTEOCHONDRITIS DISSECANS; SSOAOD	0.018181799999999998	0.10351901191577399
HIRSCHSPRUNG DISEASE WITH TYPE D BRACHYDACTYLY	0.018181799999999998	0.10351901191577399
THUMB DEFORMITY AND ALOPECIA	0.018181799999999998	0.10351901191577399
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.018178362	0.10349943748623643
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.018178362	0.10349943748623643
#230000 FUCOSIDOSIS;;ALPHA-L-FUCOSIDASE DEFICIENCY	0.01816554	0.1034264347708406
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.018153792	0.10335954692959348
CHROMOSOME Xq27.3-q28 DUPLICATION SYNDROME	0.018085282	0.10296948172667905
ZTTK SYNDROME; ZTTKS	0.018085282	0.10296948172667905
CROUZON SYNDROME	0.01800725	0.1025252025278202
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.01794221	0.10215489394808652
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.01794221	0.10215489394808652
NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM	0.01794221	0.10215489394808652
#603194 MECKEL SYNDROME, TYPE 2; MKS2;;MECKEL-GRUBER SYNDROME, TYPE 2	0.017866530000000002	0.10172400598200035
MECKEL SYNDROME, TYPE 5	0.017866530000000002	0.10172400598200035
BRACHIAL AMELIA, CLEFT LIP, AND HOLOPROSENCEPHALY; ACLH	0.0178571	0.10167031579278003
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 6	0.0178571	0.10167031579278003
#614465 JOUBERT SYNDROME 16; JBTS16	0.0178571	0.10167031579278003
MENTAL RETARDATION SYNDROME, BELGIAN TYPE	0.0178571	0.10167031579278003
MACROPHTHALMIA, COLOBOMATOUS, WITH MICROCORNEA; MACOM	0.0178571	0.10167031579278003
SHUKLA-VERNON SYNDROME; SHUVER	0.017799602	0.1013429479773199
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.017570892	0.10004077584830864
%165660 OSLAM SYNDROME;;OSTEOSARCOMA, LIMB ANOMALIES, AND MACROCYTOSIS;;OSTEOSARCOMA, LIMB ANOMALIES, AND ERYTHROID MACROCYTOSIS WITH MEGALOBLASTICMARROW	0.0175439	0.09988709551029863
#113500 BRACHYOLMIA TYPE 3;;BRACHYOLMIA, AUTOSOMAL DOMINANT;;BRACHYRACHIA	0.0175439	0.09988709551029863
109300 BANKI SYNDROME	0.0175439	0.09988709551029863
#188025 THROMBOCYTOPENIA, PARIS-TROUSSEAU TYPE; TCPT;;CHROMOSOME 11q23 DELETION SYNDROME	0.0175439	0.09988709551029863
#225410 EHLERS-DANLOS SYNDROME, TYPE VII, AUTOSOMAL RECESSIVE;;EHLERS-DANLOS SYNDROME, DERMATOSPARAXIS TYPE;;DERMATOSPARAXIS;;EDS VIIC;;EDS7C	0.01754303	0.09988214212062506
#154780 MARSHALL SYNDROME; MRSHS	0.01746452	0.09943514140422144
#222748 DIHYDROPYRIMIDINASE DEFICIENCY;;DIHYDROPYRIMIDINURIA;;DPYS DEFICIENCY;;DPH DEFICIENCY	0.01733448	0.09869475198680802
ADAMS-OLIVER SYNDROME 3; AOS3	0.017270892	0.09833271044363295
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.017267042	0.09831079027093964
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.01724382	0.09817857462151504
SCAPULOPERONEAL SPINAL MUSCULAR ATROPHY; SPSMA	0.0172414	0.09816479622725065
#300868 MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 2; MCAHS2	0.017143572	0.0976078074858886
HEMIFACIAL MICROSOMIA	0.01709865	0.09735204177219248
DEAFNESS, CONDUCTIVE, WITH PTOSIS AND SKELETAL ANOMALIES	0.01709773	0.09734680370495147
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.017079	0.09724016348818623
FRAGILE X TREMOR/ATAXIA SYNDROME; FXTAS	0.017079	0.09724016348818623
CHIARI MALFORMATION TYPE I	0.017079	0.09724016348818623
NEURODEGENERATION WITH ATAXIA, DYSTONIA, AND GAZE PALSY, CHILDHOOD-ONSET	0.017079	0.09724016348818623
Adrenoleukodystrophy	0.017079	0.09724016348818623
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.017024372	0.09692913616509748
OPSISMODYSPLASIA; OPSMD	0.01701024	0.09684867489743455
MICROPHTHALMIA, SYNDROMIC 12	0.01697303	0.09663681785174127
MEHMO SYNDROME; MEHMO	0.016932872	0.0964081762166714
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.016906762	0.09625951759095111
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.01683023	0.09582377871911567
SPASTIC PARAPLEGIA 29, AUTOSOMAL DOMINANT	0.01683023	0.09582377871911567
NEUROFIBROMATOSIS, TYPE I	0.0168173	0.09575016110017415
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.016808280000000002	0.0956988052670069
JOUBERT SYNDROME 1	0.016759412	0.09542057279968794
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.016716882	0.09517842606081839
NOONAN SYNDROME 6; NS6	0.016707902	0.09512729796970511
MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES	0.01667222	0.09492414067047299
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.0166667	0.09489271226702695
#615541 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 39; MRT39	0.016662472	0.09486863993192374
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.016662472	0.09486863993192374
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.016581251999999998	0.09440620969136451
COFFIN-SIRIS SYNDROME 8; CSS8	0.01656228	0.09429819163517283
JOUBERT SYNDROME 30; JBTS30	0.016550862000000003	0.0942331826658709
MICROCEPHALY, CONGENITAL HEART DISEASE, UNILATERAL RENAL AGENESIS,AND HYPOSEGMENTED LUNGS	0.01642701	0.09352802494420458
LATERAL MENINGOCELE SYNDROME	0.01635917	0.0931417744206939
#614816 LOEYS-DIETZ SYNDROME, TYPE 4; LDS4;;ANEURYSM, AORTIC AND CEREBRAL, WITH ARTERIAL TORTUOSITY AND SKELETALMANIFESTATIONS	0.01635154	0.09309833262390167
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.016177442	0.09210709672115758
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.016149412000000002	0.0919475064768474
PEHO SYNDROME; PEHO	0.016149412000000002	0.0919475064768474
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.016066982	0.091478187039156
MENTAL RETARDATION, BUENOS AIRES TYPE	0.01604083	0.09132928928427905
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.015995382	0.09107052876257339
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.015940862	0.09076011634303034
SHORT-RIB THORACIC DYSPLASIA 15 WITH POLYDACTYLY; SRTD15	0.01591553	0.09061588730025952
183802 SPLIT-HAND WITH OBSTRUCTIVE UROPATHY, SPINA BIFIDA, AND DIAPHRAGMATICDEFECTS	0.015872999999999998	0.09037374056139
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2K; CMT2K	0.015872999999999998	0.09037374056139
ECTRODACTYLY AND ECTODERMAL DYSPLASIA WITHOUT CLEFT LIP/PALATE	0.015872999999999998	0.09037374056139
129830 ECTRODACTYLY-CLEFT PALATE SYNDROME;;ECP SYNDROME	0.015872999999999998	0.09037374056139
SPLIT-HAND AND SPLIT-FOOT WITH HYPODONTIA	0.015872999999999998	0.09037374056139
#246560 SPLIT-HAND/FOOT MALFORMATION 3; SHFM3;;SHSF3;;LIMB DEFICIENCIES, DISTAL, WITH MICROGNATHIA;;CHROMOSOME 10Q24 DUPLICATION SYNDROME	0.015872999999999998	0.09037374056139
#612576 CHROMOSOME 17P13.3, TELOMERIC, DUPLICATION SYNDROME;;SPLIT-HAND/FOOT MALFORMATION WITH LONG BONE DEFICIENCY 3; SHFLD3	0.015872999999999998	0.09037374056139
#607706 CHARCOT-MARIE-TOOTH DISEASE, AXONAL, WITH VOCAL CORD PARESIS, AUTOSOMALRECESSIVE;;CMT2 WITH VOCAL CORD PARESIS, AUTOSOMAL RECESSIVE;;CHARCOT-MARIE-TOOTH DISEASE, TYPE 4A, AXONAL FORM;;CHARCOT-MARIE-TOOTH NEUROPATHY, AXONAL, WITH VOCAL CORD PARESIS, AUTOSOMALRECESSIVE	0.015872999999999998	0.09037374056139
#605726 SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 2; DSMA2;;NEURONOPATHY, DISTAL HEREDITARY MOTOR, JERASH TYPE;;NEUROPATHY, DISTAL HEREDITARY MOTOR, JERASH TYPE; HMNJ;;SPINAL MUSCULAR ATROPHY, JERASH TYPE	0.015872999999999998	0.09037374056139
#614455 CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE E; CMTDIE;;CHARCOT-MARIE-TOOTH NEUROPATHY WITH FOCAL SEGMENTAL GLOMERULONEPHRITIS	0.015872999999999998	0.09037374056139
LIMB DEFECTS, DISTAL TRANSVERSE, WITH MENTAL RETARDATION AND SPASTICITY	0.015872999999999998	0.09037374056139
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.015770002	0.08978731615955407
248760 MARFANOID HABITUS WITH MICROCEPHALY AND GLOMERULONEPHRITIS	0.01576831	0.08977768267067168
BARDET-BIEDL SYNDROME 21; BBS21	0.015706980000000002	0.0894284971664425
ECTODERMAL DYSPLASIA AND NEUROSENSORY DEAFNESS	0.01570243	0.0894025915078049
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIm; CDG2M	0.015632892	0.08900667333410378
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.015631251999999998	0.08899733590989153
SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	0.01556121	0.08859854818631058
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.015392822	0.08763982246176882
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.015336682	0.08732018648904051
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.015336682	0.08732018648904051
ABLEPHARON-MACROSTOMIA SYNDROME	0.015324220000000001	0.08724923345213029
LYMPHEDEMA, PRIMARY, WITH MYELODYSPLASIA	0.015305530000000001	0.08714282097741899
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 5	0.01523882	0.08676300416693261
ZECHI-CEIDE SYNDROME	0.015151499999999998	0.086265843263145
241519 HYPOPHOSPHATEMIA, RENAL, WITH INTRACEREBRAL CALCIFICATIONS	0.015151499999999998	0.086265843263145
HOLOPROSENCEPHALY, SEMILOBAR, WITH CRANIOSYNOSTOSIS	0.015151499999999998	0.086265843263145
%155050 MAXILLONASAL DYSPLASIA, BINDER TYPE;;BINDER SYNDROME	0.015151499999999998	0.086265843263145
EPIPHYSEAL DYSPLASIA, MULTIPLE, 2; EDM2	0.015151499999999998	0.086265843263145
VITAMIN K-DEPENDENT CLOTTING FACTORS, COMBINED DEFICIENCY OF, 1; VKCFD1	0.015151499999999998	0.086265843263145
CURVED NAIL OF FOURTH TOE	0.015151499999999998	0.086265843263145
CURRARINO SYNDROME	0.015129582	0.0861410520046794
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.015129582	0.0861410520046794
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.015129582	0.0861410520046794
YOU-HOOVER-FONG SYNDROME; YHFS	0.015092462000000001	0.08592970737860753
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.015069162	0.08579704763217771
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.01502531	0.08554737401842492
RETINAL DEGENERATION WITH NANOPHTHALMOS, CYSTIC MACULAR DEGENERATION,AND ANGLE CLOSURE GLAUCOMA	0.015012250000000001	0.08547301623780805
MICROPHTHALMIA, ISOLATED 1	0.015012250000000001	0.08547301623780805
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.015012250000000001	0.08547301623780805
CRYPTOPHTHALMOS, UNILATERAL OR BILATERAL, ISOLATED; CRYPTOP	0.015012250000000001	0.08547301623780805
VITREORETINOCHOROIDOPATHY; VRCP	0.015012250000000001	0.08547301623780805
MICROPHTHALMIA WITH HYPEROPIA, RETINAL DEGENERATION, MACROPHAKIA,AND DENTAL ANOMALIES	0.015012250000000001	0.08547301623780805
CATARACT 9, MULTIPLE TYPES; CTRCT9	0.015012250000000001	0.08547301623780805
CHROMOSOME 3q13.31 DELETION SYNDROME	0.01496757	0.08521862836353834
MICROSPHEROPHAKIA AND/OR MEGALOCORNEA, WITH ECTOPIA LENTIS AND WITH OR WITHOUT SECONDARY GLAUCOMA; MSPKA	0.014958560000000001	0.0851673294658846
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.014926120000000001	0.08498263066012567
MENTAL RETARDATION, X-LINKED 19	0.01481348	0.08434130903618343
ASPARTYLGLUCOSAMINURIA; AGU	0.0147502	0.08398102110682384
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.014700532	0.08369823379842574
EMANUEL SYNDROME	0.014583992	0.08303470732422272
MENTAL RETARDATION, X-LINKED 97; MRX97	0.01454308	0.08280177275143576
OROFACIODIGITAL SYNDROME V; OFD5	0.01451694	0.08265294331917501
CONGENITAL HEART DEFECTS, HAMARTOMAS OF TONGUE, AND POLYSYNDACTYLY	0.01451694	0.08265294331917501
MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY	0.01451694	0.08265294331917501
601095 HARROD SYNDROME	0.0144928	0.0825155009896121
ALPHA-2-DEFICIENT COLLAGEN DISEASE	0.0144928	0.0825155009896121
MYOPATHY, CENTRONUCLEAR, X-LINKED; CNMX	0.0144928	0.0825155009896121
%614100 CUTIS LAXA, NEONATAL, WITH MARFANOID PHENOTYPE;;CUTIS LAXA-MARFANOID SYNDROME	0.0144928	0.0825155009896121
OSTEOGENESIS IMPERFECTA, TYPE XIII	0.0144928	0.0825155009896121
%217990 CORPUS CALLOSUM, AGENESIS OF;;ACC	0.01443341	0.08217736097499982
ARTHROGRYPOSIS, DISTAL, TYPE 2E	0.01443341	0.08217736097499982
PEROXISOME BIOGENESIS DISORDER 3B	0.014377412000000001	0.08185853348656306
IMMUNODEFICIENCY 49; IMD49	0.014350272	0.0817040105029534
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.014350272	0.0817040105029534
THIEMANN DISEASE	0.0142857	0.081336366505251
207720 APNEA, CENTRAL SLEEP;;SLEEP APNEA, LETHAL CENTRAL	0.0142857	0.081336366505251
SPASTIC PARAPLEGIA 76, AUTOSOMAL RECESSIVE	0.0142857	0.081336366505251
MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO	0.0142857	0.081336366505251
SPINOCEREBELLAR ATAXIA 42	0.0142857	0.081336366505251
SPASTIC PARAPLEGIA, ATAXIA, AND MENTAL RETARDATION	0.0142857	0.081336366505251
#270700 SPASTIC PARAPLEGIA 15, AUTOSOMAL RECESSIVE; SPG15;;SPASTIC PARAPLEGIA AND RETINAL DEGENERATION;;KJELLIN SYNDROME	0.0142857	0.081336366505251
BRACHYDACTYLY-SYNDACTYLY SYNDROME	0.0142857	0.081336366505251
MULTIPLE SYSTEM ATROPHY 1, SUSCEPTIBILITY TO; MSA1	0.0142857	0.081336366505251
SPINOCEREBELLAR ATAXIA 48; SCA48	0.0142857	0.081336366505251
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.0142857	0.081336366505251
#182601 SPASTIC PARAPLEGIA 4, AUTOSOMAL DOMINANT; SPG4;;FAMILIAL SPASTIC PARAPLEGIA, AUTOSOMAL DOMINANT, 2; FSP2	0.0142857	0.081336366505251
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.0142857	0.081336366505251
#604187 SPASTIC PARAPLEGIA 10, AUTOSOMAL DOMINANT; SPG10;;SPASTIC PARAPLEGIA 10 WITH OR WITHOUT PERIPHERAL NEUROPATHY	0.0142857	0.081336366505251
EPILEPSY, PROGRESSIVE MYOCLONIC, 10	0.0142857	0.081336366505251
SPASTIC PARAPLEGIA 13, AUTOSOMAL DOMINANT	0.0142857	0.081336366505251
AMYOTROPHIC DYSTONIC PARAPLEGIA	0.0142857	0.081336366505251
SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT	0.0142857	0.081336366505251
#603563 SPASTIC PARAPLEGIA 8, AUTOSOMAL DOMINANT; SPG8	0.0142857	0.081336366505251
INDIFFERENCE TO PAIN, CONGENITAL, AUTOSOMAL RECESSIVE; CIP	0.0142857	0.081336366505251
SPASTIC PARAPLEGIA 12, AUTOSOMAL DOMINANT	0.0142857	0.081336366505251
%611945 SPASTIC PARAPLEGIA 37, AUTOSOMAL DOMINANT; SPG37	0.0142857	0.081336366505251
SPASTIC PARAPLEGIA 36, AUTOSOMAL DOMINANT; SPG36	0.0142857	0.081336366505251
SANDHOFF DISEASE	0.0142857	0.081336366505251
BRACHYDACTYLY-ECTRODACTYLY WITH FIBULAR APLASIA OR HYPOPLASIA	0.0142857	0.081336366505251
SYRINGOMYELIA, ISOLATED	0.0142857	0.081336366505251
#603516 SPINOCEREBELLAR ATAXIA 10; SCA10	0.0142857	0.081336366505251
SPASTIC PARAPLEGIA 19, AUTOSOMAL DOMINANT	0.0142857	0.081336366505251
METACHROMATIC LEUKODYSTROPHY, ADULT-ONSET, WITH NORMAL ARYLSULFATASEA	0.0142857	0.081336366505251
#607259 SPASTIC PARAPLEGIA 7, AUTOSOMAL RECESSIVE; SPG7	0.0142857	0.081336366505251
#607136 SPINOCEREBELLAR ATAXIA 17; SCA17;;HUNTINGTON DISEASE-LIKE 4; HDL4	0.0142857	0.081336366505251
NEURAL TUBE DEFECTS, SUSCEPTIBILITY TO; NTD	0.0142857	0.081336366505251
SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING; IAHSP	0.0142857	0.081336366505251
#182600 SPASTIC PARAPLEGIA 3, AUTOSOMAL DOMINANT; SPG3A;;SPG3;;STRUMPELL DISEASE;;FAMILIAL SPASTIC PARAPLEGIA, AUTOSOMAL DOMINANT, 1; FSP1	0.0142857	0.081336366505251
#176000 PORPHYRIA, ACUTE INTERMITTENT;;AIP;;PORPHYRIA, SWEDISH TYPE;;PORPHOBILINOGEN DEAMINASE DEFICIENCY;;PBGD DEFICIENCY;;UROPORPHYRINOGEN SYNTHASE DEFICIENCY;;UPS DEFICIENCYPORPHYRIA, ACUTE INTERMITTENT, NONERYTHROID VARIANT, INCLUDED;;PORPHYRIA, CHESTER TYPE, INCLUDED; PORC, INCLUDED	0.0142857	0.081336366505251
ARTERIOSCLEROSIS, SEVERE JUVENILE	0.0142857	0.081336366505251
SECKEL SYNDROME 2; SCKL2	0.01423578	0.08105214442191297
#602482 AXENFELD-RIEGER SYNDROME, TYPE 3; RIEG3;;AXENFELD-RIEGER ANOMALY WITH OR WITHOUT CARDIAC DEFECTS AND/OR SENSORINEURALHEARING LOSS;;ANTERIOR SEGMENT MESENCHYMAL DYSGENESIS;;ANTERIOR CHAMBER CLEAVAGE SYNDROME;;RIEGER SYNDROME, TYPE 3AXENFELD ANOMALY, INCLUDED;;RIEGER ANOMALY, INCLUDED;;AXENFELD-RIEGER ANOMALY, INCLUDED	0.01420719	0.08088936578884737
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.014196921999999999	0.08083090440359667
BARBER-SAY SYNDROME; BBRSAY	0.01417585	0.08071092988957226
CEREBELLOFACIODENTAL SYNDROME	0.014167592000000003	0.0806639125425329
#612462 PSEUDOHYPOPARATHYROIDISM, TYPE IC; PHP1C;;PHP IC	0.014039890000000001	0.07993683464817325
#612463 PSEUDOPSEUDOHYPOPARATHYROIDISM; PPHP;;ALBRIGHT HEREDITARY OSTEODYSTROPHY WITHOUT MULTIPLE HORMONE RESISTANCE	0.014039890000000001	0.07993683464817325
CHROMOSOME 1q41-q42 DELETION SYNDROME	0.013950241999999998	0.07942641915684535
Xq28 (MECP2) duplication	0.013947242000000002	0.0794093385027986
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.013884092000000002	0.0790497907351144
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.013882891999999999	0.07904295847349567
#613456 FRONTONASAL DYSPLASIA 3; FND3	0.01386979	0.07896836156372214
OHDO SYNDROME	0.01380257	0.07858564104204781
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.013793652	0.07853486595111815
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.013793652	0.07853486595111815
MELANOCYTIC NEVUS SYNDROME, CONGENITAL; CMNS	0.01362344	0.07756575518891597
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.013538172000000001	0.07708027745249635
LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET; PLDECO	0.0135135	0.07693980615361581
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 45; MRT45	0.0135135	0.07693980615361581
#612292 BIRK-BAREL MENTAL RETARDATION DYSMORPHISM SYNDROME;;BIRK-BAREL SYNDROME;;MENTAL RETARDATION WITH HYPOTONIA AND FACIAL DYSMORPHISM	0.0135135	0.07693980615361581
JOUBERT SYNDROME 7	0.013502082000000002	0.07687479718431386
Bardet-Biedl syndrome 2	0.013502082000000002	0.07687479718431386
OROFACIODIGITAL SYNDROME XVI; OFD16	0.013502082000000002	0.07687479718431386
ARIMA SYNDROME	0.013502082000000002	0.07687479718431386
#143200 WAGNER VITREORETINOPATHY; WGVRP;;EROSIVE VITREORETINOPATHY; ERVR;;WAGNER VITREORETINAL DEGENERATION;;HYALOIDEORETINAL DEGENERATION OF WAGNER;;WAGNER SYNDROME 1; WGN1	0.01342711	0.07644794025258271
EXFOLIATION SYNDROME; XFS	0.01342711	0.07644794025258271
ANIRIDIA 3	0.01342711	0.07644794025258271
RENAL TUBULAR ACIDOSIS, PROXIMAL, WITH OCULAR ABNORMALITIES AND MENTALRETARDATION	0.01342711	0.07644794025258271
ANIRIDIA	0.01342711	0.07644794025258271
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.01342711	0.07644794025258271
IRIS PIGMENT LAYER, CLEAVAGE OF	0.01342711	0.07644794025258271
ANIRIDIA AND ABSENT PATELLA	0.01342711	0.07644794025258271
MEGALOCORNEA	0.01342711	0.07644794025258271
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.013353039999999998	0.07602621890416827
CRANIOFACIAL DYSOSTOSIS WITH DIAPHYSEAL HYPERPLASIA	0.01323287	0.0753420248385687
CHONDRODYSPLASIA WITH JOINT DISLOCATIONS, GPAPP TYPE	0.013210000000000001	0.07521181331921892
ATAXIA-TELANGIECTASIA WITH GENERALIZED SKIN PIGMENTATION AND EARLY DEATH	0.0131579	0.07491517929394025
264010 PRADER-WILLI HABITUS, OSTEOPENIA, AND CAMPTODACTYLY;;URBAN-ROGERS-MEYER SYNDROME	0.0131579	0.07491517929394025
ARTHROGRYPOSIS, DISTAL, TYPE 1B	0.0131579	0.07491517929394025
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 4	0.0131579	0.07491517929394025
PORPHYRIA, CONGENITAL ERYTHROPOIETIC; CEP	0.0131579	0.07491517929394025
LYMPHEDEMA-HYPOPARATHYROIDISM SYNDROME	0.013147	0.07485311958423703
ROIFMAN-CHITAYAT SYNDROME	0.013119322000000001	0.07469553347000166
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.013103360000000001	0.07460465300337021
PELVIS-SHOULDER DYSPLASIA	0.01296027	0.0737899627408534
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.01294977	0.07373018045168975
224550 DYSTONIA WITH RINGBINDEN	0.01294977	0.07373018045168975
DYSTONIA 16; DYT16	0.01294977	0.07373018045168975
#309801 MICROPHTHALMIA, SYNDROMIC 7; MCOPS7;;MICROPHTHALMIA WITH LINEAR SKIN DEFECTS; MLS;;MICROPHTHALMIA, DERMAL APLASIA, AND SCLEROCORNEA;;MIDAS SYNDROME	0.01290033	0.0734486912729992
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.012892082000000003	0.07340173086147332
#190440 TRIGONOCEPHALY 1; TRIGNO1;;CRANIOSYNOSTOSIS, METOPIC	0.01276981	0.0727055689509383
9q subtelomeric deletion syndrome	0.01276981	0.0727055689509383
BRITTLE CORNEA SYNDROME 2; BCS2	0.01269429	0.07227559195306796
MYASTHENIC SYNDROME, CONGENITAL, 7, PRESYNAPTIC; CMS7	0.01269429	0.07227559195306796
ANGELMAN SYNDROME	0.012671732	0.07214715682173904
POLYDACTYLY, POSTAXIAL, TYPE A2	0.012658200000000001	0.07207011168488547
#607361 MECKEL SYNDROME, TYPE 3; MKS3;;MECKEL-GRUBER SYNDROME, TYPE 3	0.012658200000000001	0.07207011168488547
DANDY-WALKER MALFORMATION WITH POSTAXIAL POLYDACTYLY	0.012658200000000001	0.07207011168488547
241800 HYPOTHALAMIC HAMARTOMASCONGENITAL HYPOTHALAMIC HAMARTOMA SYNDROME, INCLUDED; CHHS, INCLUDED	0.012658200000000001	0.07207011168488547
POLYDACTYLY, POSTAXIAL, WITH PROGRESSIVE MYOPIA	0.012658200000000001	0.07207011168488547
#615937 MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 2;MPPH2	0.012658200000000001	0.07207011168488547
POLYDACTYLY, POSTAXIAL, TYPE A9; PAPA9	0.012658200000000001	0.07207011168488547
OLIVER SYNDROME	0.012658200000000001	0.07207011168488547
LAMBOTTE SYNDROME	0.01265806	0.07206931458769661
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP B	0.012651560000000001	0.07203230650392865
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD	0.012651560000000001	0.07203230650392865
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 5; PEOA5	0.012597220000000001	0.07172291892362839
JOINT LAXITY, SHORT STATURE, AND MYOPIA; JLSM	0.012597220000000001	0.07172291892362839
WOLFRAM-LIKE SYNDROME, AUTOSOMAL DOMINANT; WFSL	0.012597220000000001	0.07172291892362839
%606772 MENTAL RETARDATION, OBESITY, MANDIBULAR PROGNATHISM, AND EYE AND SKINANOMALIES;;MOMES SYNDROME	0.012572590000000002	0.07158268675390451
MARINESCO-SJOGREN SYNDROME; MSS	0.012536092000000002	0.07137488351677168
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.012491532	0.07112117886866384
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.012390102	0.070543681955343
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.012285502	0.06994813648424608
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.012260592	0.0698063101201445
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.012226432	0.06961181840606544
OSTEOGENESIS IMPERFECTA, TYPE XVI; OI16	0.01213909	0.06911453224414817
LYMPHEDEMA, HEREDITARY, III	0.012049152	0.0686024656229291
HURIEZ SYNDROME; HRZ	0.012048200000000002	0.06859704536204493
#236250 HOMOCYSTINURIA DUE TO DEFICIENCY OF N(5,10)-METHYLENETETRAHYDROFOLATEREDUCTASE ACTIVITY;;METHYLENETETRAHYDROFOLATE REDUCTASE DEFICIENCY;;MTHFR DEFICIENCYMTHFR DEFICIENCY, THERMOLABILE TYPE, INCLUDED	0.012020382000000001	0.0684386621506207
ADENYLOSUCCINASE DEFICIENCY	0.011970892	0.0681568882943627
STROMME SYNDROME; STROMS	0.011965769999999999	0.06812772592435352
LOWRY-MACLEAN SYNDROME	0.011923312000000002	0.06788598912118114
HIRSUTISM, SKELETAL DYSPLASIA, AND MENTAL RETARDATION	0.011918789999999999	0.06786024288198131
DEAFNESS, AUTOSOMAL DOMINANT 23; DFNA23	0.01189032	0.0676981474750776
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.011853151999999999	0.06748652955854098
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.011832882000000001	0.0673711212726984
CHROMOSOME 1p35 DELETION SYNDROME	0.011796562	0.06716433148770566
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.011790691999999998	0.0671309103412875
#232400 GLYCOGEN STORAGE DISEASE III;;GSD III; GSD3;;FORBES DISEASE;;CORI DISEASE;;LIMIT DEXTRINOSIS;;AMYLO-1,6-GLUCOSIDASE DEFICIENCY;;AGL DEFICIENCY;;GLYCOGEN DEBRANCHER DEFICIENCY;;GDE DEFICIENCYGLYCOGEN STORAGE DISEASE IIIa, INCLUDED; GSD IIIa, INCLUDED;;GLYCOGEN STORAGE DISEASE IIIb, INCLUDED; GSD IIIb, INCLUDED;;GLYCOGEN STORAGE DISEASE IIIc, INCLUDED; GSD IIIc, INCLUDED;;GLYCOGEN STORAGE DISEASE IIId, INCLUDED; GSD IIId, INCLUDED	0.011764700000000001	0.06698292355462641
BREASTS AND/OR NIPPLES, APLASIA OR HYPOPLASIA OF, 2; BNAH2	0.011764700000000001	0.06698292355462641
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.011730072000000001	0.06678576725851605
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.011670871999999999	0.06644870901866003
GAPO SYNDROME; GAPOS	0.01166266	0.06640195357498271
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.011644602	0.06629913942472394
MENTAL RETARDATION, X-LINKED 73	0.011494299999999999	0.06544338726987872
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16	0.011494299999999999	0.06544338726987872
EPILEPSY-TELANGIECTASIA	0.011494299999999999	0.06544338726987872
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.01141671	0.06500162462071611
PACHYGYRIA, FRONTOTEMPORAL	0.01138255	0.06480713290663705
PAPILLORENAL SYNDROME	0.01137605	0.06477012482286908
#310600 NORRIE DISEASE; ND;;ATROPHIA BULBORUM HEREDITARIA;;EPISKOPI BLINDNESS	0.01137605	0.06477012482286908
#610915 OSTEOGENESIS IMPERFECTA, TYPE VIII; OI8;;OI, TYPE VIII	0.011260582000000002	0.0641127018357121
%608572 BURN-MCKEOWN SYNDROME	0.011204529999999999	0.06379356689550249
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 13; COXPD13	0.01119285	0.06372706621574713
MENTAL RETARDATION, X-LINKED 12; MRX12	0.0111765	0.0636339766511923
SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE; SPG64	0.0111765	0.0636339766511923
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.011168282000000002	0.06358718704620689
%164220 SCHILBACH-ROTT SYNDROME;;OCULAR HYPOTELORISM, SUBMUCOSAL CLEFT PALATE, AND HYPOSPADIAS;;CLEFT PALATE, HYPOTELORISM, AND HYPOSPADIAS;;BLEPHAROFACIOSKELETAL SYNDROME; BRSS	0.01115536	0.06351361497567615
NOONAN SYNDROME 3; NS3	0.011114592	0.06328150027428343
ABSENT EYEBROWS AND EYELASHES WITH MENTAL RETARDATION	0.011079430000000001	0.06308130362175275
113470 BRACHYMESOMELIA-RENAL SYNDROME	0.010989	0.06256643577327001
BILIARY MALFORMATION WITH RENAL TUBULAR INSUFFICIENCY	0.010989	0.06256643577327001
MACS SYNDROME	0.010989	0.06256643577327001
CRANIOSYNOSTOSIS WITH FIBULAR APLASIA	0.010989	0.06256643577327001
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.010985082	0.06254412843908494
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.010959732	0.06239979691238984
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.010950912	0.06234957978949238
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.010950912	0.06234957978949238
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.010906042000000001	0.06209411014046639
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.010858652	0.06182429274204112
FACIOCARDIOMELIC SYNDROME	0.010799320000000001	0.06148648295340707
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.010767712	0.06130652118237044
LISSENCEPHALY 8; LIS8	0.010767712	0.06130652118237044
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.010767712	0.06130652118237044
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.010744872	0.061176480469561124
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.010744872	0.061176480469561124
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.010744872	0.061176480469561124
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.010744872	0.061176480469561124
HYPERMANGANESEMIA WITH DYSTONIA 2	0.010744872	0.061176480469561124
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.010744872	0.061176480469561124
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.010744872	0.061176480469561124
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.010744872	0.061176480469561124
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.010647802000000001	0.06062380744012157
%147770 JOHNSON NEUROECTODERMAL SYNDROME;;JOHNSON-MCMILLIN SYNDROME; JMS;;ALOPECIA-ANOSMIA-DEAFNESS-HYPOGONADISM SYNDROME;;AADH SYNDROME	0.0106213	0.06047291694227251
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.010600651999999999	0.060355356494020025
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.010585052	0.06026653709297689
MENTAL RETARDATION, X-LINKED 90	0.010515182000000001	0.059868728660227945
HAREL-YOON SYNDROME; HAYOS	0.010515182	0.05986872866022793
#215100 RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 1; RCDP1;;PEROXISOME BIOGENESIS DISORDER 9; PBD9;;CHONDRODYSPLASIA PUNCTATA, RHIZOMELIC FORM; CDPR;;CHONDRODYSTROPHIA CALCIFICANS PUNCTATA	0.01044256	0.05945525157416675
#608027 PONTOCEREBELLAR HYPOPLASIA, TYPE 3; PCH3;;CEREBELLAR ATROPHY WITH PROGRESSIVE MICROCEPHALY; CLAM;;PCH WITH OPTIC ATROPHY	0.010439902000000001	0.059440118114681334
CZECH DYSPLASIA, METATARSAL TYPE	0.010416700000000001	0.05930801633628371
BRACHYDACTYLY, TYPE E	0.010416700000000001	0.05930801633628371
RHIZOMELIC DYSPLASIA, PATTERSON-LOWRY TYPE	0.010416700000000001	0.05930801633628371
PSEUDOHYPOPARATHYROIDISM, TYPE IB	0.010416700000000001	0.05930801633628371
EXOSTOSES, MULTIPLE, TYPE I	0.010416700000000001	0.05930801633628371
266910 RENAL DYSPLASIA-LIMB DEFECTS SYNDROME;;RL SYNDROME	0.010416700000000001	0.05930801633628371
BRACHYDACTYLY-NYSTAGMUS-CEREBELLAR ATAXIA	0.010416700000000001	0.05930801633628371
EPIPHYSEAL DYSPLASIA, MULTIPLE, 3; EDM3	0.010416700000000001	0.05930801633628371
EXOSTOSES, MULTIPLE, TYPE II	0.010416700000000001	0.05930801633628371
ATELOSTEOGENESIS, TYPE I; AO1	0.010416700000000001	0.05930801633628371
BRACHYDACTYLY, TYPE E2; BDE2	0.010416700000000001	0.05930801633628371
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.010401852	0.059223478485854956
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.010376502	0.05907914695915986
#615280 CARDIOFACIOCUTANEOUS SYNDROME 4; CFC4	0.010367692000000001	0.05902898677177589
RAHMAN SYNDROME	0.010367692000000001	0.05902898677177589
JOUBERT SYNDROME 35; JBTS35	0.010367692000000001	0.05902898677177589
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.010284241999999999	0.0585538599117086
AMASTIA, BILATERAL, WITH URETERAL TRIPLICATION AND DYSMORPHISM	0.01027071	0.05847681477485503
CDAGS SYNDROME	0.010191132	0.05802373334561076
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.01010703	0.057544894290063986
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G; XPG	0.01010703	0.057544894290063986
#613150 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYEANOMALIES), TYPE A, 2; MDDGA2;;WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, POMT2-RELATED	0.01010703	0.057544894290063986
INCONTINENTIA PIGMENTI; IP	0.01010703	0.057544894290063986
CHITAYAT SYNDROME	0.01006216	0.05728942464103799
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.010028762	0.057099271413086794
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.010028762	0.057099271413086794
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.009943292	0.056612643579294686
OPTIC ATROPHY 11; OPA11	0.009937822	0.056581499853416116
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.009937822	0.056581499853416116
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.00992383	0.05650183568294203
TREMOR, HEREDITARY ESSENTIAL, AND IDIOPATHIC NORMAL PRESSURE HYDROCEPHALUS	0.00990099	0.05637179497013273
#214500 CHEDIAK-HIGASHI SYNDROME; CHS	0.00990099	0.05637179497013273
#164300 OCULOPHARYNGEAL MUSCULAR DYSTROPHY; OPMD;;MUSCULAR DYSTROPHY, OCULOPHARYNGEAL	0.00990099	0.05637179497013273
#600116 PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE; PARK2;;PARKINSON DISEASE, JUVENILE, AUTOSOMAL RECESSIVE; PDJ;;PARKINSONISM, EARLY-ONSET, WITH DIURNAL FLUCTUATION; EPDF	0.00990099	0.05637179497013273
NEMALINE MYOPATHY 7; NEM7	0.00990099	0.05637179497013273
NONAKA MYOPATHY	0.00990099	0.05637179497013273
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.00990099	0.05637179497013273
SPASTIC PARAPLEGIA 80, AUTOSOMAL DOMINANT; SPG80	0.00990099	0.05637179497013273
PARALYSIS AGITANS, JUVENILE, OF HUNT	0.00990099	0.05637179497013273
SPASTIC ATAXIA 1, AUTOSOMAL DOMINANT; SPAX1	0.00990099	0.05637179497013273
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.00990099	0.05637179497013273
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.00990099	0.05637179497013273
KUFOR-RAKEB SYNDROME	0.00990099	0.05637179497013273
#612020 SPASTIC PARAPLEGIA 39, AUTOSOMAL RECESSIVE; SPG39;;NTE-RELATED MOTOR NEURON DISORDER; NTEMND	0.00990099	0.05637179497013273
%271630 BRACHYOLMIA TYPE 1, TOLEDO TYPE;;SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, TOLEDO TYPE;;SED, CHONDROITIN SULFATE TYPE;;PAPS-CHONDROITIN SULFATE SULFOTRANSFERASE DEFICIENCY	0.00990099	0.05637179497013273
%300660 LEUKOENCEPHALOPATHY WITH METAPHYSEAL CHONDRODYSPLASIA; LKMCD	0.00990099	0.05637179497013273
TRYPTOPHANURIA WITH DWARFISM	0.00990099	0.05637179497013273
MAST SYNDROME	0.00990099	0.05637179497013273
INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 1	0.00990099	0.05637179497013273
CATARACT, CONGENITAL, WITH MENTAL IMPAIRMENT AND DENTATE GYRUS ATROPHY	0.00990099	0.05637179497013273
CHOREOATHETOSIS, FAMILIAL INVERTED	0.00990099	0.05637179497013273
#608030 AMYOTROPHIC LATERAL SCLEROSIS 6, WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA;ALS6AMYOTROPHIC LATERAL SCLEROSIS 6, AUTOSOMAL RECESSIVE, INCLUDED	0.00990099	0.05637179497013273
DYSTONIA 23; DYT23	0.00990099	0.05637179497013273
ALZHEIMER DISEASE 3; AD	0.00990099	0.05637179497013273
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4J	0.00990099	0.05637179497013273
POLYGLUCOSAN BODY NEUROPATHY, ADULT FORM	0.00990099	0.05637179497013273
#615156 PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS,AUTOSOMAL DOMINANT, 6; PEOA6;;PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA, AUTOSOMAL DOMINANT, 6	0.00990099	0.05637179497013273
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 5	0.00990099	0.05637179497013273
PARKINSON DISEASE 22, AUTOSOMAL DOMINANT; PARK22	0.00990099	0.05637179497013273
MYASTHENIC SYNDROME, CONGENITAL, 16; CMS16	0.00990099	0.05637179497013273
#609161 STRIATAL DEGENERATION, AUTOSOMAL DOMINANT; ADSD	0.00990099	0.05637179497013273
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 4; LGMDD4	0.00990099	0.05637179497013273
SPASTIC PARAPLEGIA 78, AUTOSOMAL RECESSIVE	0.00990099	0.05637179497013273
BARTH SYNDROME; BTHS	0.00990099	0.05637179497013273
SPASTIC PARAPLEGIA 43, AUTOSOMAL RECESSIVE; SPG43	0.00990099	0.05637179497013273
NEMALINE MYOPATHY 6	0.00990099	0.05637179497013273
#118700 CHOREA, BENIGN HEREDITARY; BHC;;BCH;;HEREDITARY PROGRESSIVE CHOREA WITHOUT DEMENTIA	0.00990099	0.05637179497013273
BEHR SYNDROME	0.00990099	0.05637179497013273
DYSTONIA, CHILDHOOD-ONSET, WITH OPTIC ATROPHY AND BASAL GANGLIA ABNORMALITIES; DYTOABG	0.00990099	0.05637179497013273
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.00990099	0.05637179497013273
MYOCLONIC EPILEPSY OF LAFORA	0.00990099	0.05637179497013273
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, OKINAWA TYPE; HMSNO	0.00990099	0.05637179497013273
115645 CATARACT, ABERRANT ORAL FRENULA, AND GROWTH RETARDATION	0.009879849999999999	0.056251433294616585
#162100 AMYOTROPHY, HEREDITARY NEURALGIC; HNA;;NEURITIS WITH BRACHIAL PREDILECTION; NAPB;;BRACHIAL PLEXUS NEUROPATHY, HEREDITARY;;AMYOTROPHY, HEREDITARY NEURALGIC, WITH PREDILECTION FOR BRACHIAL PLEXUS	0.009879849999999999	0.056251433294616585
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.0098515	0.056090021113874726
CUTIS MARMORATA TELANGIECTATICA CONGENITA	0.00980392	0.055819121940693175
GLAUCOMA 1, PRIMARY OPEN ANGLE, C; GLC1C	0.00980392	0.055819121940693175
SPASTIC PARESIS, GLAUCOMA, AND MENTAL RETARDATION	0.00980392	0.055819121940693175
SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1	0.00980392	0.055819121940693175
GLAUCOMA 3, PRIMARY CONGENITAL, E; GLC3E	0.00980392	0.055819121940693175
MICROCORIA, CONGENITAL	0.00980392	0.055819121940693175
CATARACT 22, MULTIPLE TYPES; CTRCT22	0.00980392	0.055819121940693175
SENGERS SYNDROME	0.00980392	0.055819121940693175
CORNEAL DYSTROPHY, POSTERIOR POLYMORPHOUS, 1	0.00980392	0.055819121940693175
WEILL-MARCHESANI SYNDROME 4; WMS4	0.00980392	0.055819121940693175
SORSBY FUNDUS DYSTROPHY; SFD	0.00980392	0.055819121940693175
AXENFELD-RIEGER SYNDROME, TYPE 1; RIEG1	0.00980392	0.055819121940693175
SINGLETON-MERTEN SYNDROME 2; SGMRT2	0.00980392	0.055819121940693175
#610048 CORNEAL DYSTROPHY, CONGENITAL STROMAL; CSCD;;CONGENITAL STROMAL CORNEAL DYSTROPHY	0.00980392	0.055819121940693175
#177700 GLAUCOMA 1, OPEN ANGLE, P; GLC1P	0.00980392	0.055819121940693175
ANTERIOR SEGMENT DYSGENESIS 3	0.00980392	0.055819121940693175
ACKERMAN SYNDROME	0.00980392	0.055819121940693175
IRIS HYPOPLASIA WITH GLAUCOMA; IHG	0.00980392	0.055819121940693175
MICROCORNEA, GLAUCOMA, AND ABSENT FRONTAL SINUSES	0.00980392	0.055819121940693175
SCHEIE SYNDROME	0.00980392	0.055819121940693175
#115900 CATARACT 42; CTRCT42	0.00980392	0.055819121940693175
IRIDOGONIODYSGENESIS, TYPE 2	0.00980392	0.055819121940693175
GLAUCOMA 1, OPEN ANGLE, A	0.00980392	0.055819121940693175
ASCITES, CHYLOUS	0.00980392	0.055819121940693175
FRONTONASAL DYSPLASIA 2; FND2	0.00975677	0.05555067099459164
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.009694522	0.05519625881022414
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.009689052	0.055165115084345545
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.009689052	0.055165115084345545
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.009689052	0.055165115084345545
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.009675402	0.05508739810843281
DIAPHRAGMATIC DEFECTS, LIMB DEFICIENCIES, AND OSSIFICATION DEFECTS OF SKULL	0.00961068	0.05471890007802808
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.009532619999999999	0.054274461459731464
CYSTIC FIBROSIS WITH HELICOBACTER PYLORI GASTRITIS, MEGALOBLASTIC ANEMIA, AND MENTAL RETARDATION	0.00952381	0.054224301272347494
MULTIPLE ACYL-CoA DEHYDROGENASE DEFICIENCY; MADD	0.00952381	0.054224301272347494
22q11 duplication syndrome	0.00952381	0.054224301272347494
FRONTONASAL DYSPLASIA WITH ALAR CLEFTS	0.00952381	0.054224301272347494
TELECANTHUS	0.00952381	0.054224301272347494
CRANIOECTODERMAL DYSPLASIA 3	0.00952381	0.054224301272347494
%193250 VOLVULUS OF MIDGUT;;INTESTINAL MALROTATION, FAMILIAL	0.00952381	0.054224301272347494
TRISOMY 18-LIKE SYNDROME	0.00952381	0.054224301272347494
BLEPHARONASOFACIAL MALFORMATION SYNDROME	0.00952381	0.054224301272347494
ANIRIDIA, PARTIAL, WITH UNILATERAL RENAL AGENESIS AND PSYCHOMOTORRETARDATION	0.00952381	0.054224301272347494
FETAL AKINESIA SYNDROME, X-LINKED	0.00952381	0.054224301272347494
SIMOSA CRANIOFACIAL SYNDROME	0.00952381	0.054224301272347494
MULLERIAN DUCT APLASIA, UNILATERAL RENAL AGENESIS, AND CERVICOTHORACICSOMITE ANOMALIES	0.00934579	0.05321073526121295
MICROTIA WITH MEATAL ATRESIA AND CONDUCTIVE DEAFNESS	0.00934579	0.05321073526121295
OTOFACIOCERVICAL SYNDROME	0.00934579	0.05321073526121295
FAMILIAL EXPANSILE OSTEOLYSIS	0.00934579	0.05321073526121295
PARAGANGLIOMAS 1	0.00934579	0.05321073526121295
RHYNS SYNDROME; RHYNS	0.00934579	0.05321073526121295
#607842 AURAL ATRESIA, CONGENITAL; CAA;;AURAL ATRESIA, CONGENITAL, WITH HYPOSMIA	0.00934579	0.05321073526121295
ATRESIA OF EXTERNAL AUDITORY CANAL AND CONDUCTION DEAFNESS	0.00934579	0.05321073526121295
TREACHER COLLINS-FRANCESCHETTI SYNDROME	0.00934579	0.05321073526121295
DEAFNESS, CONDUCTIVE, WITH MALFORMED EXTERNAL EAR	0.00934579	0.05321073526121295
OTOSCLEROSIS	0.00934579	0.05321073526121295
DIAMOND-BLACKFAN ANEMIA 14 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA14	0.00934579	0.05321073526121295
124490 DEAFNESS, CONDUCTIVE STAPEDIAL, WITH EAR MALFORMATION AND FACIAL PALSY	0.00934579	0.05321073526121295
DIAMOND-BLACKFAN ANEMIA 10	0.00934579	0.05321073526121295
#244400 CILIARY DYSKINESIA, PRIMARY, 1; CILD1;;PCD;;CILIARY DYSKINESIA, PRIMARY, 1, WITH OR WITHOUT SITUS INVERSUS;;IMMOTILE CILIA SYNDROME; ICS;;POLYNESIAN BRONCHIECTASISKARTAGENER SYNDROME, INCLUDED;;DEXTROCARDIA, BRONCHIECTASIS, AND SINUSITIS, INCLUDED;;SIEWERT SYNDROME, INCLUDED	0.00934579	0.05321073526121295
MANDIBULOFACIAL DYSOSTOSIS WITH ALOPECIA; MFDA	0.00934579	0.05321073526121295
CILIARY DYSKINESIA, PRIMARY, 33	0.00934579	0.05321073526121295
CILIARY DYSKINESIA, PRIMARY, 38; CILD38	0.00934579	0.05321073526121295
OSTEOPETROSIS, AUTOSOMAL DOMINANT 1; OPTA1	0.00934579	0.05321073526121295
AGNATHIA-OTOCEPHALY COMPLEX	0.00934579	0.05321073526121295
XIA-GIBBS SYNDROME	0.009325142	0.05309317481296047
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.009126341999999999	0.05196129680479538
PEHO-LIKE SYNDROME; PEHOL	0.009126341999999999	0.05196129680479538
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.009126341999999999	0.05196129680479538
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.00909394	0.05177681435398772
SECKEL SYNDROME 5; SCKL5	0.00902745	0.05139825012479809
BOWEN-CONRADI SYNDROME	0.00902745	0.05139825012479809
MICROCEPHALY 24, PRIMARY, AUTOSOMAL RECESSIVE; MCPH24	0.00902745	0.05139825012479809
MICROCEPHALY-CARDIOMYOPATHY	0.00902745	0.05139825012479809
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.009008732	0.05129167823064903
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.008922112000000001	0.05079850281280568
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.008917792	0.05077390667097835
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.008917792	0.05077390667097835
FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3	0.00885064	0.050391573310795745
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.008845512	0.05036237677947848
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.00884517	0.05036042958491715
COLOBOMA-OBESITY-HYPOGENITALISM-MENTAL RETARDATION SYNDROME	0.008831519999999999	0.05028271260900441
#269400 CORNEAL OPACIFICATION WITH OTHER OCULAR ANOMALIES; COPOA;;SCLEROCORNEA WITH OTHER OCULAR ANOMALIES	0.008831519999999999	0.05028271260900441
#221900 PERSISTENT HYPERPLASTIC PRIMARY VITREOUS, AUTOSOMAL RECESSIVE; PHPVAR;;RETINAL NONATTACHMENT, NONSYNDROMIC CONGENITAL; RNANC; NCRNA;;RETINAL NONATTACHMENT AND FALCIFORM DETACHMENT;;PERSISTENT FETAL VASCULATURE	0.008831519999999999	0.05028271260900441
MICROPHTHALMIA, ISOLATED, WITH CATARACT 1	0.008831519999999999	0.05028271260900441
CATARACT 11, MULTIPLE TYPES; CTRCT11	0.008831519999999999	0.05028271260900441
MICROPHTHALMIA, ISOLATED 5	0.008831519999999999	0.05028271260900441
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.008831519999999999	0.05028271260900441
#273395 TETRAAMELIA, AUTOSOMAL RECESSIVE	0.008831519999999999	0.05028271260900441
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.008741912000000001	0.049772524859730494
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.008741912000000001	0.049772524859730494
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.008741912000000001	0.049772524859730494
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.00873926	0.04975742556155315
#301835 ARTS SYNDROME; ARTS;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARTS TYPE; MRXSARTS;;ATAXIA, FATAL X-LINKED, WITH DEAFNESS AND LOSS OF VISION;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 18; MRXS18	0.008662312	0.04931931817235654
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.008662312	0.04931931817235654
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.008662312	0.04931931817235654
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.008662312	0.04931931817235654
CROUZON SYNDROME WITH ACANTHOSIS NIGRICANS	0.00866146	0.04931446726660725
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.00866146	0.04931446726660725
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.008595822	0.04894075394316692
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.008595822	0.04894075394316692
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.008543052	0.04864030523848447
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.00853071	0.048570035427736115
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.00848126	0.048288489313532065
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 3; HKLLS3	0.00848126	0.048288489313532065
Pontine tegmental cap dysplasia	0.008413542	0.047902933403285976
#177980 PTERYGIA, MENTAL RETARDATION, AND DISTINCTIVE CRANIOFACIAL FEATURES;;HASPESLAGH SYNDROME	0.008411970000000001	0.04789398314056549
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.008295932	0.04723331482913963
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.00820342	0.04670659300674843
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, cblX TYPE	0.00807823	0.04599381731337728
PELIZAEUS-MERZBACHER DISEASE	0.007961472	0.045329049644980204
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.00794794	0.045252004508126636
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.007921252	0.045100055009726685
#616006 HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 2; HKLLS2	0.00790937	0.045032404232598834
NIJMEGEN BREAKAGE SYNDROME	0.00789803	0.04496783936030209
#608233 HERMANSKY-PUDLAK SYNDROME 2; HPS2	0.00789803	0.04496783936030209
OPTICOCOCHLEODENTATE DEGENERATION	0.007818430000000001	0.044514632672928156
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.007818430000000001	0.044514632672928156
269870 SHORT STATURE-OBESITY SYNDROME; SSOS	0.00775194	0.044136068443738526
KERATOSIS PALMARIS ET PLANTARIS WITH CLINODACTYLY	0.00775194	0.044136068443738526
MOLAR I REINCLUSION	0.00775194	0.044136068443738526
TETRALOGY OF FALLOT	0.00775194	0.044136068443738526
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.007727752	0.043998352823710875
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.007727752	0.043998352823710875
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.007727752	0.043998352823710875
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.007727752	0.043998352823710875
CORPUS CALLOSUM, AGENESIS OF, WITH MENTAL RETARDATION, OCULAR COLOBOMA,AND MICROGNATHIA	0.00769917	0.04383561973905607
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.007646602	0.0435363211317461
BARDET-BIEDL SYNDROME 8; BBS8	0.007646602	0.0435363211317461
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.007515852	0.04279188929287495
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.007466402	0.04251034317867091
CHROMOSOME 22q13 DUPLICATION SYNDROME	0.007466402	0.04251034317867091
HOLOPROSENCEPHALY 7	0.007466402	0.04251034317867091
MENTAL RETARDATION, X-LINKED 107; MRX107	0.007466402	0.04251034317867091
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.007466402	0.04251034317867091
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.007466402	0.04251034317867091
HOLOPROSENCEPHALY 2; HPE2	0.007327721999999999	0.041720761477602834
HOLOPROSENCEPHALY 1; HPE1	0.007327721999999999	0.041720761477602834
ADAMS-OLIVER SYNDROME 1; AOS1	0.007327721999999999	0.041720761477602834
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.007327721999999999	0.041720761477602834
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.007327721999999999	0.041720761477602834
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.007326140000000001	0.04171175427936886
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.007260372	0.04133730079425316
HARTSFIELD SYNDROME; HRTFDS	0.007235462	0.04119547443015158
RING CHROMOSOME 14 SYNDROME	0.007235462	0.04119547443015158
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.007149992	0.04070884659635948
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.007144522	0.0406777028704809
MUCOLIPIDOSIS IV; ML4	0.007144522	0.0406777028704809
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.007144522	0.0406777028704809
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.007144522	0.0406777028704809
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.007144522	0.0406777028704809
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.007144522	0.0406777028704809
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.007144522	0.0406777028704809
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.007144522	0.0406777028704809
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.007144522	0.0406777028704809
AICARDI-GOUTIERES SYNDROME 7	0.007144522	0.0406777028704809
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.007144522	0.0406777028704809
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.007144522	0.0406777028704809
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.007144522	0.0406777028704809
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.007144522	0.0406777028704809
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.007144522	0.0406777028704809
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.007144522	0.0406777028704809
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.007144522	0.0406777028704809
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.007144522	0.0406777028704809
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.007144522	0.0406777028704809
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.007144522	0.0406777028704809
AL-RAQAD SYNDROME; ARS	0.007144522	0.0406777028704809
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.007144522	0.0406777028704809
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.007144522	0.0406777028704809
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.007144522	0.0406777028704809
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.007144522	0.0406777028704809
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.007144522	0.0406777028704809
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.007144522	0.0406777028704809
#612438 LEUKODYSTROPHY, HYPOMYELINATING, 6; HLD6;;LEUKODYSTROPHY, HYPOMYELINATING, WITH ATROPHY OF THE BASAL GANGLIAAND CEREBELLUM; HABC	0.00711759	0.040524364145551814
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3	0.00711759	0.040524364145551814
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.00711759	0.040524364145551814
#115470 CAT EYE SYNDROME; CES;;SCHMID-FRACCARO SYNDROME;;CHROMOSOME 22 PARTIAL TETRASOMY;;INV DUP(22)(q11)	0.00706707	0.04023672593140443
SHORT-RIB THORACIC DYSPLASIA 13 WITH OR WITHOUT POLYDACTYLY; SRTD13	0.00706707	0.04023672593140443
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.007026912000000001	0.04000808429633454
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.007026912	0.04000808429633454
%265300 LYMPHANGIECTASIA, PULMONARY, CONGENITAL; CPL;;LYMPHANGIOMATOSIS, PULMONARY;;PULMONARY CYSTIC LYMPHANGIECTASIS	0.0070133800000000005	0.03993103915948097
COLE-CARPENTER SYNDROME 2; CLCRP2	0.0070133800000000005	0.03993103915948097
AL-GAZALI-BAKALINOVA SYNDROME; AGBK	0.0070133800000000005	0.03993103915948097
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.0070116020000000005	0.03992091602518259
#613076 MYOPATHY, MITOCHONDRIAL PROGRESSIVE, WITH CONGENITAL CATARACT, HEARINGLOSS, AND DEVELOPMENTAL DELAY;;MYOPATHY WITH CATARACT AND COMBINED RESPIRATORY CHAIN DEFICIENCY;;MITOCHONDRIAL COMPLEX DEFICIENCY, COMBINED	0.0070116020000000005	0.03992091602518259
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.006894512	0.03925425809773767
#612951 LEUKOENCEPHALOPATHY, CYSTIC, WITHOUT MEGALENCEPHALY	0.0068688199999999994	0.03910797937648125
300064 MENTAL RETARDATION, X-LINKED, WITH CRANIOFACIAL DYSMORPHISM;;MENTAL RETARDATION, X-LINKED, HYDE-FORSTER TYPE	0.00680272	0.03873163563231771
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.00680272	0.03873163563231771
HUMERORADIAL SYNOSTOSISHUMERORADIAL/MULTIPLE SYNOSTOSIS SYNDROME	0.00680272	0.03873163563231771
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.00680272	0.03873163563231771
CLEIDOCRANIAL DYSPLASIA, RECESSIVE FORM	0.00680272	0.03873163563231771
OSTEOGENESIS IMPERFECTA, TYPE XI; OI11	0.00680272	0.03873163563231771
MENTAL RETARDATION, X-LINKED 1	0.00680272	0.03873163563231771
MENTAL RETARDATION, TRUNCAL OBESITY, RETINAL DYSTROPHY, AND MICROPENIS SYNDROME; MORMS	0.00667197	0.03798720379344656
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.0066457420000000005	0.03783787332866712
TETRA-AMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES	0.00662252	0.03770565767924252
VICI SYNDROME; VICIS	0.006522661999999999	0.03713711102864217
OCULOPALATOCEREBRAL SYNDROME	0.006483839999999999	0.036916075978174444
WARBURG MICRO SYNDROME 1	0.006483839999999999	0.036916075978174444
MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20	0.006483839999999999	0.036916075978174444
MICROPHTHALMIA, SYNDROMIC 8; MCOPS8	0.006483839999999999	0.036916075978174444
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.0064371920000000004	0.03665048319485008
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.0064371920000000004	0.03665048319485008
GALACTOSE EPIMERASE DEFICIENCY	0.006437192	0.03665048319485007
OSTEOGENESIS IMPERFECTA CONGENITA, MICROCEPHALY, AND CATARACTS	0.006430150000000001	0.03661038920625099
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.006430150000000001	0.03661038920625099
ALLAN-HERNDON-DUDLEY SYNDROME	0.006430150000000001	0.03661038920625099
SHORT STATURE AND FACIOAURICULOTHORACIC MALFORMATIONS	0.006430150000000001	0.03661038920625099
%300719 DEAFNESS, CATARACT, RETINITIS PIGMENTOSA, AND SPERM ABNORMALITIES	0.00641649	0.03653261529482476
LISSENCEPHALY 5; LIS5	0.00641649	0.03653261529482476
SPASTIC PARAPARESIS AND DEAFNESS	0.00641649	0.03653261529482476
EHLERS-DANLOS SYNDROME, BEASLEY-COHEN TYPE	0.00641649	0.03653261529482476
OPTIC ATROPHY 3, AUTOSOMAL DOMINANT	0.00641649	0.03653261529482476
ALPORT SYNDROME, AUTOSOMAL RECESSIVE	0.00641649	0.03653261529482476
NATHALIE SYNDROME	0.00641649	0.03653261529482476
CHROMOSOME 13q14 DELETION SYNDROME	0.00630611	0.035904161096931085
#309548 MENTAL RETARDATION, X-LINKED, ASSOCIATED WITH FRAGILE SITE FRAXE;;FRAXE MENTAL RETARDATION SYNDROME	0.00630611	0.035904161096931085
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.00630064	0.035873017371052494
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.00630064	0.035873017371052494
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.00630064	0.035873017371052494
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.00630064	0.035873017371052494
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.00630064	0.035873017371052494
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.00630064	0.035873017371052494
NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS	0.00630064	0.035873017371052494
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.00630064	0.035873017371052494
MICROCEPHALY 21, PRIMARY, AUTOSOMAL RECESSIVE; MCPH21	0.00630064	0.035873017371052494
RICHARDS-RUNDLE SYNDROME; RRNS	0.006181712000000001	0.03519589469622827
LEBER CONGENITAL AMAUROSIS, TYPE I	0.00616772	0.035116230525754195
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.00616772	0.035116230525754195
NEURAMINIDASE DEFICIENCY	0.00616772	0.035116230525754195
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.00616772	0.035116230525754195
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1; PEOA1	0.00616772	0.035116230525754195
REFSUM DISEASE	0.00616772	0.035116230525754195
DYSTONIA, JUVENILE-ONSET	0.00616772	0.035116230525754195
PEROXISOME BIOGENESIS DISORDER 9B; PBD9B	0.00616772	0.035116230525754195
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.0060522119999999995	0.034458579796543265
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.0060522119999999995	0.034458579796543265
GRACILE BONE DYSPLASIA; GCLEB	0.0060522119999999995	0.034458579796543265
CRANIOTELENCEPHALIC DYSPLASIA	0.0060522119999999995	0.034458579796543265
PHACE ASSOCIATION	0.0060522119999999995	0.034458579796543265
#614402 MICROPHTHALMIA, SYNDROMIC 11; MCOPS11	0.0060522119999999995	0.034458579796543265
#615279 CARDIOFACIOCUTANEOUS SYNDROME 3; CFC3	0.005998522	0.03415289302461981
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.005998522	0.03415289302461981
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.005959952	0.03393329274909201
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.005959952	0.03393329274909201
DIAPHANOSPONDYLODYSOSTOSIS	0.005959952	0.03393329274909201
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.005959952	0.03393329274909201
NOONAN SYNDROME 5; NS5	0.005959952	0.03393329274909201
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.005869012	0.03341552118942132
MENTAL RETARDATION, X-LINKED 103	0.005869012	0.03341552118942132
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.005869012	0.03341552118942132
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.005869012	0.03341552118942132
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.005869012	0.03341552118942132
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.005869012	0.03341552118942132
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.005869012	0.03341552118942132
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.005869012	0.03341552118942132
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.005869012	0.03341552118942132
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.005869012	0.03341552118942132
#300886 MENTAL RETARDATION, X-LINKED, SYNDROMIC 32; MRXS32	0.005869012	0.03341552118942132
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.005869012	0.03341552118942132
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.005869012	0.03341552118942132
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.005869012	0.03341552118942132
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.005869012	0.03341552118942132
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.005869012	0.03341552118942132
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.005869012	0.03341552118942132
#616341 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 30; EIEE30	0.005869012	0.03341552118942132
MENTAL RETARDATION, X-LINKED 104; MRX104	0.005869012	0.03341552118942132
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.005869012	0.03341552118942132
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.005869012	0.03341552118942132
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.005869012	0.03341552118942132
#614970 JOUBERT SYNDROME 20; JBTS20	0.005869012	0.03341552118942132
RAYNAUD-CLAES SYNDROME; MRXSRC	0.005869012	0.03341552118942132
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.005869012	0.03341552118942132
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.005869012	0.03341552118942132
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.005869012	0.03341552118942132
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.005869012	0.03341552118942132
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.005869012	0.03341552118942132
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.005869012	0.03341552118942132
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.005869012	0.03341552118942132
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.005869012	0.03341552118942132
#300894 NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 5; NBIA5;;BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION; BPAN;;STATIC ENCEPHALOPATHY OF CHILDHOOD WITH NEURODEGENERATION IN ADULTHOOD;SENDA	0.005869012	0.03341552118942132
#615473 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 17; EIEE17	0.005869012	0.03341552118942132
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.005869012	0.03341552118942132
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.005869012	0.03341552118942132
MENTAL RETARDATION, X-LINKED 101; MRX101	0.005869012	0.03341552118942132
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.005869012	0.03341552118942132
#300755 AGAMMAGLOBULINEMIA, X-LINKED; XLA;;BRUTON-TYPE AGAMMAGLOBULINEMIA;;AGAMMAGLOBULINEMIA, X-LINKED, TYPE 1; AGMX1;;IMMUNODEFICIENCY 1; IMD1HYPOGAMMAGLOBULINEMIA, X-LINKED, INCLUDED	0.00584208	0.03326218246449224
CHROMOSOME 8Q21.11 DELETION SYNDROME	0.005801860000000001	0.033033187829238725
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.005751402	0.03274590261527497
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.005751402	0.03274590261527497
CHROMOSOME 16p11.2 DELETION SYNDROME, 593-KB	0.005751402	0.03274590261527497
DIGEORGE SYNDROME; DGS	0.005751402	0.03274590261527497
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.005751402	0.03274590261527497
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.005742582	0.0326956854923775
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.005742582	0.0326956854923775
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.005742582	0.0326956854923775
#251290 BAND-LIKE CALCIFICATION WITH SIMPLIFIED GYRATION AND POLYMICROGYRIA;BLCPMG;;PSEUDO-TORCH SYNDROME	0.005742582	0.0326956854923775
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.005742582	0.0326956854923775
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.005742582	0.0326956854923775
MEVALONIC ACIDURIA; MEVA	0.005742582	0.0326956854923775
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.005742582	0.0326956854923775
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.005742582	0.0326956854923775
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.005742582	0.0326956854923775
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.0053767220000000004	0.03061264279586203
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.0053767220000000004	0.03061264279586203
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.0053767220000000004	0.03061264279586203
OGDEN SYNDROME; OGDNS	0.0053767220000000004	0.03061264279586203
CHROMOSOME 14q11-q22 DELETION SYNDROME	0.0053767220000000004	0.03061264279586203
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIl; CDG2L	0.0053767220000000004	0.03061264279586203
DEAFNESS, AUTOSOMAL RECESSIVE 20; DFNB20	0.00533783	0.030391209196799874
COWCHOCK SYNDROME; COWCK	0.00533783	0.030391209196799874
DEAFNESS, AUTOSOMAL RECESSIVE 29	0.00533783	0.030391209196799874
STEEL SYNDROME; STLS	0.005247152	0.0298749293475826
#609528 CEREBRAL DYSGENESIS, NEUROPATHY, ICHTHYOSIS, AND PALMOPLANTAR KERATODERMASYNDROME;;CEDNIK SYNDROME	0.005247152	0.0298749293475826
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.005247152	0.0298749293475826
#300422 FG SYNDROME 4; FGS4MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT NYSTAGMUS, INCLUDED	0.005247152	0.0298749293475826
NOONAN SYNDROME 11; NS11	0.005247152	0.0298749293475826
#609549 NANOPHTHALMOS 2; NNO2;;NANOPHTHALMIA 2;;NANOPHTHALMOS, AUTOSOMAL RECESSIVE	0.00520833	0.02965389429711487
#610093 MICROPHTHALMIA, ISOLATED 2; MCOP2;;ANOPHTHALMIA, CLINICAL, ISOLATED	0.00520833	0.02965389429711487
NANOPHTHALMOS 4; NNO4	0.00520833	0.02965389429711487
#305390 EXUDATIVE VITREORETINOPATHY 2, X-LINKED; EVR2;;EXUDATIVE VITREORETINOPATHY, FAMILIAL, 2;;EVRX;;FEVR, X-LINKED; FEVRX	0.00520833	0.02965389429711487
DEXTROCARDIA WITH UNUSUAL FACIES AND MICROPHTHALMIA	0.00520833	0.02965389429711487
CHONDRODYSPLASIA WITH PLATYSPONDYLY, DISTINCTIVE BRACHYDACTYLY, HYDROCEPHALY, AND MICROPHTHALMIA	0.00520833	0.02965389429711487
MICROPHTHALMIA, ISOLATED 6; MCOP6	0.00520833	0.02965389429711487
RODRIGUES BLINDNESS	0.00520833	0.02965389429711487
KENNY-CAFFEY SYNDROME, TYPE 2; KCS2	0.00520833	0.02965389429711487
OCULOCEREBROCUTANEOUS SYNDROME	0.00520833	0.02965389429711487
FACIAL DYSMORPHISM, LENS DISLOCATION, ANTERIOR SEGMENT ABNORMALITIES, AND SPONTANEOUS FILTERING BLEBS; FDLAB	0.00520833	0.02965389429711487
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 10; MCOPCB10	0.00520833	0.02965389429711487
MICROPHTHALMIA, ISOLATED, WITH CORECTOPIA	0.00520833	0.02965389429711487
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 5	0.00520833	0.02965389429711487
248110 MACROSOMIA WITH MICROPHTHALMIA, LETHAL	0.00520833	0.02965389429711487
MICROPHTHALMIA, ISOLATED 7; MCOP7	0.00520833	0.02965389429711487
FOVEAL HYPOPLASIA 2; FVH2	0.00520833	0.02965389429711487
PREMATURE OVARIAN FAILURE 12	0.00520833	0.02965389429711487
COLOBOMA, OCULAR	0.00520833	0.02965389429711487
MICROPHTHALMIA, ISOLATED 3	0.00520833	0.02965389429711487
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.0051681719999999995	0.029425252662044984
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.0051681719999999995	0.029425252662044984
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.0051681719999999995	0.029425252662044984
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.0051681719999999995	0.029425252662044984
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.0051681719999999995	0.029425252662044984
#604317 MICROCEPHALY 2, PRIMARY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT CORTICALMALFORMATIONS; MCPH2	0.0051681719999999995	0.029425252662044984
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.0051681719999999995	0.029425252662044984
#614728 SECKEL SYNDROME 6; SCKL6	0.0051681719999999995	0.029425252662044984
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.0051681719999999995	0.029425252662044984
LIG4 SYNDROME	0.0051681719999999995	0.029425252662044984
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.0051681719999999995	0.029425252662044984
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.0051681719999999995	0.029425252662044984
FORSYTHE-WAKELING SYNDROME; FWS	0.0051681719999999995	0.029425252662044984
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.0051681719999999995	0.029425252662044984
NEMALINE MYOPATHY 11, AUTOSOMAL RECESSIVE; NEM11	0.00515464	0.02934820752519142
OSTEOFIBROUS DYSPLASIA, SUSCEPTIBILITY TO; OSFD	0.00515464	0.02934820752519142
Osteogenesis imperfecta, type IX	0.00515464	0.02934820752519142
#610682 OSTEOGENESIS IMPERFECTA, TYPE VII; OI7;;OI, TYPE VII;;OSTEOGENESIS IMPERFECTA, TYPE IIB, FORMERLY; OI2B, FORMERLY	0.00515464	0.02934820752519142
#100100 PRUNE BELLY SYNDROME; PBS;;ABDOMINAL MUSCLES, ABSENCE OF, WITH URINARY TRACT ABNORMALITY ANDCRYPTORCHIDISM;;EAGLE-BARRETT SYNDROME; EGBRS	0.00515464	0.02934820752519142
EHLERS-DANLOS SYNDROME, AUTOSOMAL RECESSIVE, CARDIAC VALVULAR FORM	0.00515464	0.02934820752519142
THORACIC DYSOSTOSIS, ISOLATED	0.00515464	0.02934820752519142
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 4; MDDGC4	0.00515464	0.02934820752519142
OSTEOGENESIS IMPERFECTA, TYPE XIX; OI19	0.00515464	0.02934820752519142
OPHTHALMOPLEGIA, EXTERNAL, WITH RIB AND VERTEBRAL ANOMALIES; EORVA	0.00515464	0.02934820752519142
FRAGILE X MENTAL RETARDATION SYNDROME	0.00515464	0.02934820752519142
FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3B	0.00515464	0.02934820752519142
%157700 MITRAL VALVE PROLAPSE 1; MVP1;;MITRAL VALVE PROLAPSE, MYXOMATOUS 1; MMVP1;;MYXOMATOUS MITRAL VALVE PROLAPSE 1;;MITRAL VALVE PROLAPSE, FAMILIAL; MVP PROLAPSED MITRAL VALVE; PMV;;MITRAL REGURGITATION, FAMILIAL;;FLOPPY MITRAL VALVE;;BARLOW SYNDROME;;MYXOMATOUS VALVULAR DISEASE, FAMILIAL;;CLICK-MURMUR SYNDROME	0.00515464	0.02934820752519142
AORTIC ANEURYSM, FAMILIAL THORACIC 10; AAT10	0.00515464	0.02934820752519142
MUSCULAR DYSTROPHY, CONGENITAL, DAVIGNON-CHAUVEAU TYPE; MDCDC	0.00515464	0.02934820752519142
169300 PECTUS EXCAVATUM;;FUNNEL CHEST	0.00515464	0.02934820752519142
PIERRE ROBIN SEQUENCE WITH PECTUS EXCAVATUM AND RIB AND SCAPULAR ANOMALIES	0.00515464	0.02934820752519142
GROWTH FACTORS, COMBINED DEFECT OF	0.00515464	0.02934820752519142
NEMALINE MYOPATHY 1; NEM1	0.00515464	0.02934820752519142
#611554 LEOPARD SYNDROME 2	0.00511607	0.029128607249663617
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME	0.00511607	0.029128607249663617
#613506 AGAMMAGLOBULINEMIA 5, AUTOSOMAL DOMINANT; AGM5;;AGAMMAGLOBULINEMIA, AUTOSOMAL DOMINANT, DUE TO LRRC8A DEFECT	0.00511607	0.029128607249663617
HYPERTELORISM AND TETRALOGY OF FALLOT	0.00511607	0.029128607249663617
601450 DISLOCATION OF HIP, CONGENITAL, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM;;HIP, CONGENITAL DISLOCATION OF, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM	0.00511607	0.029128607249663617
SHORT-RIB THORACIC DYSPLASIA 18 WITH POLYDACTYLY; SRTD18	0.00511607	0.029128607249663617
HYPERURICEMIA, INFANTILE, WITH ABNORMAL BEHAVIOR AND NORMAL HYPOXANTHINEGUANINE PHOSPHORIBOSYLTRANSFERASE	0.00502513	0.02861083568999293
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.00502513	0.02861083568999293
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 4; MMDS4	0.00502513	0.02861083568999293
MENTAL RETARDATION, X-LINKED 105; MRX105	0.00502513	0.02861083568999293
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.00502513	0.02861083568999293
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69; EIEE69	0.00502513	0.02861083568999293
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.00502513	0.02861083568999293
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.00502513	0.02861083568999293
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.00502513	0.02861083568999293
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 74; EIEE74	0.00502513	0.02861083568999293
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.00502513	0.02861083568999293
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.00502513	0.02861083568999293
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 29	0.00502513	0.02861083568999293
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.00502513	0.02861083568999293
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.004912692000000001	0.027970664163423187
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.004912692000000001	0.027970664163423187
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.004912692000000001	0.027970664163423187
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.004912692000000001	0.027970664163423187
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.00490752	0.027941217115846576
PHENYLKETONURIA	0.004898700000000001	0.02789099999294911
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.004898700000000001	0.02789099999294911
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.004898700000000001	0.02789099999294911
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	0.004898700000000001	0.02789099999294911
MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE; MCPH10	0.004898700000000001	0.02789099999294911
#604804 MICROCEPHALY 3, PRIMARY, AUTOSOMAL RECESSIVE; MCPH3	0.004663922000000001	0.026554279394352627
#220120 D-GLYCERIC ACIDURIA;;D-GLYCERIC ACIDEMIA;;GLYCERATE KINASE DEFICIENCY	0.004663922000000001	0.026554279394352627
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.004663922000000001	0.026554279394352627
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.004663922000000001	0.026554279394352627
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.004663922	0.026554279394352624
#612938 GROWTH RETARDATION, DEVELOPMENTAL DELAY, COARSE FACIES, AND EARLYDEATH; GDFD	0.004663922	0.026554279394352624
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.004663922	0.026554279394352624
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.004663922	0.026554279394352624
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.004663922	0.026554279394352624
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.004663922	0.026554279394352624
3MC SYNDROME 3	0.0046520400000000005	0.026486628617224773
CRANIODIAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; CDD	0.0046520400000000005	0.026486628617224773
%614187 HYPERTELORISM, PREAURICULAR SINUS, PUNCTAL PITS, AND DEAFNESS; HPPD	0.0046520400000000005	0.026486628617224773
COFFIN-SIRIS SYNDROME 10; CSS10	0.00453284	0.025807957296433634
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.004467072	0.025433503811317933
#613730 HEMORRHAGIC DESTRUCTION OF THE BRAIN, SUBEPENDYMAL CALCIFICATION,AND CATARACTS; HDBSCC	0.004467072	0.025433503811317933
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.004467072	0.025433503811317933
PELLAGRA-LIKE SYNDROME	0.004467072	0.025433503811317933
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.004467072	0.025433503811317933
#613707 LEOPARD SYNDROME 3; LPRD3	0.00440327	0.02507024384815421
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 2; VCRL2	0.00432429	0.02462056716261659
MICROCEPHALY, CATARACTS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSTONIA WITH ABNORMAL STRIATUM; MCIDDS	0.00432429	0.02462056716261659
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 24	0.00432429	0.02462056716261659
Recurrent 16p12.1 microdeletion (neurodevelopmental susceptibility locus)	0.00432429	0.02462056716261659
#300558 MENTAL RETARDATION, X-LINKED 30; MRX30;;MENTAL RETARDATION, X-LINKED 47; MRX47	0.00432429	0.02462056716261659
#602541 MUSCULAR DYSTROPHY, CONGENITAL, MEGACONIAL TYPE; MDCMC;;MUSCULAR DYSTROPHY, CONGENITAL, WITH MITOCHONDRIAL STRUCTURAL ABNORMALITIES	0.00432429	0.02462056716261659
MEIER-GORLIN SYNDROME 3; MGORS3	0.00432429	0.02462056716261659
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.00432429	0.02462056716261659
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 28	0.00432429	0.02462056716261659
#613603 CHROMOSOME 4q32.1-q32.2 TRIPLICATION SYNDROME	0.004101212	0.023350461114802455
INFANTILE SIALIC ACID STORAGE DISEASE	0.004101212	0.023350461114802455
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.004101212	0.023350461114802455
BAKER-GORDON SYNDROME; BAGOS	0.004101212	0.023350461114802455
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.004101212	0.023350461114802455
JOUBERT SYNDROME 10	0.004101212	0.023350461114802455
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.004101212	0.023350461114802455
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.004101212	0.023350461114802455
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.004101212	0.023350461114802455
OCULOECTODERMAL SYNDROME; OES	0.004101212	0.023350461114802455
156620 MICROCEPHALY-DEAFNESS SYNDROME	0.004068810000000001	0.023165978663994793
XFE PROGEROID SYNDROME; XFEPS	0.004068810000000001	0.023165978663994793
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	0.004068810000000001	0.023165978663994793
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.004068810000000001	0.023165978663994793
MENTAL RETARDATION, X-LINKED 102	0.004068810000000001	0.023165978663994793
CYCLIC VOMITING SYNDROME	0.004068810000000001	0.023165978663994793
301950 BRANCHIAL ARCH SYNDROME, X-LINKED;;MANDIBULOFACIAL DYSOSTOSIS, TORIELLO TYPE	0.004068810000000001	0.023165978663994793
XYLOSIDASE DEFICIENCY	0.004068810000000001	0.023165978663994793
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.003978132	0.022649698814777516
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.003978132	0.022649698814777516
MENTAL RETARDATION, X-LINKED 106; MRX106	0.003978132	0.022649698814777516
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.003978132	0.022649698814777516
FUMARASE DEFICIENCY; FMRD	0.003978132	0.022649698814777516
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.003978132	0.022649698814777516
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.003978132	0.022649698814777516
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ik; CDG1K	0.003978132	0.022649698814777516
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.003978132	0.022649698814777516
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.003892662	0.022163070980985414
HYPERPROLINEMIA, TYPE I	0.003892662	0.022163070980985414
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.003892662	0.022163070980985414
#610951 CEROID LIPOFUSCINOSIS, NEURONAL, 7; CLN7	0.003892662	0.022163070980985414
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.003892662	0.022163070980985414
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.003892662	0.022163070980985414
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.003892662	0.022163070980985414
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.003892662	0.022163070980985414
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.003892662	0.022163070980985414
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.003892662	0.022163070980985414
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.003892662	0.022163070980985414
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.003892662	0.022163070980985414
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.003892662	0.022163070980985414
#300653 PHOSPHOGLYCERATE KINASE 1 DEFICIENCY;;PGK1 DEFICIENCY	0.003892662	0.022163070980985414
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.003892662	0.022163070980985414
EPILEPSY, PYRIDOXINE-DEPENDENT	0.003892662	0.022163070980985414
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.003892662	0.022163070980985414
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.003892662	0.022163070980985414
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.003892662	0.022163070980985414
Cerebral creatine deficiency syndrome 3	0.003892662	0.022163070980985414
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.003892662	0.022163070980985414
#606777 GLUT1 DEFICIENCY SYNDROME 1; GLUT1DS1;;GLUCOSE TRANSPORT DEFECT, BLOOD-BRAIN BARRIERGLUT1 DEFICIENCY SYNDROME 1, AUTOSOMAL RECESSIVE, INCLUDED	0.003892662	0.022163070980985414
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.003892662	0.022163070980985414
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.003892662	0.022163070980985414
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.003892662	0.022163070980985414
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.003892662	0.022163070980985414
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.003892662	0.022163070980985414
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.003892662	0.022163070980985414
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.003892662	0.022163070980985414
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.003892662	0.022163070980985414
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.003892662	0.022163070980985414
SALLA DISEASE	0.003892662	0.022163070980985414
#615516 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 38; MRT38	0.003892662	0.022163070980985414
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.003892662	0.022163070980985414
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.003892662	0.022163070980985414
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.003892662	0.022163070980985414
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.003892662	0.022163070980985414
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.003892662	0.022163070980985414
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.003892662	0.022163070980985414
LANDAU-KLEFFNER SYNDROME	0.003892662	0.022163070980985414
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.003892662	0.022163070980985414
#136570 CHROMOSOME 16p12.1 DELETION SYNDROME, 520-KBFRAGILE SITE 16p12, INCLUDED	0.003892662	0.022163070980985414
#300848 MENTAL RETARDATION, X-LINKED 89; MRX89	0.003892662	0.022163070980985414
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.003892662	0.022163070980985414
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.003892662	0.022163070980985414
Cerebral creatine deficiency syndrome 2	0.003892662	0.022163070980985414
DE SANCTIS-CACCHIONE SYNDROME	0.0038200400000000002	0.02174959389492423
KEARNS-SAYRE SYNDROME; KSS	0.0038200400000000002	0.02174959389492423
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 50; MRT50	0.0038200400000000002	0.02174959389492423
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A; XPA	0.0038200400000000002	0.02174959389492423
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.003637182	0.020708482482363615
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.003637182	0.020708482482363615
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.003637182	0.020708482482363615
MEIER-GORLIN SYNDROME 7	0.003637182	0.020708482482363615
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.003637182	0.020708482482363615
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.003637182	0.020708482482363615
#300895 OHDO SYNDROME, X-LINKED; OHDOX;;BLEPHAROPHIMOSIS-MENTAL RETARDATION SYNDROME, MAAT-KIEVIT-BRUNNERTYPE	0.003637182	0.020708482482363615
#245400 MITOCHONDRIAL DNA DEPLETION SYNDROME 9 (ENCEPHALOMYOPATHIC TYPE WITHMETHYLMALONIC ACIDURIA); MTDPS9;;LACTIC ACIDOSIS, FATAL INFANTILE, FORMERLY	0.003637182	0.020708482482363615
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.003637182	0.020708482482363615
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.003637182	0.020708482482363615
BARDET-BIEDL SYNDROME 16; BBS16	0.003637182	0.020708482482363615
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.003637182	0.020708482482363615
MITOCHONDRIAL SHORT-CHAIN ENOYL-CoA HYDRATASE 1 DEFICIENCY; ECHS1D	0.003637182	0.020708482482363615
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.003637182	0.020708482482363615
HYDROXYKYNURENINURIA	0.003637182	0.020708482482363615
MYOTONIC DYSTROPHY 1	0.00362319	0.02062881831188954
KERATOSIS FOLLICULARIS SPINULOSA DECALVANS, AUTOSOMAL DOMINANT; KFSD	0.00362319	0.02062881831188954
#262300 ACHROMATOPSIA 3; ACHM3;;PINGELAPESE BLINDNESS;;TOTAL COLORBLINDNESS WITH MYOPIA;;ACHROMATOPSIA WITH MYOPIA;;ACHM1, FORMERLY;;ROD MONOCHROMATISM 1, FORMERLY;;ROD MONOCHROMACY 1, FORMERLY; RMCH1, FORMERLY	0.00362319	0.02062881831188954
HYPERTROPHIC NEUROPATHY AND CATARACT	0.00362319	0.02062881831188954
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.00362319	0.02062881831188954
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 24; SCAR24	0.00362319	0.02062881831188954
SHORT-RIB THORACIC DYSPLASIA 5 WITH OR WITHOUT POLYDACTYLY; SRTD5	0.00362319	0.02062881831188954
CHOREA, REMITTING, WITH NYSTAGMUS AND CATARACT	0.00362319	0.02062881831188954
INTELLECTUAL DEVELOPMENTAL DISORDER AND RETINITIS PIGMENTOSA; IDDRP	0.00362319	0.02062881831188954
116100 CATARACT, MEMBRANOUS	0.00362319	0.02062881831188954
SPASTIC PARAPLEGIA 26, AUTOSOMAL RECESSIVE; SPG26	0.00362319	0.02062881831188954
EXUDATIVE VITREORETINOPATHY 6; EVR6	0.00362319	0.02062881831188954
MUCOEPITHELIAL DYSPLASIA, HEREDITARY	0.00362319	0.02062881831188954
LEBER CONGENITAL AMAUROSIS 8; LCA8	0.00362319	0.02062881831188954
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.00362319	0.02062881831188954
#612018 CATARACT, JUVENILE, WITH MICROCORNEA AND GLUCOSURIA;;CJMG	0.00362319	0.02062881831188954
LEBER CONGENITAL AMAUROSIS 16	0.00362319	0.02062881831188954
#180104 RETINITIS PIGMENTOSA 9; RP9	0.00362319	0.02062881831188954
#613154 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYEANOMALIES), TYPE A, 6; MDDGA6;;WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, LARGE-RELATED	0.00362319	0.02062881831188954
CATARACT, CRYSTALLINE CORALLIFORM	0.00362319	0.02062881831188954
#614878 AUTOINFLAMMATION, ANTIBODY DEFICIENCY, AND IMMUNE DYSREGULATION, PLCG2-ASSOCIATED;APLAID	0.00362319	0.02062881831188954
VITREORETINAL DEGENERATION, SNOWFLAKE TYPE; SVD	0.00362319	0.02062881831188954
%609376 CATARACT 35; CTRCT35;;CATARACT, CONGENITAL NUCLEAR, AUTOSOMAL RECESSIVE 1; CATCN1	0.00362319	0.02062881831188954
HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH	0.00362319	0.02062881831188954
RETINITIS PIGMENTOSA 4; RP4	0.00362319	0.02062881831188954
CONE-ROD DYSTROPHY 16	0.00362319	0.02062881831188954
HEMOCHROMATOSIS, TYPE 4; HFE4	0.00362319	0.02062881831188954
CATARACT 15, MULTIPLE TYPES; CTRCT15	0.00362319	0.02062881831188954
BARDET-BIEDL SYNDROME 18; BBS18	0.00362319	0.02062881831188954
LEBER CONGENITAL AMAUROSIS, TYPE II	0.00362319	0.02062881831188954
#613826 LEBER CONGENITAL AMAUROSIS 6; LCA6	0.00362319	0.02062881831188954
ANIRIDIA 2	0.00362319	0.02062881831188954
ANIRIDIA, MICROCORNEA, AND SPONTANEOUSLY REABSORBED CATARACT	0.00362319	0.02062881831188954
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE I	0.00362319	0.02062881831188954
ENHANCED S-CONE SYNDROME	0.00362319	0.02062881831188954
ANTERIOR SEGMENT DYSGENESIS 8	0.00362319	0.02062881831188954
#612285 JOUBERT SYNDROME 9; JBTS9JOUBERT SYNDROME 9/15, DIGENIC, INCLUDED	0.00362319	0.02062881831188954
ENCEPHALOPATHY, AXONAL, WITH NECROTIZING MYOPATHY, CARDIOMYOPATHY, AND CATARACTS	0.00362319	0.02062881831188954
HYPOGONADISM-CATARACT SYNDROME	0.00362319	0.02062881831188954
GALACTOKINASE DEFICIENCY	0.00362319	0.02062881831188954
POLYCYSTIC KIDNEY, CATARACT, AND CONGENITAL BLINDNESS	0.00362319	0.02062881831188954
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.00362319	0.02062881831188954
CATARACT AND CONGENITAL ICHTHYOSIS	0.00362319	0.02062881831188954
%225200 ECTOPIA LENTIS ET PUPILLAE;;ECTOPIA LENTIS WITH ECTOPIA OF PUPIL	0.00362319	0.02062881831188954
#608810 MYOPATHY, MYOFIBRILLAR, 2, MFM2;;MYOPATHY, MYOFIBRILLAR, ALPHA-B CRYSTALLIN-RELATED;;MYOPATHY, DESMIN-RELATED, ASSOCIATED WITH MUTATION IN THE CRYAB GENE;;ALPHA-B CRYSTALLINOPATHY	0.00362319	0.02062881831188954
MUSCULAR DYSTROPHY, CONGENITAL, WITH INFANTILE CATARACT AND HYPOGONADISM	0.00362319	0.02062881831188954
#611131 RETINITIS PIGMENTOSA 37; RP37	0.00362319	0.02062881831188954
#613829 LEBER CONGENITAL AMAUROSIS 7; LCA7	0.00362319	0.02062881831188954
#312600 RETINITIS PIGMENTOSA 2; RP2	0.00362319	0.02062881831188954
GROENOUW TYPE I CORNEAL DYSTROPHY	0.00362319	0.02062881831188954
POIKILODERMA, HEREDITARY FIBROSING, WITH TENDON CONTRACTURES, MYOPATHY, AND PULMONARY FIBROSIS; POIKTMP	0.00362319	0.02062881831188954
RETINITIS PIGMENTOSA 84; RP84	0.00362319	0.02062881831188954
#613887 CATARACT, AUTOSOMAL RECESSIVE CONGENITAL 4; CATC4	0.00362319	0.02062881831188954
GALACTOSEMIA	0.00362319	0.02062881831188954
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.00362319	0.02062881831188954
#610019 CATARACT, AUTOSOMAL RECESSIVE CONGENITAL 2; CATC2	0.00362319	0.02062881831188954
THANATOPHORIC DYSPLASIA, GLASGOW VARIANT	0.00362319	0.02062881831188954
#614292 MYOPIA, HIGH, WITH CATARACT AND VITREORETINAL DEGENERATION; MCVD	0.00362319	0.02062881831188954
#615418 MITOCHONDRIAL DNA DEPLETION SYNDROME 12 (CARDIOMYOPATHIC TYPE); MTDPS12	0.00362319	0.02062881831188954
TRICHOMEGALY; TCMGLY	0.00362319	0.02062881831188954
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.0033884120000000004	0.019292097713293054
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.0033884120000000004	0.019292097713293054
#614873 PEROXISOME BIOGENESIS DISORDER 7B; PBD7B	0.0033884120000000004	0.019292097713293054
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.0033884120000000004	0.019292097713293054
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.0033884120000000004	0.019292097713293054
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.0033884120000000004	0.019292097713293054
PEROXISOME BIOGENESIS DISORDER 6B	0.0033884120000000004	0.019292097713293054
JOUBERT SYNDROME 21	0.0033884120000000004	0.019292097713293054
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.0033884120000000004	0.019292097713293054
#249270 THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME; TRMA;;THIAMINE METABOLISM DYSFUNCTION SYNDROME 1 (MEGALOBLASTIC ANEMIA,DIABETES MELLITUS, AND DEAFNESS TYPE); THMD1;;MEGALOBLASTIC ANEMIA, THIAMINE-RESPONSIVE, WITH DIABETES MELLITUSAND SENSORINEURAL DEAFNESS;;ROGERS SYNDROME;;THIAMINE-RESPONSIVE ANEMIA SYNDROME;;THIAMINE-RESPONSIVE MYELODYSPLASIA	0.0033884120000000004	0.019292097713293054
#615066 OSTEOGENESIS IMPERFECTA, TYPE XIV; OI14 ;;OI, TYPE XIV	0.0033884120000000004	0.019292097713293054
WAARDENBURG-SHAH SYNDROME	0.0033884120000000004	0.019292097713293054
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.0033884120000000004	0.019292097713293054
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.0033884120000000004	0.019292097713293054
PEROXISOME BIOGENESIS DISORDER 5B	0.0033884120000000004	0.019292097713293054
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.0033884120000000004	0.019292097713293054
LEIGH SYNDROME; LS	0.0033884120000000004	0.019292097713293054
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.0033884120000000004	0.019292097713293054
EPICANTHUS	0.00325733	0.01854577561537406
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.00325733	0.01854577561537406
SHPRINTZEN OMPHALOCELE SYNDROME	0.00325733	0.01854577561537406
MECKEL SYNDROME, TYPE 10; MKS10	0.00325733	0.01854577561537406
JOUBERT SYNDROME 3; JBTS3	0.00325733	0.01854577561537406
Mulchandani-Bhoj-Conlin syndrome	0.00325733	0.01854577561537406
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA	0.00325733	0.01854577561537406
EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 2; EDSCL2	0.00325733	0.01854577561537406
HYPERTRICHOSIS, CONGENITAL GENERALIZED, WITH OR WITHOUT GINGIVAL HYPERPLASIA	0.00325733	0.01854577561537406
GAUCHER DISEASE, PERINATAL LETHAL	0.00313425	0.01784501331534912
NEU-LAXOVA SYNDROME 2; NLS2	0.00313425	0.01784501331534912
INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL; ILNEB	0.00313425	0.01784501331534912
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.00313425	0.01784501331534912
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.00313425	0.01784501331534912
#614485 TRIGONOCEPHALY 2; TRIGNO2;;CRANIOSYNOSTOSIS, METOPIC	0.00313425	0.01784501331534912
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.00304878	0.017358385481557024
FG SYNDROME 2; FGS2	0.00304878	0.017358385481557024
SPECIFIC LANGUAGE IMPAIRMENT 1; SLI1	0.00304878	0.017358385481557024
HYPOGLOSSIA WITH SITUS INVERSUS	0.00304878	0.017358385481557024
SPINOCEREBELLAR ATAXIA 44; SCA44	0.00304878	0.017358385481557024
#300705 MENTAL RETARDATION, X-LINKED 17; MRX17;;MENTAL RETARDATION, X-LINKED 31; MRX31	0.00304878	0.017358385481557024
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.00304878	0.017358385481557024
8p23.1 duplication syndrome	0.00304878	0.017358385481557024
#615633 SHORT-RIB THORACIC DYSPLASIA 11 WITH OR WITHOUT POLYDACTYLY; SRTD11	0.00304878	0.017358385481557024
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.00304878	0.017358385481557024
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 8; MDDGC8	0.00304878	0.017358385481557024
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.00304878	0.017358385481557024
PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID	0.00304878	0.017358385481557024
7q11.23 duplication syndrome	0.00304878	0.017358385481557024
SPASTIC ATAXIA 4, AUTOSOMAL RECESSIVE; SPAX4	0.00304878	0.017358385481557024
HYPERPARATHYROIDISM, TRANSIENT NEONATAL; HRPTTN	0.00304878	0.017358385481557024
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 8; NBIA8	0.00304878	0.017358385481557024
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 25	0.00304878	0.017358385481557024
RETINITIS PIGMENTOSA 71; RP71	0.00304878	0.017358385481557024
#309510 PARTINGTON X-LINKED MENTAL RETARDATION SYNDROME; PRTS;;PARTINGTON SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 1; MRXS1;;MENTAL RETARDATION, X-LINKED, WITH DYSTONIC MOVEMENTS, ATAXIA, ANDSEIZURES;;MENTAL RETARDATION, X-LINKED 36; MRX36	0.00304878	0.017358385481557024
22q13 deletion syndrome (Phelan-Mcdermid syndrome)	0.00304878	0.017358385481557024
PORETTI-BOLTSHAUSER SYNDROME; PTBHS	0.00304878	0.017358385481557024
MENTAL RETARDATION, X-LINKED 95	0.00304878	0.017358385481557024
CRANIOSYNOSTOSIS 7	0.00304878	0.017358385481557024
#605407 SEGAWA SYNDROME, AUTOSOMAL RECESSIVE;;PARKINSONISM, INFANTILE, AUTOSOMAL RECESSIVE;;DYSTONIA, DOPA-RESPONSIVE, AUTOSOMAL RECESSIVE;;DOPA-RESPONSIVE DYSTONIA, AUTOSOMAL RECESSIVE;;TYROSINE HYDROXYLASE DEFICIENCY	0.00304878	0.017358385481557024
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 14	0.00304878	0.017358385481557024
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.00304878	0.017358385481557024
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.00304878	0.017358385481557024
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 6	0.00304878	0.017358385481557024
CHROMOSOME 15q11-q13 DUPLICATION SYNDROME	0.00304878	0.017358385481557024
OSTEOGENESIS IMPERFECTA, TYPE XVIII; OI18	0.00304878	0.017358385481557024
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.00304878	0.017358385481557024
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.00304878	0.017358385481557024
SPEECH DEVELOPMENT, DELAYED, WITH FACIAL ASYMMETRY, STRABISMUS, ANDTRANSVERSE EARLOBE CREASE	0.00304878	0.017358385481557024
MAXILLOFACIAL DYSOSTOSIS	0.00304878	0.017358385481557024
MENTAL RETARDATION, X-LINKED 93	0.00304878	0.017358385481557024
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 54	0.00304878	0.017358385481557024
MYASTHENIC SYNDROME, CONGENITAL, 24, PRESYNAPTIC; CMS24	0.00304878	0.017358385481557024
AUTISM	0.00304878	0.017358385481557024
22q11 deletion syndrome (Velocardiofacial / DiGeorge syndrome)	0.00304878	0.017358385481557024
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.00304878	0.017358385481557024
THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL DOMINANT	0.00304878	0.017358385481557024
STRIATONIGRAL DEGENERATION, CHILDHOOD-ONSET	0.00304878	0.017358385481557024
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.00304878	0.017358385481557024
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.00304878	0.017358385481557024
HYPOTONIA, ATAXIA, DEVELOPMENTAL DELAY, AND TOOTH ENAMEL DEFECT SYNDROME; HADDTS	0.00304878	0.017358385481557024
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.00304878	0.017358385481557024
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18	0.00304878	0.017358385481557024
HYPERLYSINEMIA, TYPE I	0.00304878	0.017358385481557024
POLYMICROGYRIA, BILATERAL PERISYLVIAN	0.00304878	0.017358385481557024
#609152 HYPERTHYROIDISM, NONAUTOIMMUNE;;HYPERTHYROIDISM, CONGENITAL NONAUTOIMMUNE;;HYPERTHYROIDISM, NONAUTOIMMUNE, AUTOSOMAL DOMINANT;;TOXIC THYROID HYPERPLASIA, AUTOSOMAL DOMINANT	0.00304878	0.017358385481557024
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.00304878	0.017358385481557024
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 7; NBIA7	0.00304878	0.017358385481557024
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.0027933000000000003	0.01590379698293522
MYOCLONUS, CEREBELLAR ATAXIA, AND DEAFNESS	0.0027933000000000003	0.01590379698293522
NEUROFIBROMATOSIS, TYPE II	0.0027933000000000003	0.01590379698293522
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.0027933000000000003	0.01590379698293522
#600971 DEAFNESS, AUTOSOMAL RECESSIVE 6; DFNB6;;NEUROSENSORY NONSYNDROMIC RECESSIVE DEAFNESS 6; NSRD6	0.0027933000000000003	0.01590379698293522
PAGET DISEASE OF BONE 3; PDB3	0.0027933000000000003	0.01590379698293522
DEAFNESS, CONGENITAL, WITH TOTAL ALBINISM	0.0027933000000000003	0.01590379698293522
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 2	0.0027933000000000003	0.01590379698293522
DEAFNESS, AUTOSOMAL DOMINANT 24	0.0027933000000000003	0.01590379698293522
SPINOCEREBELLAR ATAXIA 13	0.0027933000000000003	0.01590379698293522
CILIARY DYSKINESIA, PRIMARY, 37; CILD37	0.0027933000000000003	0.01590379698293522
%607683 DEAFNESS, AUTOSOMAL DOMINANT 52; DFNA52;;DEAFNESS, AUTOSOMAL DOMINANT 42; DFNA42	0.0027933000000000003	0.01590379698293522
OTOSCLEROSIS 8; OTSC8	0.0027933000000000003	0.01590379698293522
#614153 SPINOCEREBELLAR ATAXIA 36; SCA36	0.0027933000000000003	0.01590379698293522
%614617 DEAFNESS, AUTOSOMAL RECESSIVE 86; DFNB86	0.0027933000000000003	0.01590379698293522
RAMON SYNDROME	0.0027933000000000003	0.01590379698293522
121450 CORNEAL DEGENERATION, RIBBONLIKE, WITH DEAFNESS;;BAND KERATOPATHY WITH DEAFNESS	0.0027933000000000003	0.01590379698293522
#614944 DEAFNESS, AUTOSOMAL RECESSIVE 84B; DFNB84B	0.0027933000000000003	0.01590379698293522
AUDITORY NEUROPATHY AND OPTIC ATROPHY; ANOA	0.0027933000000000003	0.01590379698293522
FETAL IODINE DEFICIENCY DISORDER	0.0027933000000000003	0.01590379698293522
HYPOGONADOTROPIC HYPOGONADISM 17 WITH OR WITHOUT ANOSMIA; HH17	0.0027933000000000003	0.01590379698293522
#307200 ISOLATED GROWTH HORMONE DEFICIENCY, TYPE III; IGHD3;;IGHD III;;GROWTH HORMONE DEFICIENCY WITH HYPOGAMMAGLOBULINEMIA;;HYPOGAMMAGLOBULINEMIA AND ISOLATED GROWTH HORMONE DEFICIENCY, X-LINKED;;AGAMMAGLOBULINEMIA AND ISOLATED GROWTH HORMONE DEFICIENCY, X-LINKED;;FLEISHER SYNDROME	0.0027933000000000003	0.01590379698293522
DEAFNESS, AUTOSOMAL RECESSIVE 107; DFNB107	0.0027933000000000003	0.01590379698293522
TUNE DEAFNESS	0.0027933000000000003	0.01590379698293522
FACIAL PARESIS, HEREDITARY CONGENITAL, 2; HCFP2	0.0027933000000000003	0.01590379698293522
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.0027933000000000003	0.01590379698293522
HYPOGONADOTROPIC HYPOGONADISM 21 WITH OR WITHOUT ANOSMIA; HH21	0.0027933000000000003	0.01590379698293522
%614414 DEAFNESS, AUTOSOMAL RECESSIVE 96; DFNB96	0.0027933000000000003	0.01590379698293522
PAGET DISEASE OF BONE 4; PDB4	0.0027933000000000003	0.01590379698293522
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 3	0.0027933000000000003	0.01590379698293522
ABCD SYNDROME	0.0027933000000000003	0.01590379698293522
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.0027933000000000003	0.01590379698293522
DYSOSTEOSCLEROSIS	0.0027933000000000003	0.01590379698293522
DEAFNESS-CRANIOFACIAL SYNDROME	0.0027933000000000003	0.01590379698293522
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.0027933000000000003	0.01590379698293522
HARDIKAR SYNDROME	0.0027933000000000003	0.01590379698293522
%615654 DEAFNESS, AUTOSOMAL DOMINANT 58; DFNA58	0.0027933000000000003	0.01590379698293522
#239100 HYPEROSTOSIS CORTICALIS GENERALISATA;;VAN BUCHEM DISEASE; VBCH;;HYPERPHOSPHATASEMIA TARDA;;ENDOSTEAL HYPEROSTOSIS, AUTOSOMAL RECESSIVE	0.0027933000000000003	0.01590379698293522
OSTEOGENESIS IMPERFECTA, TYPE IV	0.0027933000000000003	0.01590379698293522
#613558 DEAFNESS, AUTOSOMAL DOMINANT 51; DFNA51;;CHROMOSOME 9Q21.11 DUPLICATION SYNDROME	0.0027933000000000003	0.01590379698293522
THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL RECESSIVE	0.0027933000000000003	0.01590379698293522
#300914 DEAFNESS, X-LINKED 6; DFNX6	0.0027933000000000003	0.01590379698293522
CANAVAN DISEASE	0.0027933000000000003	0.01590379698293522
DEAFNESS, AUTOSOMAL RECESSIVE 47	0.0027933000000000003	0.01590379698293522
ANUS, IMPERFORATE	0.0027933000000000003	0.01590379698293522
CEREBRAL SCLEROSIS, DIFFUSE, SCHOLZ TYPE	0.0027933000000000003	0.01590379698293522
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 26; MC1DN26	0.0027933000000000003	0.01590379698293522
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.0027933000000000003	0.01590379698293522
EAR EXOSTOSES	0.0027933000000000003	0.01590379698293522
%613916 DEAFNESS, AUTOSOMAL RECESSIVE 89; DFNB89	0.0027933000000000003	0.01590379698293522
KRABBE DISEASE	0.0027933000000000003	0.01590379698293522
HYPERLIPOPROTEINEMIA, TYPE II, AND DEAFNESS	0.0027933000000000003	0.01590379698293522
AUROCEPHALOSYNDACTYLY	0.0027933000000000003	0.01590379698293522
#129400 RAPP-HODGKIN SYNDROME; RHS;;ECTODERMAL DYSPLASIA, ANHIDROTIC, WITH CLEFT LIP/PALATEOROFACIAL CLEFT 8, INCLUDED; OFC8, INCLUDED;;CLEFT LIP WITH OR WITHOUT CLEFT PALATE, NONSYNDROMIC, 8, INCLUDED	0.0027933000000000003	0.01590379698293522
DWARFISM, LOW-BIRTH-WEIGHT TYPE, WITH UNRESPONSIVENESS TO GROWTH HORMONE	0.0027933000000000003	0.01590379698293522
RENAL, GENITAL, AND MIDDLE EAR ANOMALIES	0.0027933000000000003	0.01590379698293522
DEAFNESS, AUTOSOMAL RECESSIVE 65; DFNB65	0.0027933000000000003	0.01590379698293522
DEAFNESS, AUTOSOMAL DOMINANT 73; DFNA73	0.0027933000000000003	0.01590379698293522
#614504 USHER SYNDROME, TYPE IIIB; USH3B	0.0027933000000000003	0.01590379698293522
DEAFNESS, X-LINKED 5; DFNX5	0.0027933000000000003	0.01590379698293522
OTOSCLEROSIS 3; OTSC3	0.0027933000000000003	0.01590379698293522
PULMONIC STENOSIS AND DEAFNESS	0.0027933000000000003	0.01590379698293522
USHER SYNDROME, TYPE IID; USH2D	0.0027933000000000003	0.01590379698293522
#614934 DEAFNESS, AUTOSOMAL RECESSIVE 70; DFNB70	0.0027933000000000003	0.01590379698293522
COXOAURICULAR SYNDROME	0.0027933000000000003	0.01590379698293522
#613718 DEAFNESS, AUTOSOMAL RECESSIVE 74; DFNB74	0.0027933000000000003	0.01590379698293522
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	0.0027933000000000003	0.01590379698293522
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2; CMT2A2	0.0027933000000000003	0.01590379698293522
PIEBALD TRAIT WITH NEUROLOGIC DEFECTS	0.0027933000000000003	0.01590379698293522
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4C; CMT4C	0.0027933000000000003	0.01590379698293522
#610896 BRANCHIOOTORENAL SYNDROME 2; BOR2	0.0027933000000000003	0.01590379698293522
#614896 SINOATRIAL NODE DYSFUNCTION AND DEAFNESS; SANDD	0.0027933000000000003	0.01590379698293522
HYPOGONADOTROPIC HYPOGONADISM 18 WITH OR WITHOUT ANOSMIA; HH18	0.0027933000000000003	0.01590379698293522
#615629 DEAFNESS, AUTOSOMAL DOMINANT 56; DFNA56	0.0027933000000000003	0.01590379698293522
#606763 CILIARY DYSKINESIA, PRIMARY, 2; CILD2;;CILIARY DYSKINESIA, PRIMARY, 2, WITH OR WITHOUT SITUS INVERSUS	0.0027933000000000003	0.01590379698293522
RETINAL VENOUS BEADING	0.0027933000000000003	0.01590379698293522
SPASTIC QUADRIPLEGIA, RETINITIS PIGMENTOSA, AND MENTAL RETARDATION	0.0027933000000000003	0.01590379698293522
DEAFNESS, CONGENITAL, WITH VITILIGO AND ACHALASIA	0.0027933000000000003	0.01590379698293522
DEAFNESS, AUTOSOMAL RECESSIVE 18B; DFNB18B	0.0027933000000000003	0.01590379698293522
BRANCHIOOTIC SYNDROME 2	0.0027933000000000003	0.01590379698293522
BONE MARROW FAILURE SYNDROME 1; BMFS1	0.0027933000000000003	0.01590379698293522
CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS	0.0027933000000000003	0.01590379698293522
DEMENTIA, FAMILIAL DANISH	0.0027933000000000003	0.01590379698293522
DEAFNESS, AUTOSOMAL RECESSIVE 106; DFNB106	0.0027933000000000003	0.01590379698293522
#158901 FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 2; FSHD2;;FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 2, DIGENIC;;FSHD2, DIGENIC;;MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL, TYPE 2;;MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL, TYPE 1B; FSHD1B	0.0027933000000000003	0.01590379698293522
KNUCKLE PADS, LEUKONYCHIA, AND SENSORINEURAL DEAFNESS	0.0027933000000000003	0.01590379698293522
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.0027933000000000003	0.01590379698293522
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.0027933000000000003	0.01590379698293522
DEAFNESS, AUTOSOMAL RECESSIVE 55	0.0027933000000000003	0.01590379698293522
#614614 DEAFNESS, AUTOSOMAL DOMINANT 4B; DFNA4B	0.0027933000000000003	0.01590379698293522
DEAFNESS, CONGENITAL, AND FAMILIAL MYOCLONIC EPILEPSY	0.0027933000000000003	0.01590379698293522
#614899 DEAFNESS, AUTOSOMAL RECESSIVE 93; DFNB93	0.0027933000000000003	0.01590379698293522
USHER SYNDROME, TYPE ID	0.0027933000000000003	0.01590379698293522
DEAFNESS, AUTOSOMAL DOMINANT 74; DFNA74	0.0027933000000000003	0.01590379698293522
#612645 DEAFNESS, AUTOSOMAL RECESSIVE 1B; DFNB1B	0.0027933000000000003	0.01590379698293522
DEAFNESS, AUTOSOMAL RECESSIVE 33	0.0027933000000000003	0.01590379698293522
OSTEOGENESIS IMPERFECTA, TYPE I	0.0027933000000000003	0.01590379698293522
#602459 DEAFNESS, AUTOSOMAL DOMINANT 15; DFNA15	0.0027933000000000003	0.01590379698293522
SCHIMKE X-LINKED MENTAL RETARDATION SYNDROME	0.0027933000000000003	0.01590379698293522
MENIERE DISEASE	0.0027933000000000003	0.01590379698293522
%615649 DEAFNESS, AUTOSOMAL DOMINANT 54; DFNA54	0.0027933000000000003	0.01590379698293522
CAMURATI-ENGELMANN DISEASE	0.0027933000000000003	0.01590379698293522
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL RECESSIVE, TYPE 2A2B; CMT2A2B	0.0027933000000000003	0.01590379698293522
#236792 L-2-HYDROXYGLUTARIC ACIDURIA;;L-2-HYDROXYGLUTARIC ACIDEMIA	0.0027933000000000003	0.01590379698293522
N SYNDROME	0.0027933000000000003	0.01590379698293522
#174800 MCCUNE-ALBRIGHT SYNDROME; MAS;;ALBRIGHT SYNDROMEPOLYOSTOTIC FIBROUS DYSPLASIA, INCLUDED; PFD, INCLUDED; POFD, INCLUDED	0.0027933000000000003	0.01590379698293522
DEAFNESS, AUTOSOMAL RECESSIVE 84; DFNB84	0.0027933000000000003	0.01590379698293522
WILDERVANCK SYNDROME	0.0027933000000000003	0.01590379698293522
#615429 DEAFNESS, AUTOSOMAL RECESSIVE 88; DFNB88	0.0027933000000000003	0.01590379698293522
CONE-ROD DYSTROPHY 1; CORD1	0.0027933000000000003	0.01590379698293522
GLYCOGEN STORAGE DISEASE II	0.0027933000000000003	0.01590379698293522
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.0027933000000000003	0.01590379698293522
EPIPHYSEAL DYSPLASIA OF FEMORAL HEAD, MYOPIA, AND DEAFNESS	0.0027933000000000003	0.01590379698293522
DEAFNESS, AUTOSOMAL RECESSIVE 32, WITH OR WITHOUT IMMOTILE SPERM; DFNB32	0.0027933000000000003	0.01590379698293522
HYPOGONADOTROPIC HYPOGONADISM 19 WITH OR WITHOUT ANOSMIA; HH19	0.0027933000000000003	0.01590379698293522
CHOLESTASIS, BENIGN RECURRENT INTRAHEPATIC 1	0.0027933000000000003	0.01590379698293522
#614202 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 15; MRT15	0.002702622	0.015387517133717946
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.002702622	0.015387517133717946
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.002702622	0.015387517133717946
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.002702622	0.015387517133717946
DIAMOND-BLACKFAN ANEMIA 5	0.002702622	0.015387517133717946
JOUBERT SYNDROME 26	0.002702622	0.015387517133717946
NOONAN SYNDROME 9; NS9	0.002702622	0.015387517133717946
JOUBERT SYNDROME 32; JBTS32	0.002702622	0.015387517133717946
GLYCEROL KINASE DEFICIENCY; GKD	0.002702622	0.015387517133717946
#275900 SPASTIC PARAPLEGIA 20, AUTOSOMAL RECESSIVE; SPG20;;TROYER SYNDROME;;SPASTIC PARAPARESIS, CHILDHOOD-ONSET, WITH DISTAL MUSCLE WASTING;;SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, TROYER TYPE	0.002702622	0.015387517133717946
CHROMOSOME 4q21 DELETION SYNDROME	0.002702622	0.015387517133717946
TEMTAMY SYNDROME; TEMTYS	0.002702622	0.015387517133717946
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.002702622	0.015387517133717946
FRIAS SYNDROME	0.002702622	0.015387517133717946
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.002702622	0.015387517133717946
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.00254453	0.014487412213864658
#104200 ALPORT SYNDROME, AUTOSOMAL DOMINANT	0.00254453	0.014487412213864658
FRIEDREICH ATAXIA, SO-CALLED, WITH OPTIC ATROPHY AND SENSORINEURALDEAFNESS	0.00254453	0.014487412213864658
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2N	0.00254453	0.014487412213864658
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, WITH DEAFNESS, MENTAL RETARDATION,AND ABSENT SENSORY LARGE MYELINATED FIBERS	0.00254453	0.014487412213864658
%607017 DEAFNESS, AUTOSOMAL DOMINANT 21; DFNA21	0.00254453	0.014487412213864658
CONE-ROD DYSTROPHY AND HEARING LOSS 2; CRDHL2	0.00254453	0.014487412213864658
DEAFNESS, AUTOSOMAL DOMINANT 66	0.00254453	0.014487412213864658
RETINITIS PIGMENTOSA INVERSA WITH DEAFNESS	0.00254453	0.014487412213864658
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 3	0.00254453	0.014487412213864658
#520000 DIABETES AND DEAFNESS, MATERNALLY INHERITED; MIDD;;DIABETES-DEAFNESS SYNDROME, MATERNALLY TRANSMITTED;;BALLINGER-WALLACE SYNDROME;;DIABETES MELLITUS, TYPE II, WITH DEAFNESS;;NONINSULIN-DEPENDENT DIABETES MELLITUS WITH DEAFNESS;;NIDDM WITH DEAFNESS	0.00254453	0.014487412213864658
#276900 USHER SYNDROME, TYPE I; USH1;;US1;;RETINITIS PIGMENTOSA AND CONGENITAL DEAFNESSUSHER SYNDROME, TYPE IB, INCLUDED; USH1B, INCLUDED;;USHER SYNDROME, TYPE IA, FORMERLY, INCLUDED; USH1A, FORMERLY, INCLUDED;;USHER SYNDROME, TYPE I, FRENCH VARIETY, FORMERLY, INCLUDED	0.00254453	0.014487412213864658
SPINOCEREBELLAR ATAXIA 31	0.00254453	0.014487412213864658
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.00254453	0.014487412213864658
DEAFNESS, SENSORINEURAL, WITH PITUITARY DWARFISM	0.00254453	0.014487412213864658
DEAFNESS, AUTOSOMAL RECESSIVE 16; DFNB16	0.00254453	0.014487412213864658
#612674 POLYNEUROPATHY, HEARING LOSS, ATAXIA, RETINITIS PIGMENTOSA, AND CATARACT;PHARC	0.00254453	0.014487412213864658
DEAFNESS, AUTOSOMAL RECESSIVE 100; DFNB100	0.00254453	0.014487412213864658
DEAFNESS, AUTOSOMAL RECESSIVE 66; DFNB66	0.00254453	0.014487412213864658
#220290 DEAFNESS, AUTOSOMAL RECESSIVE 1A; DFNB1ADEAFNESS, DIGENIC, GJB2/GJB6, INCLUDED;;DEAFNESS, DIGENIC, GJB2/GJB3, INCLUDED	0.00254453	0.014487412213864658
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.00254453	0.014487412213864658
DEAFNESS, AUTOSOMAL RECESSIVE 23	0.00254453	0.014487412213864658
ATAXIA, DEAFNESS, AND CARDIOMYOPATHY	0.00254453	0.014487412213864658
DEAFNESS, AUTOSOMAL DOMINANT 71; DFNA71	0.00254453	0.014487412213864658
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IA; HSAN1A	0.00254453	0.014487412213864658
DEAFNESS, AUTOSOMAL RECESSIVE 9	0.00254453	0.014487412213864658
#609242 KANZAKI DISEASE;;ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY, TYPE II;;ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY, ADULT-ONSET;;NAGA DEFICIENCY, TYPE II;;SCHINDLER DISEASE, TYPE II	0.00254453	0.014487412213864658
MACROTHROMBOCYTOPENIA AND GRANULOCYTE INCLUSIONS WITH OR WITHOUT NEPHRITIS OR SENSORINEURAL HEARING LOSS; MATINS	0.00254453	0.014487412213864658
STICKLER SYNDROME, TYPE V; STL5	0.00254453	0.014487412213864658
DEAFNESS, AUTOSOMAL RECESSIVE 57; DFNB57	0.00254453	0.014487412213864658
#613266 WAARDENBURG SYNDROME, TYPE 4C; WS4C;;WAARDENBURG SYNDROME WITH HIRSCHSPRUNG DISEASE, TYPE 4C;;WAARDENBURG SYNDROME, TYPE IVC	0.00254453	0.014487412213864658
#610220 DEAFNESS, AUTOSOMAL RECESSIVE 59; DFNB59	0.00254453	0.014487412213864658
#609706 DEAFNESS, AUTOSOMAL RECESSIVE 53; DFNB53	0.00254453	0.014487412213864658
NEUROENDOCRINE CARCINOMA OF SALIVARY GLANDS, SENSORINEURAL HEARING LOSS, AND ENAMEL HYPOPLASIA	0.00254453	0.014487412213864658
ARTHROGRYPOSIS-LIKE HAND ANOMALY AND SENSORINEURAL DEAFNESS	0.00254453	0.014487412213864658
ALPORT SYNDROME, X-LINKED; ATS	0.00254453	0.014487412213864658
DEAFNESS, AUTOSOMAL RECESSIVE 14	0.00254453	0.014487412213864658
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67	0.00254453	0.014487412213864658
#602540 ICHTHYOSIS, HYSTRIX-LIKE, WITH DEAFNESS;;HID SYNDROME	0.00254453	0.014487412213864658
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 5	0.00254453	0.014487412213864658
#607453 DEAFNESS, AUTOSOMAL DOMINANT 44; DFNA44	0.00254453	0.014487412213864658
RENAL TUBULAR ACIDOSIS, DISTAL, WITH PROGRESSIVE NERVE DEAFNESS	0.00254453	0.014487412213864658
#609057 NEPHROPATHY WITH PRETIBIAL EPIDERMOLYSIS BULLOSA AND DEAFNESS	0.00254453	0.014487412213864658
CARDIOMYOPATHY, DILATED, 1J; CMD1J	0.00254453	0.014487412213864658
PERRAULT SYNDROME 2; PRLTS2	0.00254453	0.014487412213864658
DEAFNESS, AUTOSOMAL DOMINANT 64; DFNA64	0.00254453	0.014487412213864658
HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL RECESSIVE	0.00254453	0.014487412213864658
WOODHOUSE-SAKATI SYNDROME	0.00254453	0.014487412213864658
DEAFNESS, AUTOSOMAL DOMINANT 69	0.00254453	0.014487412213864658
WOLFRAM SYNDROME 2; WFS2	0.00254453	0.014487412213864658
ICHTHYOSIFORM ERYTHRODERMA, CORNEAL INVOLVEMENT, AND DEAFNESS	0.00254453	0.014487412213864658
ATAXIA, COMBINED CEREBELLAR AND PERIPHERAL, WITH HEARING LOSS AND DIABETES MELLITUS; ACPHD	0.00254453	0.014487412213864658
DEAFNESS, AUTOSOMAL DOMINANT 53	0.00254453	0.014487412213864658
#262000 BJORNSTAD SYNDROME; BJS;;PILI TORTI AND NERVE DEAFNESS;;PTD	0.00254453	0.014487412213864658
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00254453	0.014487412213864658
STICKLER SYNDROME, TYPE III	0.00254453	0.014487412213864658
ENLARGED VESTIBULAR AQUEDUCT	0.00254453	0.014487412213864658
Deafness, autosomal recessive 99	0.00254453	0.014487412213864658
HYPOGONADOTROPIC HYPOGONADISM 5 WITH OR WITHOUT ANOSMIA	0.00254453	0.014487412213864658
AUDITORY NEUROPATHY, AUTOSOMAL DOMINANT, 1	0.00254453	0.014487412213864658
%614211 DEAFNESS, AUTOSOMAL DOMINANT 33; DFNA33	0.00254453	0.014487412213864658
#158900 FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 1; FSHD1;;MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL, TYPE 1;;FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; FSHD; FMD;;MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL, TYPE 1A; FSHD1A;;LANDOUZY-DEJERINE MUSCULAR DYSTROPHYFACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY, INFANTILE, INCLUDED;;FACIOSCAPULOHUMERAL DYSTROPHY WITH SENSORINEURAL HEARING LOSS ANDTORTUOSITY OF RETINAL ARTERIOLES, INCLUDED	0.00254453	0.014487412213864658
#616357 DEAFNESS, AUTOSOMAL DOMINANT 40; DFNA40	0.00254453	0.014487412213864658
THYROCEREBRORETINAL SYNDROME	0.00254453	0.014487412213864658
CEREBELLAR ATAXIA, DEAFNESS, AND NARCOLEPSY, AUTOSOMAL DOMINANT; ADCADN	0.00254453	0.014487412213864658
#608389 BRANCHIOOTIC SYNDROME 3; BOS3;;BO SYNDROME 3	0.00254453	0.014487412213864658
MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1	0.00254453	0.014487412213864658
DEAFNESS, AUTOSOMAL DOMINANT 47	0.00254453	0.014487412213864658
CONE-ROD DYSTROPHY AND HEARING LOSS; CRDHL	0.00254453	0.014487412213864658
#103470 ALBINISM, OCULAR, WITH SENSORINEURAL DEAFNESS;;WAARDENBURG SYNDROME, TYPE 2, WITH OCULAR ALBINISM, AUTOSOMAL RECESSIVE;WS2-OA	0.00254453	0.014487412213864658
OCULOPHARYNGODISTAL MYOPATHY; OPDM	0.00254453	0.014487412213864658
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 42	0.00254453	0.014487412213864658
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.00254453	0.014487412213864658
DEAFNESS, AUTOSOMAL DOMINANT 27	0.00254453	0.014487412213864658
HYPERLEUCINE-ISOLEUCINEMIA	0.00254453	0.014487412213864658
NEUROPATHY, HEREDITARY SENSORY, TYPE IE; HSN1E	0.00254453	0.014487412213864658
IMMUNODEFICIENCY 47	0.00254453	0.014487412213864658
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00254453	0.014487412213864658
USHER SYNDROME, TYPE IG	0.00254453	0.014487412213864658
MENTAL RETARDATION, X-LINKED 46	0.00254453	0.014487412213864658
%605818 DEAFNESS, AUTOSOMAL RECESSIVE 27; DFNB27	0.00254453	0.014487412213864658
DEAFNESS, AUTOSOMAL RECESSIVE 97	0.00254453	0.014487412213864658
OPTIC ATROPHY 7 WITH OR WITHOUT AUDITORY NEUROPATHY; OPA7	0.00254453	0.014487412213864658
#607039 DEAFNESS, AUTOSOMAL RECESSIVE 22; DFNB22	0.00254453	0.014487412213864658
DEAFNESS, NEURAL, CONGENITAL MODERATE	0.00254453	0.014487412213864658
MANDIBULAR HYPOPLASIA, DEAFNESS, PROGEROID FEATURES, AND LIPODYSTROPHY SYNDROME; MDPL	0.00254453	0.014487412213864658
#234580 HEIMLER SYNDROME 1; HMLR1;;HEARING LOSS, SENSORINEURAL, WITH ENAMEL HYPOPLASIA AND NAIL DEFECTS;;PEROXISOME BIOGENESIS DISORDER 1C; PBD1C	0.00254453	0.014487412213864658
256120 NEPHROPATHY, DEAFNESS, AND HYPERPARATHYROIDISM	0.00254453	0.014487412213864658
DEAFNESS, NEURAL, WITH ATYPICAL ATOPIC DERMATITIS	0.00254453	0.014487412213864658
MITOCHONDRIAL DNA DEPLETION SYNDROME 14	0.00254453	0.014487412213864658
#608565 DEAFNESS, AUTOSOMAL RECESSIVE 35; DFNB35	0.00254453	0.014487412213864658
WAARDENBURG SYNDROME, TYPE 4B; WS4B	0.00254453	0.014487412213864658
ATHEROSCLEROSIS, PREMATURE, WITH DEAFNESS, NEPHROPATHY, DIABETES MELLITUS,PHOTOMYOCLONUS, AND DEGENERATIVE NEUROLOGIC DISEASE	0.00254453	0.014487412213864658
PRUNE BELLY SYNDROME WITH PULMONIC STENOSIS, MENTAL RETARDATION, ANDDEAFNESS	0.00254453	0.014487412213864658
Deafness, autosomal recessive 113	0.00254453	0.014487412213864658
DEAFNESS, AUTOSOMAL DOMINANT 72; DFNA72	0.00254453	0.014487412213864658
DEAFNESS, AUTOSOMAL RECESSIVE 17; DFNB17	0.00254453	0.014487412213864658
DEAFNESS, AUTOSOMAL RECESSIVE 68	0.00254453	0.014487412213864658
DEAFNESS, AUTOSOMAL RECESSIVE 110; DFNB110	0.00254453	0.014487412213864658
DEAFNESS, Y-LINKED 2; DFNY2	0.00254453	0.014487412213864658
#614134 STICKLER SYNDROME, TYPE IV; STL4	0.00254453	0.014487412213864658
CHANARIN-DORFMAN SYNDROME	0.00254453	0.014487412213864658
#193300 VON HIPPEL-LINDAU SYNDROME; VHLVON HIPPEL-LINDAU SYNDROME, MODIFIERS OF, INCLUDED	0.00254453	0.014487412213864658
ERMINE PHENOTYPE	0.00254453	0.014487412213864658
DEAFNESS, AUTOSOMAL DOMINANT 30	0.00254453	0.014487412213864658
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 28	0.00254453	0.014487412213864658
HYPOGONADOTROPIC HYPOGONADISM 2 WITH OR WITHOUT ANOSMIA	0.00254453	0.014487412213864658
DEAFNESS, CHILDHOOD-ONSET NEUROSENSORY, AUTOSOMAL RECESSIVE 8	0.00254453	0.014487412213864658
HYPOPARATHYROIDISM, SENSORINEURAL DEAFNESS, AND RENAL DISEASE	0.00254453	0.014487412213864658
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 5; PEOB5	0.00254453	0.014487412213864658
OPTIC ATROPHY 8	0.00254453	0.014487412213864658
SPLIT-FOOT MALFORMATION WITH MESOAXIAL POLYDACTYLY; SFMMP	0.00254453	0.014487412213864658
#616340 DEAFNESS, AUTOSOMAL DOMINANT 67; DFNA67	0.00254453	0.014487412213864658
DEAFNESS, AUTOSOMAL RECESSIVE 114; DFNB114	0.00254453	0.014487412213864658
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.00254453	0.014487412213864658
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.00254453	0.014487412213864658
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 13	0.00254453	0.014487412213864658
DEAFNESS, AUTOSOMAL RECESSIVE 26	0.00254453	0.014487412213864658
DEAFNESS, AUTOSOMAL RECESSIVE 115; DFNB115	0.00254453	0.014487412213864658
#613865 DEAFNESS, AUTOSOMAL RECESSIVE 61; DFNB61	0.00254453	0.014487412213864658
184000 SPONDYLOEPIPHYSEAL DYSPLASIA, MYOPIA, AND SENSORINEURAL DEAFNESS	0.00254453	0.014487412213864658
DEAFNESS, Y-LINKED 1	0.00254453	0.014487412213864658
#302800 CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 1; CMTX1;;CMTX;;CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY, X-LINKED;;HEREDITARY MOTOR AND SENSORY NEUROPATHY, X-LINKED;;HMSN, X-LINKED;;CHARCOT-MARIE-TOOTH NEUROPATHY, X-LINKED, 1;;CMT2, FORMERLY	0.00254453	0.014487412213864658
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 2; PEOA2	0.00254453	0.014487412213864658
#607841 DEAFNESS, AUTOSOMAL DOMINANT 48; DFNA48	0.00254453	0.014487412213864658
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE I, WITH COUGH AND GASTROESOPHAGEAL REFLUX	0.00254453	0.014487412213864658
GROWTH RETARDATION, DEAFNESS, FEMORAL EPIPHYSEAL DYSPLASIA, AND LACRIMAL DUCT OBSTRUCTION	0.00254453	0.014487412213864658
#606705 DEAFNESS, AUTOSOMAL DOMINANT 36; DFNA36	0.00254453	0.014487412213864658
DEAFNESS, AUTOSOMAL DOMINANT 43	0.00254453	0.014487412213864658
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 7	0.00254453	0.014487412213864658
DEAFNESS, NERVE TYPE, WITH MESENTERIC DIVERTICULA OF SMALL BOWEL ANDPROGRESSIVE SENSORY NEUROPATHY	0.00254453	0.014487412213864658
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4K; CMT4K	0.00254453	0.014487412213864658
115250 COLLAGENOMA, FAMILIAL CUTANEOUS	0.00254453	0.014487412213864658
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 4	0.00254453	0.014487412213864658
#233400 PERRAULT SYNDROME 1; PRLTS1;;OVARIAN DYSGENESIS WITH SENSORINEURAL DEAFNESS;;GONADAL DYSGENESIS, XX TYPE, WITH DEAFNESS	0.00254453	0.014487412213864658
DEAFNESS, AUTOSOMAL RECESSIVE 51	0.00254453	0.014487412213864658
NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	0.00254453	0.014487412213864658
USHER SYNDROME, TYPE IIIA	0.00254453	0.014487412213864658
DEAFNESS, AUTOSOMAL DOMINANT 59	0.00254453	0.014487412213864658
RETINITIS PIGMENTOSA 59; RP59	0.00254453	0.014487412213864658
#614650 COENZYME Q10 DEFICIENCY, PRIMARY, 6; COQ10D6	0.00254453	0.014487412213864658
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 2; FCAS2	0.00254453	0.014487412213864658
CEREBELLAR ATAXIA AND NEUROSENSORY DEAFNESS	0.00254453	0.014487412213864658
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 12	0.00254453	0.014487412213864658
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33; COXPD33	0.00254453	0.014487412213864658
#614861 DEAFNESS, AUTOSOMAL RECESSIVE 98; DFNB98	0.00254453	0.014487412213864658
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.00254453	0.014487412213864658
DEAFNESS, AUTOSOMAL RECESSIVE 103; DFNB103	0.00254453	0.014487412213864658
DEAFNESS, AUTOSOMAL DOMINANT 68	0.00254453	0.014487412213864658
DEAFNESS, AUTOSOMAL DOMINANT 25	0.00254453	0.014487412213864658
#607084 DEAFNESS, AUTOSOMAL RECESSIVE 31; DFNB31;;WHIRLER, MOUSE, HOMOLOG OF	0.00254453	0.014487412213864658
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 2	0.00254453	0.014487412213864658
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 2; FTDALS2	0.00254453	0.014487412213864658
CORNEAL DYSTROPHY AND PERCEPTIVE DEAFNESS	0.00254453	0.014487412213864658
DEAFNESS, X-LINKED 1	0.00254453	0.014487412213864658
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 18	0.00254453	0.014487412213864658
#601536 ATHABASKAN BRAINSTEM DYSGENESIS SYNDROME; ABDS;;NAVAJO BRAINSTEM SYNDROMEBOSLEY-SALIH-ALORAINY SYNDROME, INCLUDED; BSAS, INCLUDED	0.00254453	0.014487412213864658
DEAFNESS, AUTOSOMAL RECESSIVE 13	0.00254453	0.014487412213864658
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 10	0.00254453	0.014487412213864658
HYPEROSTOSIS CRANIALIS INTERNA; HCIN	0.00254453	0.014487412213864658
#609006 DEAFNESS, AUTOSOMAL RECESSIVE 36, WITH OR WITHOUT VESTIBULAR INVOLVEMENT;DFNB36DEAFNESS, AUTOSOMAL DOMINANT, WITHOUT VESTIBULAR INVOLVEMENT, INCLUDED	0.00254453	0.014487412213864658
#603629 DEAFNESS, AUTOSOMAL RECESSIVE 21; DFNB21	0.00254453	0.014487412213864658
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.0021193920000000003	0.012066867180487967
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.0021193920000000003	0.012066867180487967
Leukotriene C4 synthase deficiency	0.0021193920000000003	0.012066867180487967
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.0021193920000000003	0.012066867180487967
#615182 COMBINED D-2- AND L-2-HYDROXYGLUTARIC ACIDURIA; D2L2AD	0.0021193920000000003	0.012066867180487967
N-ACETYLASPARTATE DEFICIENCY; NACED	0.0021193920000000003	0.012066867180487967
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.0021193920000000003	0.012066867180487967
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.0021193920000000003	0.012066867180487967
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.0021193920000000003	0.012066867180487967
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.0021193920000000003	0.012066867180487967
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.0021193920000000003	0.012066867180487967
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.0021193920000000003	0.012066867180487967
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.0021193920000000003	0.012066867180487967
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.0021193920000000003	0.012066867180487967
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.0021193920000000003	0.012066867180487967
ALAZAMI SYNDROME; ALAZS	0.0021193920000000003	0.012066867180487967
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.0021193920000000003	0.012066867180487967
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.0021193920000000003	0.012066867180487967
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.0021193920000000003	0.012066867180487967
HOLOPROSENCEPHALY 3; HPE3	0.0021193920000000003	0.012066867180487967
DYSTONIA 28, CHILDHOOD-ONSET	0.0021193920000000003	0.012066867180487967
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.0021193920000000003	0.012066867180487967
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.0021193920000000003	0.012066867180487967
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.0021193920000000003	0.012066867180487967
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.0021193920000000003	0.012066867180487967
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.0021193920000000003	0.012066867180487967
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.0021193920000000003	0.012066867180487967
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.0021193920000000003	0.012066867180487967
#613744 SPASTIC PARAPLEGIA 51, AUTOSOMAL RECESSIVE; SPG51;;CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 4, FORMERLY; CPSQ4, FORMERLY	0.0021193920000000003	0.012066867180487967
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ix; CDG1X	0.0021193920000000003	0.012066867180487967
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.0021193920000000003	0.012066867180487967
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.0021193920000000003	0.012066867180487967
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.0021193920000000003	0.012066867180487967
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.0021193920000000003	0.012066867180487967
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iw; CDG1W	0.0021193920000000003	0.012066867180487967
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.0021193920000000003	0.012066867180487967
2,4-DIENOYL-CoA REDUCTASE DEFICIENCY; DECRD	0.0021193920000000003	0.012066867180487967
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.0021193920000000003	0.012066867180487967
#612716 DYSTONIA, DOPA-RESPONSIVE, DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY;;SEPIAPTERIN REDUCTASE DEFICIENCY;;SPR DEFICIENCY	0.0021193920000000003	0.012066867180487967
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.0021193920000000003	0.012066867180487967
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.0021193920000000003	0.012066867180487967
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.0021193920000000003	0.012066867180487967
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.0021193920000000003	0.012066867180487967
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.0021193920000000003	0.012066867180487967
#614322 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 12; SCAR12;;SPINOCEREBELLAR ATAXIA WITH MENTAL RETARDATION AND EPILEPSY	0.0021193920000000003	0.012066867180487967
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.0021193920000000003	0.012066867180487967
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.0021193920000000003	0.012066867180487967
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.0021193920000000003	0.012066867180487967
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.0021193920000000003	0.012066867180487967
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.0021193920000000003	0.012066867180487967
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.0021193920000000003	0.012066867180487967
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.0021193920000000003	0.012066867180487967
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iy; CDG1Y	0.0021193920000000003	0.012066867180487967
LISSENCEPHALY 2; LIS2	0.0021193920000000003	0.012066867180487967
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.0021193920000000003	0.012066867180487967
LISSENCEPHALY 4	0.0021193920000000003	0.012066867180487967
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.0021193920000000003	0.012066867180487967
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.0021193920000000003	0.012066867180487967
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.0021193920000000003	0.012066867180487967
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.0021193920000000003	0.012066867180487967
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.0021193920000000003	0.012066867180487967
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.0021193920000000003	0.012066867180487967
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.0021193920000000003	0.012066867180487967
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.0021193920000000003	0.012066867180487967
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE; MAHCC	0.0021193920000000003	0.012066867180487967
SECKEL SYNDROME 8; SCKL8	0.0021193920000000003	0.012066867180487967
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.0021193920000000003	0.012066867180487967
#613180 POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.0021193920000000003	0.012066867180487967
BETA-UREIDOPROPIONASE DEFICIENCY	0.0021193920000000003	0.012066867180487967
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.0021193920000000003	0.012066867180487967
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.0021193920000000003	0.012066867180487967
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.0021193920000000003	0.012066867180487967
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.0021193920000000003	0.012066867180487967
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.0021193920000000003	0.012066867180487967
3-HYDROXY-3-METHYLGLUTARYL-CoA LYASE DEFICIENCY; HMGCLD	0.0021193920000000003	0.012066867180487967
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.0021193920000000003	0.012066867180487967
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.0021193920000000003	0.012066867180487967
AICARDI-GOUTIERES SYNDROME 6	0.0021193920000000003	0.012066867180487967
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIf; CDG2F	0.0021193920000000003	0.012066867180487967
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.0021193920000000003	0.012066867180487967
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.0021193920000000003	0.012066867180487967
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.0021193920000000003	0.012066867180487967
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.00185874	0.01058283163428955
227250 FACIAL ABNORMALITIES, KYPHOSCOLIOSIS, AND MENTAL RETARDATION	0.00185874	0.01058283163428955
TRICHOHEPATOENTERIC SYNDROME 2	0.00185874	0.01058283163428955
WHITE FORELOCK WITH MALFORMATIONS	0.00185874	0.01058283163428955
#604173 POIKILODERMA WITH NEUTROPENIA; PN;;POIKILODERMA WITH NEUTROPENIA, CLERICUZIO-TYPE	0.00185874	0.01058283163428955
RENAL AND MULLERIAN DUCT HYPOPLASIA	0.00185874	0.01058283163428955
#614195 CRANIOFACIAL ANOMALIES AND ANTERIOR SEGMENT DYSGENESIS SYNDROME; CAASDS	0.00185874	0.01058283163428955
HETEROTAXY, VISCERAL, 1, X-LINKED; HTX1	0.00185874	0.01058283163428955
KNIEST-LIKE DYSPLASIA, LETHAL	0.00185874	0.01058283163428955
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C	0.00185874	0.01058283163428955
AUTISM, SUSCEPTIBILITY TO, 18	0.00185874	0.01058283163428955
DIARRHEA 3, SECRETORY SODIUM, CONGENITAL, WITH OR WITHOUT OTHER CONGENITAL ANOMALIES	0.00185874	0.01058283163428955
#609597 PARIETAL FORAMINA 2; PFM2	0.00185874	0.01058283163428955
#217095 CONOTRUNCAL HEART MALFORMATIONS; CTHMTRUNCUS ARTERIOSUS COMMUNIS, INCLUDED;;CONOTRUNCAL ANOMALY FACE SYNDROME, INCLUDED; CAFS, INCLUDED;;DOUBLE-OUTLET RIGHT VENTRICLE, INCLUDED; DORV, INCLUDED;;PERSISTENT TRUNCUS ARTERIOSUS, INCLUDED; PTA, INCLUDED;;INTERRUPTED AORTIC ARCH, INCLUDED	0.00185874	0.01058283163428955
MEESTER-LOEYS SYNDROME; MRLS	0.00185874	0.01058283163428955
HYPER-IgE RECURRENT INFECTION SYNDROME, AUTOSOMAL DOMINANT	0.00185874	0.01058283163428955
#612475 CHROMOSOME 1q21.1 DUPLICATION SYNDROME	0.00185874	0.01058283163428955
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.00185874	0.01058283163428955
BLEPHAROCHEILODONTIC SYNDROME 1; BCDS1	0.00185874	0.01058283163428955
GASTROCUTANEOUS SYNDROME	0.00185874	0.01058283163428955
CRANIOLENTICULOSUTURAL DYSPLASIA	0.00185874	0.01058283163428955
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ih; CDG1H	0.00185874	0.01058283163428955
NF1-microdeletion syndrome	0.00185874	0.01058283163428955
ROBINOW-SORAUF SYNDROME	0.00185874	0.01058283163428955
CRANIOSYNOSTOSIS 4; CRS4	0.00185874	0.01058283163428955
SPONDYLOCOSTAL DYSOSTOSIS WITH ANAL ATRESIA AND UROGENITAL ANOMALIES	0.00185874	0.01058283163428955
NOONAN SYNDROME 10; NS10	0.00185874	0.01058283163428955
BENT BONE DYSPLASIA SYNDROME; BBDS	0.00185874	0.01058283163428955
#212780 CENANI-LENZ SYNDACTYLY SYNDROME; CLSS;;CENANI SYNDACTYLISM;;CENANI-LENZ SYNDACTYLY;;SYNDACTYLY, TYPE VII	0.00185874	0.01058283163428955
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 6; CHNG6	0.00185874	0.01058283163428955
234800 HEMANGIOMATOSIS, CUTANEOUS, WITH ASSOCIATED FEATURES	0.00185874	0.01058283163428955
DIABETES INSIPIDUS, NEUROHYPOPHYSEAL TYPE	0.00185874	0.01058283163428955
CLEFT, MEDIAN, OF UPPER LIP WITH POLYPS OF FACIAL SKIN AND NASAL MUCOSA	0.00185874	0.01058283163428955
#191830 RENAL HYPODYSPLASIA/APLASIA 1; RHDA1;;RENAL ADYSPLASIA;;RENAL AGENESIS;;RENAL APLASIA;;HEREDITARY RENAL APLASIA; HRA	0.00185874	0.01058283163428955
WIDOW'S PEAK	0.00185874	0.01058283163428955
MEMBRANOUS CRANIAL OSSIFICATION, DELAYED	0.00185874	0.01058283163428955
OROFACIODIGITAL SYNDROME XV; OFD15	0.00185874	0.01058283163428955
HYPERTELORISM	0.00185874	0.01058283163428955
BLEPHAROCHEILODONTIC SYNDROME 2; BCDS2	0.00185874	0.01058283163428955
#253250 MULIBREY NANISM;;MUSCLE-LIVER-BRAIN-EYE NANISM;;PERICARDIAL CONSTRICTION AND GROWTH FAILURE;;PERHEENTUPA SYNDROME	0.00185874	0.01058283163428955
GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME; GIDID	0.00185874	0.01058283163428955
SCHIZOPHRENIA 1; SCZD1	0.00185874	0.01058283163428955
DIAMOND-BLACKFAN ANEMIA 8	0.00185874	0.01058283163428955
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.00127551	0.00726218168105957
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.00127551	0.00726218168105957
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 2; CEMCOX2	0.00127551	0.00726218168105957
1q21.1 recurrent microdeletion (susceptibility locus for neurodevelopmental disorders)	0.00127551	0.00726218168105957
ALANINURIA WITH MICROCEPHALY, DWARFISM, ENAMEL HYPOPLASIA, AND DIABETES MELLITUS	0.00127551	0.00726218168105957
#614852 MICROCEPHALY 9, PRIMARY, AUTOSOMAL RECESSIVE; MCPH9	0.00127551	0.00726218168105957
PSEUDO-TORCH SYNDROME 2	0.00127551	0.00726218168105957
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.00127551	0.00726218168105957
OHDO SYNDROME, SBBYS VARIANT; SBBYSS	0.00127551	0.00726218168105957
ENCEPHALOMALACIA, MULTILOCULAR	0.00127551	0.00726218168105957
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.00127551	0.00726218168105957
MEIER-GORLIN SYNDROME 8; MGORS8	0.00127551	0.00726218168105957
207790 ARACHNOID CYSTS, INTRACRANIAL	0.00127551	0.00726218168105957
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4; COXPD4	0.00127551	0.00726218168105957
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.00127551	0.00726218168105957
Angelman syndrome (Type 2)	0.00127551	0.00726218168105957
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.00127551	0.00726218168105957
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 7; MC1DN7	0.00127551	0.00726218168105957
Miller-Dieker syndrome (MDS)	0.00127551	0.00726218168105957
AICARDI-GOUTIERES SYNDROME 2; AGS2	0.00127551	0.00726218168105957
Angelman syndrome (Type 1)	0.00127551	0.00726218168105957
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.00127551	0.00726218168105957
MICROCEPHALY 12, PRIMARY, AUTOSOMAL RECESSIVE; MCPH12	0.00127551	0.00726218168105957
#613804 MEIER-GORLIN SYNDROME 4; MGORS4	0.00127551	0.00726218168105957
#609060 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 1; COXPD1;;HEPATOENCEPHALOPATHY, EARLY FATAL PROGRESSIVE	0.00127551	0.00726218168105957
#611943 RIDDLE SYNDROME;;RADIOSENSITIVITY, IMMUNODEFICIENCY, DYSMORPHIC FEATURES, AND LEARNINGDIFFICULTIES	0.00127551	0.00726218168105957
SECKEL SYNDROME 4	0.00127551	0.00726218168105957
#614673 MICROCEPHALY 8, PRIMARY, AUTOSOMAL RECESSIVE; MCPH8	0.00127551	0.00726218168105957
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.00127551	0.00726218168105957
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 30	0.00127551	0.00726218168105957
HEPATIC VENOOCCLUSIVE DISEASE WITH IMMUNODEFICIENCY	0.00127551	0.00726218168105957
#613078 NIJMEGEN BREAKAGE SYNDROME-LIKE DISORDER; NBSLD;;NBS-LIKE DISORDER;;RAD50 DEFICIENCY;;MICROCEPHALY AND SPONTANEOUS CHROMOSOME INSTABILITY WITHOUT IMMUNODEFICIENCY	0.00127551	0.00726218168105957
HYPOSPADIAS-MENTAL RETARDATION SYNDROME	0.00127551	0.00726218168105957
MICROCEPHALY 23, PRIMARY, AUTOSOMAL RECESSIVE; MCPH23	0.00127551	0.00726218168105957
%270750 SPASTIC PARAPLEGIA 23; SPG23;;SPASTIC PARAPLEGIA WITH PIGMENTARY ABNORMALITIES;;SPASTIC PARAPARESIS, VITILIGO, PREMATURE GRAYING, CHARACTERISTIC FACIES;;LISON SYNDROME	0.00127551	0.00726218168105957
KERATOSIS FOLLICULARIS, DWARFISM, AND CEREBRAL ATROPHY	0.00127551	0.00726218168105957
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.00127551	0.00726218168105957
HOLOPROSENCEPHALY WITH FETAL AKINESIA/HYPOKINESIA SEQUENCE	0.00127551	0.00726218168105957
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.00127551	0.00726218168105957
PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5	0.00127551	0.00726218168105957
Cri du Chat Syndrome (5p deletion)	0.00127551	0.00726218168105957
MICROCEPHALY 7, PRIMARY, AUTOSOMAL RECESSIVE	0.00127551	0.00726218168105957
MEIER-GORLIN SYNDROME 2; MGORS2	0.00127551	0.00726218168105957
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.00127551	0.00726218168105957
MEIER-GORLIN SYNDROME 5; MGORS5	0.00127551	0.00726218168105957
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.00127551	0.00726218168105957
AORTIC ARCH ANOMALY WITH PECULIAR FACIES AND MENTAL RETARDATION	0.00127551	0.00726218168105957
SPINAL MUSCULAR ATROPHY WITH MICROCEPHALY AND MENTAL SUBNORMALITY	0.00127551	0.00726218168105957
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.00127551	0.00726218168105957
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.00127551	0.00726218168105957
FANCONI ANEMIA, COMPLEMENTATION GROUP V	0.00127551	0.00726218168105957
#615715 BONE MARROW FAILURE SYNDROME 2; BMFS2	0.00127551	0.00726218168105957
MICROCEPHALY WITH CERVICAL SPINE FUSION ANOMALIES	0.00127551	0.00726218168105957
#610127 CEROID LIPOFUSCINOSIS, NEURONAL, 10; CLN10;;CEROID LIPOFUSCINOSIS, NEURONAL, CATHEPSIN D-DEFICIENT;;NEURONAL CEROID LIPOFUSCINOSIS DUE TO CATHEPSIN D DEFICIENCYNEURONAL CEROID LIPOFUSCINOSIS, CONGENITAL, INCLUDED	0.00127551	0.00726218168105957
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.00127551	0.00726218168105957
ACROFACIAL DYSOSTOSIS, CINCINNATI TYPE; AFDCIN	0.00127551	0.00726218168105957
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.00127551	0.00726218168105957
SECKEL SYNDROME 10; SCKL10	0.00127551	0.00726218168105957
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.00127551	0.00726218168105957
MICROCEPHALY WITH CHEMOTACTIC DEFECT AND TRANSIENT HYPOGAMMAGLOBULINEMIA	0.00127551	0.00726218168105957
#616311 MENTAL RETARDATION, AUTOSOMAL DOMINANT 33; MRD33	0.00127551	0.00726218168105957
ACHALASIA-MICROCEPHALY SYNDROME	0.00127551	0.00726218168105957
HYPOGONADISM WITH LOW-GRADE MENTAL DEFICIENCY AND MICROCEPHALY	0.00127551	0.00726218168105957
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.00127551	0.00726218168105957
CHROMOSOME Xp11.3 DELETION SYNDROME	0.00127551	0.00726218168105957
SPINAL MUSCULAR ATROPHY WITH MENTAL RETARDATION	0.00127551	0.00726218168105957
608432 CRANIOSYNOSTOSIS, CALCIFICATION OF BASAL GANGLIA, AND FACIAL DYSMORPHISM	0.00127551	0.00726218168105957
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.00127551	0.00726218168105957
PAINE SYNDROME	0.00127551	0.00726218168105957
ISOLATED GROWTH HORMONE DEFICIENCY, TYPE V; IGHD5	0.00127551	0.00726218168105957
ADDUCTED THUMBS SYNDROME	0.00127551	0.00726218168105957
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.00127551	0.00726218168105957
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.00127551	0.00726218168105957
#615414 MICROCEPHALY 11, PRIMARY, AUTOSOMAL RECESSIVE; MCPH11	0.00127551	0.00726218168105957
KEPPEN-LUBINSKY SYNDROME; KPLBS	0.00127551	0.00726218168105957
Wolf-Hirschhorn Syndrome	0.00127551	0.00726218168105957
BARDET-BIEDL SYNDROME 20	0.00127551	0.00726218168105957
MICROCEPHALY 18, PRIMARY, AUTOSOMAL DOMINANT; MCPH18	0.00127551	0.00726218168105957
ATAXIA-MICROCEPHALY-CATARACT SYNDROME	0.00127551	0.00726218168105957
TRIGLYCERIDE STORAGE DISEASE, TYPE I	0.00127551	0.00726218168105957
#613151 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION),TYPE B, 3; MDDGB3;;MUSCULAR DYSTROPHY, CONGENITAL, POMGNT1-RELATED	0.00127551	0.00726218168105957
MENTAL RETARDATION, X-LINKED 63	0.00127551	0.00726218168105957
SUPRABULBAR PARESIS, CONGENITAL	0.00127551	0.00726218168105957
LACTIC ACIDURIA DUE TO D-LACTIC ACID	0.00127551	0.00726218168105957
IMMUNODEFICIENCY 55; IMD55	0.00127551	0.00726218168105957
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.00127551	0.00726218168105957
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.00127551	0.00726218168105957
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.00127551	0.00726218168105957
MECKEL SYNDROME 12; MKS12	0.00127551	0.00726218168105957
EPIPHYSEAL DYSPLASIA, MICROCEPHALY, AND NYSTAGMUS	0.00127551	0.00726218168105957
%236795 3-@HYDROXYISOBUTYRIC ACIDURIA	0.00127551	0.00726218168105957
601453 TRICHODENTAL DYSPLASIA	0.00127551	0.00726218168105957
MITOCHONDRIAL DNA DEPLETION SYNDROME 11	0.00127551	0.00726218168105957
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.00127551	0.00726218168105957
LARYNGEAL ABDUCTOR PARALYSIS	0.00127551	0.00726218168105957
HYPERREFLEXIA	0.00127551	0.00726218168105957
%600384 APHALANGIA, PARTIAL, WITH SYNDACTYLY AND DUPLICATION OF METATARSALIV	0.00127551	0.00726218168105957
MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 1; MLASA1	0.00127551	0.00726218168105957
STRUCTURAL HEART DEFECTS AND RENAL ANOMALIES SYNDROME	0.00127551	0.00726218168105957
#267430 RENAL TUBULAR DYSGENESIS; RTD;;PRIMITIVE RENAL TUBULE SYNDROMERENAL TUBULAR DYSGENESIS WITH CHOANAL ATRESIA AND ATHELIA, INCLUDED	0.00127551	0.00726218168105957
LISSENCEPHALY 3; LIS3	0.00127551	0.00726218168105957
FANCONI ANEMIA, COMPLEMENTATION GROUP R	0.00127551	0.00726218168105957
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 1; DKCB1	0.00127551	0.00726218168105957
#609308 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 1; MDDGC1;;MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2K; LGMD2K	0.00127551	0.00726218168105957
MICROHYDRANENCEPHALY; MHAC	0.00127551	0.00726218168105957
PONTOCEREBELLAR HYPOPLASIA, TYPE 12; PCH12	0.00127551	0.00726218168105957
133750 EXTRASYSTOLES, MULTIFORM VENTRICULAR, WITH SHORT STATURE, HYPERPIGMENTATIONAND MICROCEPHALY	0.00127551	0.00726218168105957
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 4; SCAR4	0.00127551	0.00726218168105957
#613630 COCOON SYNDROME;;FETAL ENCASEMENT SYNDROME	0.00127551	0.00726218168105957
#606612 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH OR WITHOUTMENTAL RETARDATION), TYPE B, 5; MDDGB5;;MUSCULAR DYSTROPHY, CONGENITAL, 1C; MDC1C;;MUSCULAR DYSTROPHY, CONGENITAL, FKRP-RELATED	0.00127551	0.00726218168105957
CARDIAC LIPIDOSIS, FAMILIAL	0.00127551	0.00726218168105957
#612390 PONTOCEREBELLAR HYPOPLASIA, TYPE 2C; PCH2C	0.00127551	0.00726218168105957
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.00127551	0.00726218168105957
MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.00127551	0.00726218168105957
#207800 ARGININEMIA;;ARGINASE DEFICIENCY;;HYPERARGININEMIA;;ARG1 DEFICIENCY	0.000843882	0.004804685499428395
ARGININOSUCCINIC ACIDURIA	0.000843882	0.004804685499428395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.000843882	0.004804685499428395
#613657 D-2-@HYDROXYGLUTARIC ACIDURIA 2;;D2HGA2	0.000843882	0.004804685499428395
TIMOTHY SYNDROME; TS	0.000843882	0.004804685499428395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.000843882	0.004804685499428395
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.000843882	0.004804685499428395
AUSTRALIA ANTIGEN	0.000843882	0.004804685499428395
#615220 OSTEOGENESIS IMPERFECTA, TYPE XV; OI15;;OI, TYPE XV	0.000843882	0.004804685499428395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.000843882	0.004804685499428395
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.000843882	0.004804685499428395
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.000843882	0.004804685499428395
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.000843882	0.004804685499428395
BARDET-BIEDL SYNDROME 14; BBS14	0.000843882	0.004804685499428395
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.000843882	0.004804685499428395
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.000843882	0.004804685499428395
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.000843882	0.004804685499428395
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.000843882	0.004804685499428395
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.000843882	0.004804685499428395
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.000843882	0.004804685499428395
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.000843882	0.004804685499428395
3-METHYLCROTONYL-CoA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.000843882	0.004804685499428395
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.000843882	0.004804685499428395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.000843882	0.004804685499428395
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.000843882	0.004804685499428395
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.000843882	0.004804685499428395
PROPIONIC ACIDEMIA	0.000843882	0.004804685499428395
GRISCELLI SYNDROME, TYPE 1	0.000843882	0.004804685499428395
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.000843882	0.004804685499428395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.000843882	0.004804685499428395
JOUBERT SYNDROME 31; JBTS31	0.000843882	0.004804685499428395
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.000843882	0.004804685499428395
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.000843882	0.004804685499428395
#614732 INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIACONGENITA, AND GENITAL ANOMALIES;;IMAGE SYNDROME	0.000843882	0.004804685499428395
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.000843882	0.004804685499428395
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.000843882	0.004804685499428395
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.000843882	0.004804685499428395
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.000843882	0.004804685499428395
300270 ADRENOMYODYSTROPHY	0.000843882	0.004804685499428395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.000843882	0.004804685499428395
JOUBERT SYNDROME 25	0.000843882	0.004804685499428395
#615432 SPECIFIC LANGUAGE IMPAIRMENT 5; SLI5	0.000843882	0.004804685499428395
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.000843882	0.004804685499428395
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.000843882	0.004804685499428395
BARDET-BIEDL SYNDROME 3; BBS3	0.000843882	0.004804685499428395
NEPHRONOPHTHISIS 11; NPHP11	0.000843882	0.004804685499428395
JOUBERT SYNDROME 8	0.000843882	0.004804685499428395
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.000843882	0.004804685499428395
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.000843882	0.004804685499428395
LISSENCEPHALY 1; LIS1	0.000843882	0.004804685499428395
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.000843882	0.004804685499428395
BARDET-BIEDL SYNDROME 17; BBS17	0.000843882	0.004804685499428395
#300673 ENCEPHALOPATHY, NEONATAL SEVERE, DUE TO MECP2 MUTATIONS	0.000843882	0.004804685499428395
#615369 EPILEPTIC ENCEPHALOPATHY, CHILDHOOD-ONSET; EEOC	0.000843882	0.004804685499428395
SULFOCYSTEINURIA	0.000843882	0.004804685499428395
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.000843882	0.004804685499428395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.000843882	0.004804685499428395
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.000843882	0.004804685499428395
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.000843882	0.004804685499428395
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.000843882	0.004804685499428395
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.000843882	0.004804685499428395
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.000843882	0.004804685499428395
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.000843882	0.004804685499428395
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.000843882	0.004804685499428395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.000843882	0.004804685499428395
#227810 FANCONI-BICKEL SYNDROME; FBS;;HEPATORENAL GLYCOGENOSIS WITH RENAL FANCONI SYNDROME;;HEPATIC GLYCOGENOSIS WITH FANCONI NEPHROPATHY;;HEPATIC GLYCOGENOSIS WITH AMINO ACIDURIA AND GLUCOSURIA;;FANCONI SYNDROME WITH INTESTINAL MALABSORPTION AND GALACTOSE INTOLERANCE;;PSEUDO-PHLORIZIN DIABETES;;GLYCOGENOSIS, FANCONI TYPE;;GLYCOGEN STORAGE DISEASE XI	0.000843882	0.004804685499428395
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.000843882	0.004804685499428395
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.000843882	0.004804685499428395
WAISMAN SYNDROME; WSMN	0.000843882	0.004804685499428395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.000843882	0.004804685499428395
#613668 MICROCEPHALY, POSTNATAL PROGRESSIVE, WITH SEIZURES AND BRAIN ATROPHY	0.000843882	0.004804685499428395
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.000843882	0.004804685499428395
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.000843882	0.004804685499428395
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.000843882	0.004804685499428395
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.000843882	0.004804685499428395
#615401 IMMUNODEFICIENCY 8; IMD8	0.000843882	0.004804685499428395
OROTIC ACIDURIA	0.000843882	0.004804685499428395
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.000843882	0.004804685499428395
WEBB-DATTANI SYNDROME; WEDAS	0.000843882	0.004804685499428395
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.000843882	0.004804685499428395
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.000843882	0.004804685499428395
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.000843882	0.004804685499428395
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.000843882	0.004804685499428395
PYRUVATE CARBOXYLASE DEFICIENCY	0.000843882	0.004804685499428395
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.000843882	0.004804685499428395
CULLER-JONES SYNDROME; CJS	0.000843882	0.004804685499428395
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.000843882	0.004804685499428395
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.000843882	0.004804685499428395
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.000843882	0.004804685499428395
MENTAL RETARDATION, X-LINKED 41	0.000843882	0.004804685499428395
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.000843882	0.004804685499428395
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.000843882	0.004804685499428395
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.000843882	0.004804685499428395
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.000843882	0.004804685499428395
HYPOTONIA-CYSTINURIA SYNDROME	0.000843882	0.004804685499428395
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.000843882	0.004804685499428395
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.000843882	0.004804685499428395
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.000843882	0.004804685499428395
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.000843882	0.004804685499428395
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.000843882	0.004804685499428395
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.000843882	0.004804685499428395
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.000843882	0.004804685499428395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.000843882	0.004804685499428395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.000843882	0.004804685499428395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.000843882	0.004804685499428395
#607208 DRAVET SYNDROME;;EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 6; EIEE6;;SEVERE MYOCLONIC EPILEPSY OF INFANCY; SMEI	0.000843882	0.004804685499428395
METHYLMALONIC ACIDURIA, CBLB TYPE	0.000843882	0.004804685499428395
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.000843882	0.004804685499428395
#614265 COMBINED MALONIC AND METHYLMALONIC ACIDURIA; CMAMMA	0.000843882	0.004804685499428395
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.000843882	0.004804685499428395
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.000843882	0.004804685499428395
#237300 CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY, HYPERAMMONEMIA DUE TO;;CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY;;CPS I DEFICIENCY	0.000843882	0.004804685499428395
#267000 PERLMAN SYNDROME; PRLMNS;;RENAL HAMARTOMAS, NEPHROBLASTOMATOSIS, AND FETAL GIGANTISM;;NEPHROBLASTOMATOSIS, FETAL ASCITES, MACROSOMIA, AND WILMS TUMOR	0.000843882	0.004804685499428395
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.000843882	0.004804685499428395
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.000843882	0.004804685499428395
JOUBERT SYNDROME 28	0.000843882	0.004804685499428395
METHYLMALONIC ACIDURIA, CBLA TYPE	0.000843882	0.004804685499428395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ic; CDG1C	0.000843882	0.004804685499428395
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.000843882	0.004804685499428395
#608443 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 3; MRT3	0.000843882	0.004804685499428395
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.000843882	0.004804685499428395
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.000843882	0.004804685499428395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.000843882	0.004804685499428395
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.000843882	0.004804685499428395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.000843882	0.004804685499428395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.000843882	0.004804685499428395
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.000843882	0.004804685499428395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.000843882	0.004804685499428395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.000843882	0.004804685499428395
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.000843882	0.004804685499428395
MECKEL SYNDROME 13; MKS13	0.000843882	0.004804685499428395
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.000843882	0.004804685499428395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.000843882	0.004804685499428395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.000843882	0.004804685499428395
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.000843882	0.004804685499428395
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.000843882	0.004804685499428395
#613752 HYPERMETHIONINEMIA WITH S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.000843882	0.004804685499428395
GM2-GANGLIOSIDOSIS, AB VARIANT	0.000843882	0.004804685499428395
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.000843882	0.004804685499428395
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.000843882	0.004804685499428395
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.000843882	0.004804685499428395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.000843882	0.004804685499428395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.000843882	0.004804685499428395
#243500 ISOVALERIC ACIDEMIA; IVA;;ISOVALERIC ACID CoA DEHYDROGENASE DEFICIENCY;;IVD DEFICIENCY	0.000843882	0.004804685499428395
HARTNUP DISORDER	0.000843882	0.004804685499428395
#615278 CARDIOFACIOCUTANEOUS SYNDROME 2; CFC2	0.000843882	0.004804685499428395
ELEJALDE DISEASE	0.000843882	0.004804685499428395
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.000843882	0.004804685499428395
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.000843882	0.004804685499428395
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.000843882	0.004804685499428395
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.000843882	0.004804685499428395
#614483 PORENCEPHALY 2; POREN2	0.000843882	0.004804685499428395
NIEMANN-PICK DISEASE, TYPE A	0.000843882	0.004804685499428395
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.000843882	0.004804685499428395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.000843882	0.004804685499428395
#611718 HYPOMAGNESEMIA 4, RENAL; HOMG4;;HYPOMAGNESEMIA, RENAL, NORMOCALCIURIC	0.000843882	0.004804685499428395
GAUCHER DISEASE, TYPE II	0.000843882	0.004804685499428395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.000843882	0.004804685499428395
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.000843882	0.004804685499428395
CITRULLINEMIA, CLASSIC	0.000843882	0.004804685499428395
JOUBERT SYNDROME 33; JBTS33	0.000843882	0.004804685499428395
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.000843882	0.004804685499428395
JOUBERT SYNDROME 17; JBTS17	0.000843882	0.004804685499428395
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.000843882	0.004804685499428395
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.000843882	0.004804685499428395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.000843882	0.004804685499428395
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.000843882	0.004804685499428395
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.000843882	0.004804685499428395
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.000843882	0.004804685499428395
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.000843882	0.004804685499428395
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.000843882	0.004804685499428395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.000843882	0.004804685499428395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.000843882	0.004804685499428395
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.000843882	0.004804685499428395
#300555 DENT DISEASE 2	0.000843882	0.004804685499428395
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000843882	0.004804685499428395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.000843882	0.004804685499428395
REVESZ SYNDROME	0.000843882	0.004804685499428395
CHROMOSOME 15Q14 DELETION SYNDROME	0.000843882	0.004804685499428395
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.000843882	0.004804685499428395
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.000843882	0.004804685499428395
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.000843882	0.004804685499428395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.000843882	0.004804685499428395
GABA-TRANSAMINASE DEFICIENCY	0.000843882	0.004804685499428395
#300257 DANON DISEASE;;VACUOLAR CARDIOMYOPATHY AND MYOPATHY, X-LINKED;;PSEUDOGLYCOGENOSIS II;;ANTOPOL DISEASE;;LYSOSOMAL GLYCOGEN STORAGE DISEASE WITHOUT ACID MALTASE DEFICIENCY,FORMERLY;;GLYCOGEN STORAGE DISEASE IIb; GSD2B, FORMERLY;;GSD IIb, FORMERLY	0.000843882	0.004804685499428395
#603387 MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME;MPPH;;MEGALENCEPHALY, POLYMICROGYRIA, MEGA CORPUS CALLOSUM SYNDROME;;MEG-PMG-MEGACC SYNDROME;;MEGALENCEPHALY, MEGA CORPUS CALLOSUM, AND COMPLETE LACK OF MOTOR DEVELOPMENT	0.000843882	0.004804685499428395
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.000843882	0.004804685499428395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iu; CDG1U	0.000843882	0.004804685499428395
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.000843882	0.004804685499428395
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.000843882	0.004804685499428395
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.000843882	0.004804685499428395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIq; CDG2Q	0.000843882	0.004804685499428395
#614845 NEPHRONOPHTHISIS 15; NPHP15	0.000843882	0.004804685499428395
MENTAL RETARDATION, X-LINKED 88	0.000843882	0.004804685499428395
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.000843882	0.004804685499428395
CHROMOSOME 22q11.2 DELETION SYNDROME, DISTAL	0.000843882	0.004804685499428395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.000843882	0.004804685499428395
#311250 ORNITHINE TRANSCARBAMYLASE DEFICIENCY, HYPERAMMONEMIA DUE TO;;ORNITHINE CARBAMOYLTRANSFERASE DEFICIENCY;;OTC DEFICIENCYVALPROATE SENSITIVITY, INCLUDED	0.000843882	0.004804685499428395
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.000843882	0.004804685499428395
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.000843882	0.004804685499428395
MENTAL RETARDATION, X-LINKED 72	0.000843882	0.004804685499428395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.000843882	0.004804685499428395
MELANOSIS, NEUROCUTANEOUS; NCMS	0.000843882	0.004804685499428395
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.000843882	0.004804685499428395
#121200 SEIZURES, BENIGN FAMILIAL NEONATAL, 1; BFNS1EPILEPSY, BENIGN NEONATAL, 1, AND/OR MYOKYMIA, INCLUDED;;SEIZURES, BENIGN FAMILIAL NEONATAL, 1, AND/OR MYOKYMIA, INCLUDED	0.000843882	0.004804685499428395
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.000843882	0.004804685499428395
SCHINDLER DISEASE, TYPE I	0.000843882	0.004804685499428395
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.000843882	0.004804685499428395
#607694 LEUKODYSTROPHY, HYPOMYELINATING, 7, WITH OR WITHOUT OLIGODONTIA AND/ORHYPOGONADOTROPIC HYPOGONADISM; HLD7;;LEUKOENCEPHALOPATHY, HYPOMYELINATING, WITH ATAXIA AND DELAYED DENTITION;;ATAXIA, DELAYED DENTITION, AND HYPOMYELINATION; ADDH;;LEUKODYSTROPHY, HYPOMYELINATING, WITH HYPODONTIA AND HYPOGONADOTROPICHYPOGONADISM;;4H SYNDROME	0.000843882	0.004804685499428395
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.000843882	0.004804685499428395
JOUBERT SYNDROME 15	0.000843882	0.004804685499428395
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.000843882	0.004804685499428395
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.000843882	0.004804685499428395
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.000843882	0.004804685499428395
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.000843882	0.004804685499428395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.000843882	0.004804685499428395
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.000843882	0.004804685499428395
SPINOCEREBELLAR ATAXIA 5; SCA5	0.000843882	0.004804685499428395
SENIOR-LOKEN SYNDROME 9	0.000843882	0.004804685499428395
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.000843882	0.004804685499428395
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.000843882	0.004804685499428395
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.000843882	0.004804685499428395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.000843882	0.004804685499428395
#300123 MENTAL RETARDATION, X-LINKED, WITH PANHYPOPITUITARISMMENTAL RETARDATION, X-LINKED, WITH ISOLATED GROWTH HORMONE DEFICIENCY,INCLUDED; MRGH, INCLUDED	0.000843882	0.004804685499428395
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.000843882	0.004804685499428395
JOUBERT SYNDROME 6	0.000843882	0.004804685499428395
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.000843882	0.004804685499428395
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.000843882	0.004804685499428395
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.000843882	0.004804685499428395
#608804 LEUKODYSTROPHY, HYPOMYELINATING, 2; HLD2;;PELIZAEUS-MERZBACHER-LIKE DISEASE, 1; PMLD1	0.000843882	0.004804685499428395
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.000843882	0.004804685499428395
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.000843882	0.004804685499428395
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.000843882	0.004804685499428395
FOLATE MALABSORPTION, HEREDITARY	0.000843882	0.004804685499428395
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.000843882	0.004804685499428395
BARDET-BIEDL SYNDROME 13; BBS13	0.000843882	0.004804685499428395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.000843882	0.004804685499428395
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.000843882	0.004804685499428395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.000843882	0.004804685499428395
#607454 SPINOCEREBELLAR ATAXIA 21; SCA21	0.000843882	0.004804685499428395
MACROCEPHALY/AUTISM SYNDROME	0.000843882	0.004804685499428395
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.000843882	0.004804685499428395
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.000843882	0.004804685499428395
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 1; CEMCOX1	0.000843882	0.004804685499428395
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.000843882	0.004804685499428395
#613641 CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE B; CMTRIB;;CHARCOT-MARIE-TOOTH NEUROPATHY, RECESSIVE INTERMEDIATE B; RI-CMTB	0.000843882	0.004804685499428395
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.000843882	0.004804685499428395
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.000843882	0.004804685499428395
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.000843882	0.004804685499428395
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.000843882	0.004804685499428395
3-METHYLCROTONYL-CoA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.000843882	0.004804685499428395
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.000843882	0.004804685499428395
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.000843882	0.004804685499428395
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.000843882	0.004804685499428395
#613721 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 11; EIEE11	0.000843882	0.004804685499428395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.000843882	0.004804685499428395
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.000843882	0.004804685499428395
#614213 NEUROPATHY, HEREDITARY SENSORY, TYPE IIC; HSN2C	0.000843882	0.004804685499428395
NIEMANN-PICK DISEASE, TYPE C2	0.000843882	0.004804685499428395
#614582 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 9; COXPD9	0.000843882	0.004804685499428395
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.000843882	0.004804685499428395
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.000843882	0.004804685499428395
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.000843882	0.004804685499428395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.000843882	0.004804685499428395
#226750 KOHLSCHUTTER-TONZ SYNDROME; KTZS;;EPILEPSY AND YELLOW TEETH;;EPILEPSY, DEMENTIA, AND AMELOGENESIS IMPERFECTA;;KOHLSCHUTTER SYNDROME	0.000843882	0.004804685499428395
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.000843882	0.004804685499428395
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.000843882	0.004804685499428395
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.000843882	0.004804685499428395
THANATOPHORIC DYSPLASIA, TYPE I	0.000843882	0.004804685499428395
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.000843882	0.004804685499428395
JOUBERT SYNDROME 27	0.000843882	0.004804685499428395
